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Summary 
The Report on the Drug Situation in Austria drawn up for the European Monitoring Centre for 
Drugs and Drug Addiction and the Federal Ministry for Social Security and Generations of 
Austria (FMSSG) appears annually and addresses the subject of illegal drugs. It gives an 
overview of current developments regarding the political and legal framework, the epidemio-
logical situation and demand reduction interventions in the reporting period 2001/2. Every 
year specific key issues are highlighted; this year demand reduction expenditures on drugs, 
drug and alcohol use among young people as well as social exclusion and reintegration have 
been selected for detailed presentation. 
What are the changes that have occurred regarding the legal,  
political and organisational framework? 
The most important change regarding the legal framework has been the adoption of the 21st 
amendment to the Road Traffic Act, which entered into force as of 1 January 2003 and 
permits obligatory blood tests if impaired ability to drive due to drug influence is suspected. 
The aim of the amendment is to improve the evidence situation with regard to driving under 
the influence of drugs, and in the long run, to reduce the number of road accidents caused 
under the influence of drugs. The adoption of this amendment was preceded by long, contro-
versial debates, in which critics primarily pointed to the problem that the results obtained by 
the available test methods might not be conclusive and also doubted the constitutionality of 
such testing. These aspects will be discussed further by a group of experts convoked by the 
Health Department of the FMSSG to deal with the issue of drugs in road traffic.  
The FMSSG’s Health Department was reorganised in spring 2002. Now drug-related 
competencies have been concentrated and the staff dealing with drug matters has been 
increased. 
The reporting period saw the completion of a major step towards the advancement of the 
drug policy framework at the provincial level. By now all nine provinces have employed 
Addiction Coordinators or Drug Coordinators and drawn up addiction or drug plans. In 
January 2002 Styria appointed an Addiction Coordinator. The Provincial Government of 
Burgenland adopted the drug plan of the province early in 2002, which is seen as a flexible 
guideline with regard to drug policy interventions at the provincial level. The addiction and 
drug plan of Upper Austria has been prepared in its draft version and will serve as a frame-
work plan for coordinated strategies and interventions. The draft of Vorarlberg’s drug plan 
further develops the existing drug plan and in particular aims at an improvement of net-
working with regard to services provided. The other provinces were implementing their 
addiction or drug plans adopted in the last few years. Generally speaking the trend towards a 
comprehensive approach to addiction problems, taking into account both legal and illegal 
substances, has been continued at the provincial level. 
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What are the characteristics of the drug situation in Austria? 
The available data on the drug situation and assessments by experts do not indicate relevant 
changes, while a number of the trends emerging last year have been confirmed. Recent 
consumption studies show high prevalence rates especially among adolescents and young 
adults. Experience of cannabis use is indicated by at least one third of the young adults 
interviewed, and a few studies even give markedly higher percentages. For the first time in 
many years biogenic drugs (mushrooms, cacti etc.) and poppers (solvents, gas etc.) have 
also been included in the surveys, and in line with reports by experts provided last year high 
prevalence rates of up to 20% were found. Experience of party drugs (in particular ecstasy), 
stimulating substances (such as amphetamines and cocaine) and especially opiates was 
indicated far less often on an average. What applies to all substances is that the prevalence 
rates tend to fall considerably in the case of use in the past year or past 30 days. So it may 
be concluded that drug consumption is often limited to experimental use at a certain phase in 
life. Therefore reports of rising poly-drug use and lack of risk awareness among young 
people rather than the increase in prevalence rates give rise to concern. 
On the whole the situation concerning problem drug use is regarded as stable. Increases are 
found only in a few, mostly rural, regions. This indicates that the levelling-out process of 
regional differences has not yet been completed. So far the increase in experience of drug 
use among young people has not led to rising numbers of young problem drug users. What 
has been reported however is that some of the young people who are addicted to drugs or in 
danger of becoming addicts have serious social and psychological problems. Parallel to this 
recent data confirms the trend towards a rise in average age of the established drug scene. 
Regarding a suspected trend towards stimulating substances in the context of poly-drug use 
the available information is contradictory. The number of drug-related deaths has markedly 
gone down in 2001 compared to the year before (2001: 184 cases; 2000: 227 cases) and 
has thus again reached the level of 1999 (174 persons). 139 deaths (in 2000: 167) were 
caused by intoxications and thus directly related to drug use. 
Which health policy measures have been taken to tackle the drug 
problem? 
Regarding health policy measures the activities that were initiated in the past few years have 
been advanced and in some cases also intensified. In the context of implementing their drug 
or addiction plans the provinces also drew up a number of new programmes which further 
diversify the available drug help services. For instance, the draft of Vorarlberg’s drug plan, as 
a response to recent epidemiological trends, includes specific services for chronic addicts 
with multiple problems, inpatient cocaine treatment and additional inpatient substitution treat-
ment options. Many provinces (e.g. Carinthia, Lower Austria, Styria and Upper Austria) plan 
a step-by-step expansion of their drug help systems to provide services tailored to meet 
actual demands and needs. Specific attention is paid to networking structures of the indivi-
dual facilities so that counselling and treatment may be organised as effectively and 
smoothly as possible. 
Health policy measures aimed at the target group of young people in danger of becoming 
addicted continue to play a central role: secondary prevention and in particular outreach 
services are being expanded, with the focus placed on integrated approaches. The rising im-
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portance of secondary prevention is also reflected in the funding practices of the Federal 
Government. The fact that quality assurance is regarded as essential shows in a rising 
number of evaluations, evaluation studies and quality management projects carried out for 
the individual drug help centres. Both the federal and the provincial governments encourage 
the adoption of specific guidelines and provide financial support for (further) education and 
training schemes. 
Key issue: Demand reduction expenditures on drugs in 1999 
Apart from a study on the situation in 1997, no data for Austria regarding demand reduction 
expenditures on drugs have been available, so ÖBIG specifically conducted a survey on this 
issue, including both the most important financing sources (federal, provincial and local 
governments, social insurance funds, Public Employment Service, Healthy Austria Fund) and 
a sample of prevention facilities and drug-help centres. In addition in some fields where a 
direct survey was difficult (e.g. substitution treatment or drug-related treatment in hospitals) 
the corresponding expenditures were estimated on the basis of available data. 
Austria’s total expenditures on drug-related demand reduction are estimated to have 
amounted to roughly EUR 60 million in 1999 and about EUR 67 million in 2001. More than 
75% of the funds are used for counselling, care and treatment, while other fields of inter-
vention such as primary prevention, outreach services, harm reduction or reintegration tend 
to play a minor role. Most of the funding is provided by the provinces (approx. 40%), followed 
by health insurance funds (approx. 20%) and the Federal Government (approx. 15%). More 
than two thirds of the expenditure of specialised facilities (addiction prevention and drug help 
centres) is accounted for by staffing costs, in particular for staff working with clients. 
Key issue: Drug and alcohol use among young people aged 12-18 
In Austria there are three groups of young drug users. Young people involved in experimen-
tal drug use constitute by far the largest group. An overview of various surveys among ado-
lescents and at schools shows a rise in lifetime experience of illicit drugs among young 
people. Cannabis continues to be most relevant, followed by party drugs. According to recent 
studies, there are high prevalence rates for biogenic drugs and poppers, which are not 
classified as illicit drugs, but are also included among the targets of prevention efforts. The 
second, much smaller, group is young people who experiment with a variety of substances 
over a longer period of time. Several non-representative surveys have shown high preva-
lence rates for various substances in certain youth cultures. The smallest group is young 
people whose use of illicit substances is regarded as problematic. In general their number is 
considered to be stable, only in some, mostly rural, areas an increase has been registered. 
In this group of young problem drug users or drug addicts massive social and psychological 
problems as well as health consequences of drug use are found. It is remarkable that the 
gender distribution is balanced in this group, and in some scenes there are even more young 
women than men involved, while among adult addicts men have a clear majority.  
Young people are an important target group in all fields of demand reduction. In the last few 
years secondary prevention measures have been highlighted, with a special focus placed on 
outreach work, in the sense of getting into contact with young people in danger of becoming 
addicted. Furthermore integrative approaches have been attributed special importance. 
 VI 
Services relating specifically to young people can also be found in the field of treatment and 
social (re)integration. 
Key issue: Social exclusion and reintegration 
The relations between drug use and social exclusion are diverse and complex, and this 
phenomenon almost exclusively concerns problem drug users and addicts. The majority of 
drug users - especially experimental or occasional users - are socially integrated, however.  
Social exclusion constitutes an important risk factor for problem drug use. It should be noted 
though that in the discussion of drug problems and addiction forming one should not point to 
individual risk factors, as an accumulation of problem situations along with a simultaneous 
lack of resources (protective factors) is decisive here. Concrete data on social exclusion as a 
cause of (problem) drug use is lacking in Austria. However a great number of reports and 
surveys have investigated the social consequences of drug use. They mainly refer to the 
drug scene and to clients of drug help facilities, i.e. mostly long-term drug addicts. In this 
group, social exclusion is encountered at many levels. Unemployment, inadequate education 
and training, homelessness, high debts, insufficient access to medical care and social bene-
fits, delinquency and marginalisation are among the gravest social problems of drug addicts.  
Accordingly social (re)integration measures for drug addicts and problem drug users are 
strongly focused on those areas. In the course of withdrawal treatment special attention is 
paid to improving the job qualification of clients. Other fields of activity include occupation 
and housing. The programmes developed over the last few years have increasingly been 
addressed to persons who already are addicted, rather than being limited to after-care 
following drug-free therapy. As has been shown on evaluation, the programmes have pro-
moted social integration, which is recognised as an important motive for stable drug use and, 
going one step further, for abstinence.  
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Introduction 
This is the 7th time the REITOX Focal Point at the Austrian Health Institute (ÖBIG) presents 
its annual Report on the Drug Situation drawn up for the European Monitoring Agency for 
Drugs and Drug Addiction (EMCDDA) and the Austrian Federal Ministry for Social Security 
and Generations (FMSSG). 
The Report on the Drug Situation in Austria deals with illicit drugs and serves both as a 
national report covering the situation in Austria and as Austria’s contribution to describing the 
drug situation in the European Union. Similar reports are submitted by the REITOX Focal 
Points in all EU member states according to a structure defined by the EMCDDA. They form 
the central basis of the EMCDDA’s Annual report on the state of the drugs problem in the 
European Union (latest publication: EMCDDA 2001). 
This year’s report follows the structure of last year in most points. The first three parts deal 
with current developments and trends concerning the drug policy framework, the epidemio-
logical situation and health policy interventions aiming at demand reduction. These parts 
refer to the reporting period from summer 2001 to summer 2002, while the routine statistics 
refer to the year 2001. As these chapters are based on the previous reports (latest report: 
ÖBIG 2001a), they have been kept concise deliberately. Part 4 gives a detailed presentation 
of selected key issues, which in the present report deals with demand reduction expenditures 
on drugs, drug and alcohol use among young people as well as social exclusion and 
reintegration. In addition the annex includes a number of tables, figures and maps with de-
tailed information and data as well as an overview of major sources of information and drug 
monitoring systems in Austria. 
This report is based on many different data and information communicated to ÖBIG by 
various experts in the field of drugs. In this respect, the reports on the drug situation in the in-
dividual Austrian provinces drawn up by the Drug Coordinators and Addiction Coordinators 
have been especially significant. In addition a number of experts have provided background 
information and specific data for individual chapters of this report (cf. key issues). We would 
like to express our gratitude for their cooperation. 
We are especially indebted to the members of the advisory working group of the REITOX 
Focal Point Austria, Mr Peter Hacker (Drug Coordinator of the City of Vienna and Provincial 
Representative), Ms Brigitte Magistris (FMSSG), Ms Helga Oberarzbacher (Addiction 
Coordinator of the Tyrol and Provincial Representative), Mr Franz Pietsch (Federal Drug 
Coordinator and head of the Federal Drug Coordination), Mr Robert Scharinger (FMSSG), 
Ms Johanna Schopper (head of the Drugs Department at the FMSSG) and Mr Wolfgang 
Werdenich (FMJ), whose comments and complements to this report have been most helpful. 

  
 
 
 
Part 1 
National Strategies:  
Institutional and Legal 
Framework
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1 Developments in Drug Policy and Responses  
1.1 Political framework in the drug field 
In the reporting period a number of ministries concerned with drugs affairs at the federal 
level were restructured. The reorganisation of the Federal Ministry for Social Security and 
Generations (FMSSG) resulted in a concentration of drug competences of the Health 
Department in one division, whose staff was increased. This also was a response to criticism 
by the Court of Audit regarding insufficient staff working in the field of drugs. And for the first 
time staff resources were specifically dedicated to federal drug coordination activities. In the 
Ministry of the Interior it was decided to set up a Federal Criminal Agency, which will also 
include the former Central Unit for Fighting Drug Delinquency. 
The FMSSG’s focus of activities in the reporting period was to advance and improve drug-
related monitoring. Cooperation with the EU candidate members has played an increasingly 
important role: Austria is a partner in PHARE Twinning projects with the Czech Republic and 
Slovenia. Apart from the FMSSG and ÖBIG as the main responsible actors other Federal 
Ministries (Interior, Justice) and a number of Provinces (Upper Austria, Vienna) also co-
operate in this field. Furthermore the FMSSG organised a Ministers’ Conference held in 
Graz, Styria, in September 2002, dealing with the theme of young people, addiction and 
health. The participants included the Ministers of Health and of Youth of Croatia, the Czech 
Republic, Hungary, Poland, Slovakia and Slovenia. The aim of the Conference was to create 
a basis for future cooperation in the field of addiction prevention. 
At the provincial level the reporting period saw the completion of a major step towards 
advancing the drug policy framework. In Styria the Addiction Coordination was established 
as a staff position in the Provincial Sanitary Direction and as of January 2002 an Addiction 
Coordinator has been employed. An addiction advisory board was also nominated. In 
Burgenland and Upper Austria, drug plans were drawn up, and in Vorarlberg the drug plan of 
1991 was amended and further developed. By now all nine provinces have employed 
Addiction Coordinators or Drug Coordinators and drawn up addiction or drug plans. 
On the whole the trend towards a comprehensive approach to addiction problems has been 
continued and intensified. The Drug Coordinator of Styria is competent for all drug matters. 
The addiction plans of Burgenland and Upper Austria also relate both to legal and illicit 
substances. In summer 2001 the Drug and Addiction Coordinator of Upper Austria also took 
over the field of alcohol-related counselling measures. Vienna saw an expansion of activities 
in spring 2002, when the Vienna Social Fund (cf. ÖBIG 2001a) was given competences for 
general health promotion as well. And in the Tyrol now two persons work as Addiction Co-
ordinators (cf. ÖBIG 2001a) and have become responsible also for alcohol-related activities. 
The new drug or addiction plans are based on the established principles of Austria’s drug 
policy and oriented at common denominators in the plans of the Provinces (for more details 
see ÖBIG 2000). Adopted by the Provincial Government in January 2002, the addiction plan 
of Burgenland is intended as a set of flexible guidelines to be adapted to the actual situation 
with regard to drug policy interventions in the province (Amt der Burgenländischen Landes-
regierung 2002). The addiction and drug plan of Upper Austria has been drafted and will 
g y
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serve as a framework plan for coordinated strategies and interventions to tackle the complex 
problem of addiction and drugs. The draft of Vorarlberg’s drug plan of 2002 prioritises the 
improvement of cooperation and networking in order to prevent a fragmentation of the 
relevant interventions and to provide a good combination of the whole range of available 
services. The three plans stress the principle of integrated drug and addiction policies aimed 
at preventing discrimination and stigmatisation on the one hand and integrating the relevant 
measures in the field of general health and social policies on the other (cf. also chapters 8.1 
and 16). 
The other provinces were implementing their drug or addiction plans in the reporting period 
(cf. ÖBIG 2001a). Lower Austria prepared a report on the implementation of interventions re-
garding prevention, counselling, treatment and integration as proposed in the addiction plan 
(cf. also Part 3), and in summer 2002 it was presented to the competent politicians at the 
provincial level. In Carinthia the focus of interventions based on the framework plan on 
addiction prevention and drug help has been placed on expanding the services of primary 
and secondary prevention as well as establishing a drug outpatient clinic. Salzburg has al-
most completed the structural measures laid down in the drug plan of 1999 (networking and 
cooperation structures; monitoring). A list of measures to be implemented was drawn up on 
behalf of the Provincial Parliament and will be discussed by the political actors in the next 
few months. Vienna has placed the focus of practical implementation on labour policy inter-
ventions on the one hand (cf. also chapters 11 and 16) and on prevention activities at the 
district level on the other. 
In all provinces the issues of drugs and addiction continue to be of great political relevance. 
In spring 2001 the Provincial Parliament of Upper Austria adopted its 11th health care target: 
by 2005 at least 80% of the young people and at least 50% of the total population of Upper 
Austria shall have received profound information about the consequences of drug use. To 
achieve this it was decided to draw up the addiction and drug plan of Upper Austria (see 
above) and as a first step the corresponding prevention activities were intensified. In Salz-
burg the Provincial Parliament held a special meeting on drugs (cf. chapter 1.4), and in Styria 
it scheduled a hearing on addiction.  
The trend towards an expansion of the organisational framework at the regional level and to-
wards networking, which has already been reported last year (cf. also chapter 8) has further 
intensified. Vienna has promoted regional platforms and networking meetings of the drug 
help centres at the district level. In Salzburg regional addiction preventing networks have 
been established. By the end of 2001 in six districts of the Tyrol groups aimed at promoting 
networking structures of organisations concerned with young persons and drugs were 
established. Carinthia established a drug forum at the provincial level integrating many actors 
in the field of health and social policy as well as criminal prosecution. In addition a number of 
districts saw the foundation of platforms on addiction prevention initiated by regional actors. 
Promotion of networking structures also plays a central role in the new drug plan of Vorarl-
berg. 
Abbildung 1.1Organisational structure of the drug sector in Austria (overview) 
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1.2 Legal framework 
Although the drug-related laws have not changed in the reporting period, there are a number 
of decisions and bills relevant for drug issues. 
At present amendments to the Decrees on Narcotic Substances, on Limit Quantities, on Psy-
chotropic Substances and on Psychotropic Limit Quantities are under preparation, which is a 
consequence of the inclusion in the list of controlled substances under the Narcotic 
Substances Act (NSA) of 2C-B, GHB and Zolpidem (implementation of the decisions of the 
44th Commission on Narcotic Drugs) as well as PMMA (implementation of the decision by 
the EU Council of February 2002). The pertinent examinations were carried out in spring 
2002, and implementation is planned for autumn. 
Early in July 2002 the Austrian Parliament adopted the 21st amendment to the Road Traffic 
Act: as of 1 January 2003 blood tests may be made if impaired ability to drive due to drug in-
fluence is suspected (Federal Collection of Statutes BGBl. I No. 128/2002). The primary aim 
of the amendment is to improve the evidence situation with regard to driving under the 
influence of drugs, and in the long run, to reduce the number of road accidents caused under 
the influence of drugs. If impaired ability to drive due to drug influence is found the eventual 
sanctions, and also the consequences if testing is refused, correspond to the regulations 
concerning alcohol. This decision marks the end of a long and highly controversial debate on 
drug tests for drivers started last year already (cf. ÖBIG 2001a). Critics primarily pointed to 
the problem that the results obtained by the available test methods might not be conclusive 
and also doubted the constitutionality of such testing. In this context the Vienna Social Fund 
carried out an expert survey in spring 2002, which showed that a strong majority of the 
experts interviewed said that the available tests (of urine, blood and saliva) could not be used 
to find out at which exact time a substance was taken, which quantities were consumed and 
whether the fitness to drive was thus impaired (FSW 2002a). In June 2002 the Innsbruck 
University Hospital of Psychiatry and the Tyrolean Chamber of Pharmacists organised a 
symposium on medicines and drugs in road traffic, where experts again expressed doubts 
and the Health State Secretary announced that an expert group would be established to 
discuss the points that had not yet been settled. This FMSSG expert group on drugs in road 
traffic held its first meeting in September 2002 and will discuss problems regarding the actual 
usefulness of the available tests, among other issues. The Vienna Drug Advisory Board also 
nominated a working group dealing with the themes of epidemiology and ways of determi-
ning the fitness to drive. 
In addition the reporting period saw a new discussion of the plan to amend the Driving 
Licences Health Decree (cf. ÖBIG 1999). Experts had repeatedly pointed out that having a 
driving licence was important for reintegrating former drug patients into the labour market, 
and demanded that corresponding regulations be adopted. Another aspect relevant for the 
issue of drugs is the plan to reform of the Code of Criminal Procedure, which was presented 
and discussed in spring 2002. Both plans are still in the discussion or examination stages. 
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1.3 Laws implementation 
In autumn 2001 Austria’s implementation of drug-related United Nations conventions was 
reviewed by representatives of the International Narcotics Control Board (INCB). The INCB’s 
assessment communicated in spring 2002 was very positive and recommended to maintain 
the time-tested balance of health and social policy interventions on the one hand and 
criminal prosecution on the other. 
At the Austrian level another issue raised in the reporting period was problems regarding the 
implementation of the examinations concerning necessary health-related measures accor-
ding to Art. 11 of the NSA. Although the official approach is to focus on (organised) drug 
trafficking as far as repression is concerned, a very large number of reports to the police still 
refers to drug users, and almost exclusively to cannabis (cf. also chapter 4.2). On the other 
hand the district health authorities (public health officers), who are in charge of indirect fe-
deral administration, prescribe obligatory health-related measures in most cases, which 
results in capacity problems of the drug help centres, who eventually lack resources for 
fulfilling their core tasks. Apart from this the implementing practices regarding Art. 11 of the 
NSA vary according to province: in Burgenland, 75% of the examinations carried out in 2001 
exclusively concerned cannabis, and in 70% of the cases health-related measures were pre-
scribed. Upper Austria saw a case where 300 reports to the police resulted in 230 referrals to 
regional drug centres for counselling and care. Salzburg also reports a strong increase in 
reports to the police, paralleled by frequent referrals to health-related measures, which has 
put considerable strain on the capacities of the drug help centres that were contacted by in-
termittent users of cannabis. On the other hand in Vienna, where as of April 2001 examina-
tions have exclusively been carried out by the new Diagnoses Institute of the Vienna Social 
Fund, health-related measures were recommended only for about 20% of the persons exa-
mined. This is more in line with estimates of Upper Austria according to which such 
measures make sense for those roughly 10% of the drug users who are found to be in at-risk 
situations and for young people under 16. In the future this problem of implementing Art. 11 
of the NSA should be taken into account to a larger extent in the future. 
These discussions touch a central aspect of Austria’s drug policy, as the principle of therapy 
instead of punishment forms a basic tenet acknowledged by all political parties. Based on an 
analysis of developments in Austria’s drug policy in the last few decades, Eisenbach-Stangl 
(2001a, 2001b) points out that Austria’s drug policy has rather been characterised by a pro-
secution-and-treatment approach. While it has been a strong tradition in Austria to regard 
addicts primarily as patients, this approach has been paralleled by a continuous increase of 
prosecution activities by the police, also due to requirements of international agreements. 
1.4 Developments in public attitudes and debates 
Drug-related attitudes were examined in studies conducted in Vienna and Vorarlberg. In 
autumn 2001 Vienna repeated the population survey carried out at regular intervals, with a 
sample of 650 persons over 15. The outcome basically confirms what was found in the 
survey of spring 2001 (FSW/IFES 2002) and described in last year’s report (ÖBIG 2001a). In 
Vorarlberg a representative telephone survey was conducted in spring 2001, for which 2 024 
persons aged between 20 and 59 were interviewed. As in Vienna, the data collected in 
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Vorarlberg indicates general acceptance of a balanced drug policy focusing on health and 
social policy measures. For instance, 86% of the respondents accept the principle of therapy 
instead of punishment for drug addicts (Vienna: 78% in favour of drug prohibition but also of 
decriminalisation of addicts); 77% approve of substitution treatment and 91% say prevention 
funds should be raised. As Austria is a neighbouring country to Switzerland, where such 
measures have already been implemented, attitudes towards liberalising cannabis use (for 
persons over 18) and prescription of heroin in medical contexts are of special interest. Both 
measures are approved of by roughly one third of the respondents in Vorarlberg (Vienna: 
24% in favour of hashish liberalisation). Pronounced differences according to educational 
level and occupation were found for all questions: persons with higher education levels and 
trainees generally adopt more liberal positions with regard to drug policy (Institut für Sucht-
forschung 2001). 
In the reporting period a central issue of political discussion, and also media coverage, was 
drug testing for drivers (cf. chapter 1.2) on the one hand and public safety in the context of 
drugs on the other. In spring 2001 the Austrian Freedom Party (FPÖ) started a neighbour-
hood watch in Graz, Styria, to maintain public safety and order, which its initiators justified in 
particular by the need to protect young persons from drug dealers. This project was criticised 
even by some members of the Freedom Party but also backed by a few local FPÖ organi-
sations. The debate of this issue was highly controversial and emotional while its implemen-
tation was slack and short-termed. Other provinces also report heated drug policy debates. 
In Salzburg, as a result of intensified police action, the number of reports sharply rose, which 
in turn led to extensive media coverage. This also gave rise to a special meeting of the Pro-
vincial Parliament held in December 2001. In the city of Salzburg the local political actors re-
fused an additional syringe vending machine, on grounds of safety. In Vienna the issue of 
public safety and order in connection with drugs – usually with regard to specific meeting 
places of the drug scene – was repeatedly raised as well, also by the media. 
Drug experts as well as the competent Drug and Addiction Coordinators point to the strong 
discrepancy between empirical data and subjective descriptions, which sometimes is also 
contrary to how the public sees the situation. For instance only 1.3% of the respondents in 
Vorarlberg (see above) said they felt disturbed by drug addicts, while 89% indicated that they 
did not, and the rest felt inconvenienced rarely or only at times. The Federal Drug Coordi-
nation of the FMSSG, however, points out that intensified repressive interventions have re-
peatedly been demanded in meetings, with reference to the safety needs of the population. 
This discrepancy between empirical data and both public and political discussion is no 
surprise, however, if one considers that drug policy (cf. Eisenbach-Stangl 2001b) may be re-
garded as symbolic to a rather large extent. Controversial attitudes on drugs, as surface phe-
nomena, often reflect large and small conflicts whose origins have nothing to do with psycho-
active substances. In the 1990s, in addition to the generation conflicts of former decades, 
drug attitudes have increasingly often become an expression of globalisation conflicts in the 
form of conflicts with foreign persons and influences. This is reflected in the fact that 
discussions of public safety are often linked with images of foreigners as drug dealers. 
The discussion of political approaches to cannabis was continued in the reporting period. 
The Federal Government is opposed to a liberalisation of cannabis, especially with reference 
to possible health hazards of cannabis use, while drug experts point out that the statutory 
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status of cannabis as an illicit substance is no longer accepted by many adolescents and 
young adults. According to the survey in Vorarlberg mentioned above 63% of the students 
and trainees, and between 40% and 45% of the young adults, high school graduates and 
university graduates are against punishment in cases of cannabis use by persons over 18. In 
another study conducted in Graz, Styria (cf. chapter 2.2), the majority of the respondents 
between 12 and 25 were in favour of hashish legalisation (X-Sample 2002). Experts are con-
cerned that the strong differences between the legal situation on the one hand and the every-
day attitude of the population might reduce the credibility of the drug policy pursued. 
1.5 Budget and funding arrangements in 2001 
With regard to this year’s key issue on demand reduction expenditures, ÖBIG conducted a 
survey for the years 1999 and 2001. The results and a detailed presentation of funding 
arrangements are given in key issues chapter 14. 
The funding arrangements basically have not changed. In the Tyrol remuneration negotia-
tions are under way concerning payment of physicians for specific medical counselling for 
drug patients, which Vienna introduced a few years ago already (cf. ÖBIG 1999). This means 
that treatment of drug patients by established doctors will be specifically remunerated by the 
health insurance fund of the province in question. In the last few years a number of provincial 
funding guidelines aimed at improved transparency and quality assurance were defined (e.g. 
in Vienna; and under preparation in Styria). 
Especially in those provinces where new interventions were planned in the context of the im-
plementation of drug or addiction plans the drug-related budgets were considerably in-
creased. For instance Lower Austria’s 2002 budget includes funds amounting to almost 
EUR 3.3 million, which is more than 10% above the budget of 2001 and more than 40% 
higher than in 2000. In the Tyrol the available funds were markedly increased in 2001 in the 
context of the general restructuring of drug and alcohol counselling throughout the province. 
Rough estimates show that Carinthia will face costs of approximately EUR 2.35 million in 
2004, when the framework plan on addiction prevention and drug help will be fully implemen-
ted, while the corresponding budget of 2000 was EUR 650 000. In the next few years Upper 
Austria would have to double its present expenditures of roughly EUR 3.6 million if the plans 
in connection with the 11th health care target (see above) and its addiction and drug plan 
were fully implemented. For the first stage an additional sum of EUR 360 000 has been 
appropriated for prevention in 2002. 
  
  
 
 
 
 
 
Part 2 
Epidemiological  
Situation 
  
 15
2 Prevalence, Patterns and Developments 
 in Drug Use 
2.1 Main developments and emerging trends 
Recent data and reports on prevalence and patterns of drug use in Austria do not indicate 
relevant changes compared to the previous year and mainly confirm the trends described 
then. 
The results of the studies on experience of drug use in the population (cf. chapter 2.2) show 
that, as in previous years, levels of lifetime experience of illicit drugs are high especially 
among adolescents and young adults. Again, this in particular applies to cannabis as the 
drug by far most frequently used. The two youth studies for the first time provide concrete 
data confirming the relevance of biogenic drugs (such as mushrooms, cacti or Solanaceae), 
which have also become an issue in other provinces. High prevalence rates are also found 
for poppers (solvents, gas etc.). A few provinces have registered an increase in poly-drug 
use among young people. Different to previous years, however, no specific link to the rave 
scene has been found (cf. chapter 15). On the whole the experience of the last few years has 
been confirmed: drug use among young persons tends to be a problem no longer restricted 
to urban areas and typical regions. 
At the same time estimates say that the (quantitative) situation regarding problem drug use in 
general continues to be stable. This does not mean however that the drug situation might not 
have worsened in specific regions. The number of young addicts or young people in danger 
of becoming addicted do not seem to have changed significantly, but on the other hand the 
social and psychological situation of the persons concerned is regarded as highly proble-
matic in some cases (cf. chapter 15). This is paralleled by other reports stating that the 
established drug scene is ageing, which poses new challenges to health policy interventions. 
One trend showing last year, namely that amphetamines seem to be on the rise while heroin 
plays a less central role, cannot be confirmed by consistent data. There are indications 
pointing to this but there are also other data according to which the situation regarding sub-
stances preferred by drug users has hardly changed. 
2.2 Drug use in the population 
Regarding experience of illicit drugs in the population the results of four regional population 
surveys are available for the reporting period: two surveys cover the whole population and 
two refer to young people. In addition other provinces have provided complementing reports 
based on estimates by experts and experience made by drug help centres. 
In autumn 2001 Vienna repeated its population survey conducted every two years since 
1993, with a sample of 650 persons over 15 (cf. chapter 1.4 and FSW/IFES 2002). A com-
parison of the results obtained over time shows that experience of cannabis has risen while 
all other substances have remained at levels between 1% and 2% (cf. figure 2.1 and table A1 
in annex B). 
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Figure 2.1: Lifetime experience of illicit substances among the population of Vienna from 1993 to 
2001; percentages 
 
Source: Vienna Social Fund; IFES Institute for Empirical Research (FSW/IFES 2002) 
The age group between 15 and 29 report above-average levels for experience of cannabis 
(lifetime prevalence: 31%; past 3 years: 24%; past 30 days: 6%). Regarding other 
substances prevalence rates are considerably lower, however (lifetime prevalence: ecstasy: 
2%; amphetamines: 3%; cocaine: 2%; opiates: 1%). Compared to 1999 and 2001 no relevant 
differences have been found. 
In the context of the representative telephone survey conducted in Vorarlberg in spring 2001, 
2 024 persons aged between 20 and 59 (cf. chapter 1.4) were also interviewed about use of 
illicit drugs among their friends as well as their own experience of illicit drugs (Institut für 
Suchtforschung 2001). About 20% of the respondents said they had already used illicit drugs 
themselves. The questions concerning drug use among their friends were more specific: 
42% are acquainted with cannabis users, 19% with ecstasy users; 15% with cocaine users, 
13% with heroin users and 12% with users of biogenic drugs. Significant differences 
according to gender and age are found for all substances except heroin: males and young 
adults (between 20 and 29 years) report drug use among their friends more often than the 
average. 
In Graz a representative study was carried out with a sample of 515 adolescents and young 
adults between 12 and 25 (X-Sample 2002). Here high prevalence rates were found re-
garding both lifetime experience and use in the previous year. 58.2% said they had already 
used cannabis (12-months prevalence: 36.7%), with percentages for party drugs of 15.4% 
(6.1%); for cocaine: 7.3% (1.4%); for speed: 6.0% (1.8%); for hallucinogens: 7.2% (3.2) and 
for opiates: 4.9% (1.4%).This study also gives high percentages regarding biogenic drugs 
(lifetime prevalence: 21.1%; 12-months prevalence: 11.1%) and poppers (9.2% and 1.1%, 
respectively). These rather high prevalence rates are explained by the design of the study, 
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which attributed great importance to confidence-building and assuring the respondents of 
anonymity. Compared to the results of school surveys (see below) one has to bear in mind 
that the setting of the survey may have great relevance and that prevalence rates reach peak 
values among young adults (cf. also chapter 15.1). 
Key issues chapter 15 gives a more detailed description of drug trends among young people, 
therefore only the most important information is presented here. In the school survey of 
Burgenland (cf. chapter 15.1), with a total number of 1 078 respondents aged between 12 
and 19, drug experience was primarily indicated for cannabis (20%), poppers (20%) and 
biogenic drugs (8%) (Schönfeldinger 2002). According to the HBSC survey of 2001 (cf. 
chapter 15.1) 14% out of a total number of 1 292 15-year old school children indicate 
experience of cannabis (Dür und Mravlag 2002). 
In the context of the ChEckiT! project, which deals with secondary prevention in the form of 
tablet testing during raves, the consumption patterns of ravers were again surveyed in 2001 
(Ivan und Schmid 2002). The prevalence of use indicated by a total number of 199 respon-
dents for the past 30 days again was very high for many substances (cannabis: 56%; 
ecstasy: 42%; speed: 24%; cocaine: 16%). One should take into account, however, that 
these figures are not representative, neither for adolescents or young adults in general nor 
for ravers. They relate to a group known for high consumption rates, and primarily serve as a 
basis for planning and coordinating secondary prevention measures. What is interesting in 
this context is that the levels for new synthetic substances are rather low: 2% for GHB, 1% 
for ketamine and 0% for 2C-B. The insignificant role these substances play – even in the 
rave scene – is confirmed by a specific GHB survey ChEckiT! conducted in summer and 
autumn 2001, for which 175 ravers were interviewed. Approximately 6% of the respondents 
said they had already taken GHB but only 2 persons indicated having used this substance 
more than once (ChEckiT! 2001). Biogenic drugs seem to be popular also among ravers 
however: 16% out of the 199 persons interviewed in 2001 said they had consumed mush-
rooms in the past 30 days, and 7 percent indicated use of so-called natural drugs. 
On the basis of estimates by experts and practical experience many provinces confirm that 
weekend and sparetime use in particular of illicit drugs tends to be increasingly important for 
adolescents and young adults. This especially applies to cannabis, however a number of 
drug users also take other substances in addition to cannabis, in particular ecstasy and 
amphetamines. Biogenic drugs and poppers are also rising in importance (cf. above), how-
ever one should not forget that the increase in drug use found among young people is mostly 
limited to experimental use and sparetime consumption at a certain phase in life. Only a 
small percentage of the young people develop patterns of problem drug use (cf. chapters 2.3 
and 15.1). Still, the political actors attribute great importance to this development. The main 
response to this situation has been the extension of secondary prevention and outreach work 
for the target group of young people (cf. chapters 9, 10 and 15.3). 
The Federal Ministry of Defence reports a rise in the last few years of conscripts prematurely 
dismissed from compulsory military service because of repeated drug incidents. To tackle 
this problem a working group was established and specific measures were taken (cf. chapter 
9). 
g 18 
In the reporting period use of Pervitin was also found. Pervitin (Vint, Shirka) is a metamphe-
tamine coming from the Czech Republic, which Upper Austrian young people bought in 
Bavaria under the name of Fliegersalz. No other new substances have been reported to play 
a relevant role in Austria. 
2.3 Problem drug use 
Here, the term problem drug use means that hard drugs (in particular opiates and cocaine) 
are used frequently, which is often accompanied by dependence and consequences for the 
health, social and legal situation (cf. chapters 3, 4 and 16). 
In Austria scientific estimates of the prevalence of problem drug use are available only for 
opiates. At present ÖBIG, in its function as REITOX Focal Point, is updating the methodolo-
gical pilot study providing an estimate of the number of problem opiate users for the period of 
1994/5 (cf. ÖBIG 2000). Initial results are available for the 2-sample capture-recapture 
method (substitution treatment and reports to the police). Consistency checks and further 
analyses based on the 3-sample capture-recapture method have not yet been completed. 
Preliminary estimates suggest that in 1999 there were 17 801 problem drug users in Austria 
(1994/5: 17 276), and 10 185 in Vienna (1994/5: 10 953). According to estimates taking 
gender into account, 74% of this group are men and 26% are women (1994/5: 70% and 
30%), and broken down by age groups the percentages are 25% (15 to 24 years), 40% (25 
to 34 years) and 35% (35 to 64 years) (1994/5: 25%; 50%; 25%). The available results of 
estimates indicate that a prevalence rate between 15 000 and 20 000 problem opiate users 
seems realistic for Austria. So the estimated overall number of problem opiate users has not 
changed compared to 1994/5, while the percentage of older opiate addicts has risen, which 
obviously reflects the trend towards a rise in average age of members of the established 
drug scene. More detailed information cannot be given before further analyses have been 
completed. 
Most provinces indicate that problem use of illicit drugs is estimated to be stable. This contra-
dicts public presentation and media coverage, which often give a very dramatic picture (cf. 
chapter 1.4). For instance, Salzburg reports that, different to fears expressed in public 
discussion, routine data provided by drug help centres do not indicate major changes in the 
situation. Although sparetime use of illicit drugs has risen among young people in the last few 
years, this has effects on problem use qualitatively rather than with regard to quantities (cf. 
also chapter 15). In the Tyrol and Salzburg a trend towards rising poly-drug use among 
young people has shown, and users seem to lack awareness of the risks involved. In spring 
the Vienna Drug Advisory Board discussed the drug situation of young people. Based on 
reports by experts it was concluded that although no quantitative increases can be found in 
this field, the affected young people often have very serious social and psychological pro-
blems (including psychiatric comorbidity; cf. chapter 3.4) and therefore need intensive, 
specified counselling (cf. chapters 8.2 and 15). 
Regarding preferred substances there is some evidence confirming the trend towards stimu-
lating drugs observed last year, and indications that heroin tends to be replaced by other 
opiates. In Salzburg opiate use has decreased in importance as a reason for clients to 
contact drug help centres. Vorarlberg reports a rising relevance of stimulating substances. 
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According to the low-threshold centre Substanz of Linz, Upper Austria, their addicted clients 
often indicate opioids as their primary drugs, which they explain by difficult access to heroin, 
among other reasons (Substanz 2002). On the other hand, the new annual report of the 
therapy community Grüner Kreis (Grüner Kreis 2002) says that the patterns of use of its 
clients have not changed and that heroin continues to be of central importance. So there is 
no unambiguous evidence of a clear trend (cf. also chapter 6). However multi-drug patterns 
of use undoubtedly still play a dominant role (cf. also ÖBIG 2001a). 
Opiates also continue to be the drugs causing the most serious health and social problems 
for users (cf. chapter 3), while there are hardly any indications of health and social problems 
due to cannabis and ecstasy use in Austria. A recent study (Dittrich und Haller 2002) 
analyses possible relations between psychotic diseases and use of cannabis, based on inter-
national studies, as no specific data for Austria is available. The authors draw the conclusion 
that chronic use of large amounts of cannabis may result in acute psychosis, while there is 
no evidence showing that occasional use may cause lasting psychotic conditions. 
Hardly any new data on ways of administration and risk behaviour of problem drug users is 
available. According to reports of practitioners intravenous use continues to be prominent 
among drug addicts. In Vienna a local scene practices chinesing (of heroin and speedballs), 
a rather untypical way of use (VWS 2002b). There is some information from drug centres 
indicating awareness among users of risky forms of consumption. On the one hand syringe 
exchange programmes (cf. chapter 10) have become more and more popular over the years 
in all provinces, and on the other, the streetworkers of Vienna report that in the last few years 
life-saving emergency measures and interventions due to overdoses have had to be taken 
less often (VWS 2002b). 
The share of women in problem drug users continues to be disproportionately low. Their 
share goes down with age and severity of drug problems (cf. chapters 3.1 and 3.2). The 
recent annual statistics of Grüner Kreis (Grüner Kreis 2002) also reflects the fact that women 
are inclined to a higher degree to undergo treatment or counselling and at an earlier time in 
their drug careers (cf. ÖBIG 2000). The differences regarding the average age of clients indi-
cate that women start inpatient treatment approximately three years earlier than men. 
The trend towards rising average ages in the established drug scene mentioned in last year’s 
report has been confirmed by current data and information. For instance, Lower Austria re-
ports a rising share of older drug users among the clients of counselling centres, and that 
social problems (cf. also chapter 16) are rising at older ages, while specific services for this 
group are still lacking (cf. chapter 8.2). The draft of Vorarlberg’s drug plan for 2002 (cf. also 
chapters 1.1 and 8.2) therefore includes interventions aimed at chronic addicts with multiple 
problems. 
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3 Health Consequences 
3.1 Drug treatment demand 
As Austria has no uniform client documentation system, only few data of limited interpretative 
value is yet available in the field of treatment. In 2001/2 the working group convoked by the 
FMSSG in spring 1999 in order to establish a uniform documentation and reporting system 
has continued its activities. The pilot version of a client questionnaire drawn up by the 
working group and sent out to several treatment and care centres has been tested success-
fully. Client data covering the whole of Austria will not be available before 2004, however. 
The data presented here refers to statistics kept by drug centres announced according to Art. 
15 of the NSA, providing aggregate data about their clients. There are certain reservations 
however regarding the quality of client data: due to its aggregate character the type of treat-
ment or assistance (e.g. examinations according to the Narcotic Substances Act, counselling 
or long-term assistance/treatment) cannot be specified. Double counts of clients cannot be 
excluded either. 
In the outpatient sector a total of 25 of the drug help centres announced according to Art. 
15 of the NSA provided data on the drug use of their clients in 2001, broken down by gender 
(cf. figure 3.1). 
Figure 3.1: Number of clients documented in the statistics of 25 outpatient drug help centres in 
Austria, by gender and (drug) problem, in 2001 
 
 
Sources: FMSSG (BMSG/Abt. VI/B/11), calculations by ÖBIG 
In view of this data one may assume that the largest share of clients receiving treatment or 
assistance because of drug problems comprises (poly-drug) users of opiates. Regarding 
inpatient services (for this field data from 4 centres announced according to Art. 15 of the 
NSA is available) the share of (poly-drug) users of opiates is even higher (69%). Exclusive 
use of hashish/hallucinogens accounts for 0%; problems only concerning alcohol for 4%; and 
poly-drug use excluding opiates for 27%. The outpatient facilities have twice as many men 
clients as women and the inpatient departments, three times as many. 
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National monitoring of substitution treatment is performed by the FMSSG and based on 
the reports of attending doctors. Although not all cases are reported or reports often come in 
late (cf. ÖBIG 1999), some broad insights may nevertheless be gained as to quantitative 
developments and characteristics of clients. The increasing acceptance of, and resort to, this 
form of treatment is reflected in the annually rising number of reports concerning persons 
currently undergoing substitution treatment. On the other hand the number of clients going in 
for substitution treatment for the first time declined somewhat in 2001 (cf. figure 3.2). 
Figure 3.2: Development of annual registrations of persons currently undergoing substitution treatment 
in Austria by first treatment and continued treatment, from 1992 to 2001 
 
Note: Continued treatments are treatments started before the respective year or repeated treatments of persons having 
undergone substitution treatment before. First treatments are treatments of persons who have never been in substitution 
treatment before. 
Sources: FMSSG (BMSG/Abt. VI/B/11), calculations by ÖBIG 
About half of the persons undergoing substitution treatment in 2001 were over 34. This is an 
indication that most of them are long-term drug addicts. The gender distribution of patients 
reported is balanced more or less in the group under 20, while the older age groups have a 
markedly higher proportion of men than women (25–34 years: ratio 2:1; over 34: 3:1; cf. 
figure 3.3). 
Another interesting aspect is that the average age of persons undergoing substitution treat-
ment for the first time in 2001 (n = 714) has gone down to 27.4 years, compared to 28.2 in 
1995, 28.4 in 1998, 28.5 in 1999 and 29.2 in 2000. As the number of first treatment patients 
has also slightly fallen (see above) this might suggest a saturation effect: the average age of 
patients receiving substitution treatment for the first time tends to get lower as a larger 
number persons with shorter drug careers start treatment and the need for substitution has 
been more or less satisfied in the group of long-term opiate users. The further development 
of this statistics will show if this interpretation has been correct. 
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As in previous years the average age of women starting their first substitution treatment in 
2001 (25.3 years) has been lower than the average age of men patients (28.3 years). 
Figure 3.3: Persons currently registered for substitution treatment in Austria by age and gender, in 
2001 
 
Note: The difference to the total sum results from cases where age and gender were not included in the database. 
Sources: FMSSG (BMSG, Abt. VIII/B/12), calculations by ÖBIG 
3.2 Drug-related mortality 
The Health Department of the FMSSG has gathered data on drug-related deaths since 1989, 
which refers both to persons dying as a direct consequence of drug use (e.g. fatal over-
doses) and to deaths where an indirect relation to drugs may be assumed (e.g. intravenous 
drug users with HIV infections dying of AIDS).  
According to the EMCDDA it is primarily persons dying as a direct consequence of drug use 
who are indicators of the current drug situation, i.e. of the gravest health consequences of 
drug use. For this reason the epidemiological key indicator Drug-Related Deaths refers to 
persons dying as a direct consequence of drug use. At the European level deaths indirectly 
caused by drug use are not included in this key indicator as they often do not provide helpful 
data on the current drug situation (e.g. a person having contracted an HIV infection due to in-
travenous drug use 10 years ago and who has now died of AIDS). On the other hand, 
standardised data-gathering with regard to persons dying as an indirect consequence of drug 
use may provide important complementary information, for instance about long-term health 
consequences, and is under discussion at the European level. 
Since 1999 a group of experts coordinated by the NFP has continually adjusted existing data 
on drug victims to EMCDDA requirements and also endeavours to improve data quality. An 
important outcome of this work is the decision to make a clearer distinction in the future 
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between directly and indirectly drug-related deaths when interpreting data. This has already 
been taken into account in the following presentation of drug-related mortality. 
While the total number of (direct and indirect) drug fatalities remained stable from 1997 to 
1999 (between 160 and 180 cases), in 2000 a marked rise to a total number of 227 drug-re-
lated deaths was reported. In 2001 the number of drug fatalities again fell to 184 (cf. figure 
3.4 and table A2 of annex B). 
Figure 3.4: Number of drug fatalities in Austria by cause of death from 1992 to 2001 
 
Note: Intoxications solely involving psychoactive medicines have not been included as of 2000 (see annex A) 
Source: FMSSE (BMSG/Abt. VI/B/11) 
As in previous years the data on deaths directly related to drug use shows a strong pre-
dominance of poly-drug intoxications including opiates (86% of all intoxications). A more de-
tailed analysis of the total number of 139 intoxications according to substances used shows 
that only 23% of the persons in question had exclusively taken opiates or other illicit drugs 
(single substances or combinations). In addition to illicit drugs in 19% of the cases alcohol 
was found, 34% had also taken psychoactive medicines and 24% had used both alcohol and 
psychoactive medicines (cf. tables A7 and A8 in annex B). 
Data broken down by cause of death regarding direct or indirect drug fatalities is given in 
table A2 of annex B. 
The share of women among persons dying as a direct consequence of drug use is 16%, 
which is in line with the long-term average. Regarding indirect drug mortality women account 
for 33%, which is slightly higher than the average of the last nine years (24%). Strikingly, 
over the years the share of women in indirect drug deaths has been elevated to some extent 
compared to direct drug fatalities. In 2000 and 2001 their share in indirect deaths was 
approximately twice as high as in direct drug fatalities (cf. tables A5 and A6 of annex B). 
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The age of the drug victims has risen over the years. While the average age of persons dying 
as a direct consequence of drug use was 27.7 in 1991, by 2001 the average age of this 
group had risen to 31.3. Almost two thirds (57%) were over 29 in 2001. The persons whose 
death was directly caused by drug use were 32.2 years old on an average in 1991 and 35.6 
years old in 2001 (cf. figure 3.5, tables A5 and A6 of annex B). 
The developments regarding the number of directly drug-related deaths differ from province 
to province. While Vienna has registered a marked decline, in Vorarlberg directly related 
deaths have increased. In the rest of the provinces no significant changes have occurred (cf. 
table A3 of annex B). However, the number of cases is low in statistical terms and there have 
been strong fluctuations in individual provinces in the course of time, so these regional 
differences should not be overinterpreted. 
The assumption that the rise in drug-related deaths of the year 2000 does not indicate a 
quantitative increase of the drug problem was correct. In addition an article published in the 
journal Wiener Zeitschrift für Suchtforschung explains that short-term changes in the number 
of drug-related deaths cannot be interpreted as changes in the general drug situation (Uhl 
2002). 
As in previous years the drug fatalities statistics of 2001 indicates two main trends relevant 
for prevention. The age of persons dying as a direct or indirect consequence of drug use is 
rising. On the one hand this indicates that harm-reducing interventions have been 
successful, but on the other hand it points to new requirements to be met in the field of 
prevention. A central aspect is that the state of health of many drug victims is very poor, 
which is confirmed by forensic findings (cf. also chapters 3.3 and 3.4). 
Figure 3.5: Age distribution of direct drug deaths in Austria from 1992 to 2001 
 
Source: FMSSG (BMSG/Abt. VI/B/11) 
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The share in directly related deaths of poly-drug intoxications including opiates has risen 
from year to year and has now stabilised at a very high level (1999: 74 %; 2000: 88 %; 2001: 
86 %). Alcohol and psychoactive medicines are also involved very often. Data from other 
fields of drug monitoring shows a rise in high-risk patterns of poly-drug use, where the effects 
of different substances may be potentiating and can hardly be controlled (cf. chapter 2.3). 
Interesting additional information on fatal overdoses is supplied by a study on drug mortality 
in Vienna focusing on drug quality and deaths caused by heroin overdoses (Risser et al. 
2000a). What applied to the period from 1987 to 1996 (cf. Risser et al. 2000b) was also con-
firmed for 1999, namely that there is no connection between the concentration of diacetyl-
morphine found in heroin intended for retail sale that was seized in Vienna, and the number 
of fatal heroin and poly-drug intoxications including heroin. Also in this study the majority of 
fatal overdoses occurring in Vienna are attributed to poly-drug use. 
Regarding cohort studies the final report of the cohort study on the mortality of opiate con-
sumers in Vienna undergoing substitution treatment has been completed (Risser et al. 
2000c). By 31 December 1998 291 persons (50 women and 241 men) out of a total number 
of 4 709 opiate users (1 447 woman and 3 262 men) starting substitution treatment between 
25 September 1987 and 31 December 1998 had died. Most deaths were due to overdoses 
(97 patients) and AIDS (96 cases). 24 patients died of liver diseases and the deaths of 74 
patients were attributed to other causes (cardiovascular diseases, etc.). The mortality rate 
has gone down since 1992, and while fatalities due to overdoses were rising till 1996 a 
downward trend has been observed since then. Over time the mortality risk for patients un-
dergoing substitution treatment was 13.6 times higher compared to the general population of 
Vienna at the same age. In most cases (two thirds) this elevated risk is due to the long-term 
consequences of past opiate use over many years. Compared to the rest of Europe the 
mortality rate of opiate users undergoing substitution treatment in Vienna ranks slightly below 
average. 
3.3 Drug-related infectious diseases 
The situation regarding infectious diseases, which is especially relevant because of the in-
fection risks involved in intravenous drug use, may only be estimated on the basis of a few 
small samples from treatment centres and low-threshold services (cf. ÖBIG 2000). For this 
reason reliable statements regarding changes and trends cannot be made. The available 
data again indicates a stable HIV prevalence rate at a low level (between 0% and 6%). The 
hepatitis prevalence rates however continue to be very high (hepatitis C: 47% to 71%, 
hepatitis B: 38% to 53%). According to experts tuberculosis infections are hardly relevant in 
the context of drug-related infectious diseases in Austria. Only isolated cases have been re-
ported. 
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Table 3.1: Data on hepatitis B, hepatitis C and HIV infection rates in 2001 
Source of data HB rate HC rate HIV rate 
Short-term therapy department Lukasfeld 48% (13/27)1 68% (23/24) 0% (34) 
Long-term therapy department of Anton Proksch 
Institute 53% (45/85)
2 71% (60/85) 1% (1/85) 
Low-threshold centre Ganslwirt 38% (26/68)3 47% (51/107) 1% (2/153) 
Drug fatalities (intoxications) not available not available 6% (8/139) 
1 This percentage relates to persons in whom antibodies to hepatitis B were found and whose medical history did not indicate a 
hepatitis B vaccination. 
2 This percentage relates to persons in whom antibodies to hepatitis B were found and for whom it was proved that they had not 
received vaccinations. An additional 15% of the patients had developed hepatitis B antibodies and had got vaccinations. 
3 This percentage relates to persons in whom hepatitis B antibodies or antigens were found and who had not yet received 
hepatitis B vaccinations (data obtained from Ganslwirt’s vaccination project). 
Sources: Riedl, F. personal information; API 2002; Haltmayer, H. personal information; FMSSE (BMSG/Abt. 
VI/B/11) 
3.4 Other drug-related morbidity 
Regarding psychiatric co-morbidity recent data has been available. In the context of a 
study on patient satisfaction at the drug outpatient department and the drug withdrawal de-
partment of Baumgartner Höhe Hospital of Psychiatry in Vienna one third out of a total 
number of 166 patients interviewed between November 1999 and July 2000 said they had al-
ready undergone psychiatric treatment already in the past. The reasons for this treatment in-
cluded drug addiction (53%), depression (9%), attempted suicide (9%), thoughts of suicide, 
borderline syndrome, nervous breakdown and anxiety disorders (4% each). Other indications 
by some patients were narcissistic personality disorders, manic depressive problems, night-
mares, suicide of a close relative, epilepsy and private problems (Essl und Hlavin 2000). 
75% of the patients of the long-term therapy department at Mödling, Lower Austria (n = 85) 
had diagnoses of personality disorders according to ICD-10 (API 2002). 
Data on the general state of health may also be indirectly derived from the cohort study on 
substitution patients in Vienna already mentioned in chapter 3.2 (Risser et al. 2000c). 
Approximately two thirds of the deaths among this group go back to (drug-associated) co-
morbidity (AIDS, liver diseases, cardiovascular diseases). 
8% out of the total of 85 patients of the API at Mödling mentioned before also had skin 
diseases (e.g. psoriasis, neurodermatitis, erythema migrans, condylomata etc.), and nine 
patients had histories of grand mal seizures in the context of withdrawal. 
In 2001 ambulance services were called 448 times in Vienna because of drug emergencies 
with suspected overdoses (1993: 705 times; 1998: 360; FSW 2002b). 
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4 Social and Legal Correlates and Consequences 
4.1 Social problems 
Recent experience of drug help centres shows that the social problems of drug addicts 
mentioned in past reports, in particular unemployment and precarious accommodation, 
continue to play an important role. For instance, Ganslwirt’s sleeping facility and the socio-
economic project Fix und Fertig register a rising number of clients wanting to spend the night 
there (VWS 2002a) and an increased demand for employment on a per-day basis (VWS 
2002c). The existing services cannot sufficiently meet this demand. For a more detailed 
description of the correlates of drug use/drug addiction and social problems see the key 
issues chapter Social Exclusion and Reintegration (cf. chapter 16). 
As has already been mentioned in part 1 (chapter 1.4) during the reporting period public dis-
cussion often linked the drug problem with public safety and nuisance. What is interesting in 
this context is a survey conducted by the Focus team of the Vienna Social Fund, aimed at in-
vestigating nuisance and irritation felt by passers-by and inhabitants when drug addicts were 
present in neighbourhood with and without the syringe exchange bus. The reason for this 
survey was discussions about the location of the syringe exchange bus and fears that the 
bus could attract drug addicts and thus give rise to public nuisance. However, the respon-
dents did not see significant changes of the situation before and after the syringe exchange 
bus was in the neighbourhood. On the other hand, without the syringe bus a larger number of 
syringes thrown away was found (FSW 2002b). 
4.2 Drug offences and drug-related crime 
In 2001 21 862 reports to the police for violations of the Narcotic Substances Act (NSA) were 
registered, which is another noticeable rise compared to preceding years (2000: 18 125 re-
ports; cf. also table A10 of annex B). A total of 21 302 reports refer to narcotic drugs, the rest 
concerns psychotropic substances. Reports to the police both for misdemeanours 
(possession and small-scale trafficking of drugs according to Art. 27 of the NSA) and felonies 
(large-scale trafficking and commercial trafficking according to Art. 28 of the NSA; cf. figure 
4.1) have markedly risen. It should be examined in this context to which extent the current 
rise in reports is due to the amendments of drug laws adopted in 2001 (in particular the re-
duction of the limit quantity of heroin; cf. ÖBIG 2001a). 
Regarding substances involved (cf. table A12 of annex B) increases compared to the 
previous year have been reported for all substances. A considerable rise has been found 
with regard to cannabis, but also opiates and cocaine (cf. figure 4.2). Great differences 
regarding substances involved have again shown in the individual provinces (cf. table A13 of 
annex B). In Vienna the proportion of reports due to opiates and cocaine is comparatively 
high, while the majority of reports in all other provinces concern cannabis. A disproportionate 
number of reports to the police referring to amphetamines have been registered in Lower 
Austria, Upper Austria and Styria. 
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Figure 4.1: Development of reports to the police for violations of the Narcotic Drugs Act/Narcotic 
Substances Act by misdemeanours and felonies in Austria from 1992 to 2001 
 
 
 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. In order to facilitate 
comparison, for the period from 1998 to 2001 only reports concerning narcotic drugs are considered here. The difference 
to the total number of reports results from reports that are not assignable. 
Source: FMI/Central Office for Combating Drug Crime (BMI – Zentralstelle für die Bekämpfung der Suchtgift-
kriminalität) 
Figure 4.2: Development of reports to the police for violations of the Narcotic Drugs Act/Narcotic 
Substances Act in Austria by drug type from 1992 to 2001 
 
 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. 
Source: FMI/Central Office for Combating Drug Crime (BMI - Zentralstelle für die Bekämpfung der Suchtgift-
kriminalität) 
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As explained in previous years, the data concerning reports to the police only permits very 
limited conclusions as to the development of consumption and misuse of illegal drugs, be-
cause they primarily reflect the intensity and focus of police activities in this field. 
Compared to almost 22 000 reports to the police in 2001, 2 577 arrests in connection with 
narcotic drug investigations were registered (2000: 2 052), but for the latter no details (type 
of offence, substance involved, etc.) are available.  
2001 saw 3 862 convictions for violations of the Narcotic Substances Act, which is a con-
siderable rise (2000: 3 240). The share of drug-related convictions in the total number of con-
victions amounts to 10% and has thus reached a new peak (1991: 2%; 2000. 7.8%). How-
ever, one has to bear in mind that the Court Criminal Statistics registers only convictions for 
the leading offence, so the role of drug-related offences is even more important with regard 
to convictions than is reflected here. The high proportion of misdemeanours (2 671 cases; 
violation of Art. 27 of the NSA – possession and small-scale trafficking) compared to felonies 
(1 141 cases; violation of Art. 28 of the NSA – trafficking; cf. table A14 of annex B) is still 
striking. About 60% of all persons convicted were punished with imprisonment (cf. table A16 
of annex B). The share of sentences that were suspended fell to about 45% (2000: approxi-
mately 50%). This means that a larger number of persons are actually imprisoned. 
 
Figure 4.3: Development and application of statutory alternatives to punishment in Austria from 1994 
to 2001 
 
 
 
 
 Art. 35 of the NSA = temporary withdrawal of report to the police by the public prosecutor 
Art. 35(4) of the NSA = temporary withdrawal of report to the police in the case of small amounts of cannabis for personal use 
Art. 37 of the NSA = temporary dismissal of proceedings by the court 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. A specification of the kind of 
alternative to punishment can be given for the period since 1998 only. Regarding Art. 39 of the NSA (suspension of prison 
sentence based on the principle of therapy instead of punishment) no reliable data is currently available. 
Source: FMSSG (BMSG/Abt. VI/B/11) 
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Complementary to the data on convictions, information concerning a temporary (provisional) 
withdrawal of reports to the police (Art. 35 of the NSA) and dismissal of proceedings (Art. 37 
of the NSA) is also relevant. These legal alternatives to criminal prosecution (cf. also chapter 
12) were made use of in 12 088 cases in 2001, which is a very strong increase compared to 
past years (2000: 8 098 cases; cf. figure 4.3). 
Again no data on crimes committed for the purpose of drug acquisition or other drug-related 
crimes could be obtained. Available information on drug use in prisons was presented in 
more detail in the key issues chapter Drug Users in Prison in last year’s report (ÖBIG 
2001a). No new, additional information is available. However, the statistics on convictions 
(see above) indicates that the percentage of persons imprisoned because of drug-related 
offences is rising. 
4.3 Social and economic costs of drug consumption 
No recent studies or data on the social and economic costs of drug use in Austria are 
available. For a presentation of the expenditures for drug-related demand reduction see key 
issues chapter 14. 
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5 Drug Markets 
According to the Federal Ministry of the Interior (FMI) a rise in seizures of cannabis, heroin 
and cocaine was registered in 2001. In the case of ecstasy the seizures remained roughly at 
the same level as in the previous year, and regarding LSD a slight decline was observed (cf. 
table A18 of annex B and figure 5.1). 
Figure 5.1: Number of seizures of narcotic drugs in Austria from 1992 to 2001 
 
 
Source: FMI/Central Office for Combating Drug Crime (BMI - Zentralstelle für die Bekämpfung der Suchtgift-
kriminalität) 
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distributed as small plastic balls, 29% were enveloped in paper, and 8% were wrapped in 
aluminium foil. An average street unit of heroin had 0.15 g, with weights ranging from 0.1 g to 
2.8 g. 90% of all units examined contained alkaline forms of heroin and the overall opiate 
content was between 0.5% and 55%, with strong variations depending on time of the year. 
On analysis all street heroin units were found to contain noscapine and/or papaverine as well 
as sugar compounds, in particular lactose. Caffeine was added to 92% of the units (average 
concentration: 29%), cocaine to 3% and lidocaine to 1%. 
In 2001 the project ChEckiT!, which tests the purity and ingredients of substances bought as 
ecstasy or speed during raves, was present at six rave parties, where 280 pills bought as 
ecstasy and 51 samples purchased under the name of speed were handed in for testing. The 
percentage of pills bought as ecstasy which did not contain psychotropic substances other 
than MDMA, MDE or MDA remained the same as in the previous year (1998: 38%, 1999: 
85%, 2000: 88%, 2001: 89%). The average dose in the samples containing MDMA was 
59.08 g per pill. 58% of the substances bought as speed and analysed by ChEckiT! had 
amphetamines as their only ingredient, while 10% combined amphetamines and caffeine, 6% 
contained amphetamines with additions of other psychotropic substances and 4% contained 
metamphetamine. In 23% no amphetamines were found (cf. table A20 and A21 of annex B). 
As in previous years the pills sold in 2001 had many different, and frequently changing, logos 
(VWS 2002e). 
No recent studies on drug prices have been drawn up in the reporting period. In the context 
of the study on drug-related deaths in Vienna (Risser et al. 2000a – cf. chapter 3.2), for 93 
out of the 415 street units of heroin that were seized also the prices were known, ranging 
between ATS 100 (EUR 7) and ATS 3 500 (EUR 255). In terms of weight this means that 
1 gram of street heroin was available at a cost between ATS 332 (EUR 24) and ATS 2 307 
(EUR 168). 
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6 Trends per Drug 
Recent consumption surveys confirm high lifetime prevalence rates for cannabis: between 
15% and 20% in the general public, and 30% or higher among adolescents and young adults 
(cf. chapter 2.2). However, regular consumption of cannabis is by far less frequent than ex-
perimental use. For instance, in the survey conducted in Vienna 31% of the group between 
15 and 29 said they had used cannabis once, and 6% indicated cannabis consumption within 
the past 30 days. There are still hardly any indications of social and health problems in the 
context of cannabis use in Austria. The number of reports to the police concerning cannabis 
has again considerably risen in the reporting period. Cannabis is mentioned in about 90% of 
all reports. 
Synthetic drugs, above all ecstasy, are the second-most consumed illegal drugs after 
cannabis and especially popular among young people. In Burgenland the figures for ecstasy 
have been 4%, which corresponds to the average of the past few years, while Graz reports 
markedly higher percentages. Both studies confirm a rising trend regarding experience of 
amphetamines among young people. In addition experimental use of hallucinogens (such as 
LSD) seems to have slightly risen. New synthetic substances (GHB, ketamine, 2C-B etc.), on 
the other hand, obviously do not play a major role in Austria; they are used in rare instances 
only. So far, health and social problems with regard to consumption of synthetic drugs have 
primarily arisen in the context of poly-drug use. The number of reports to the police has risen 
both for use of ecstasy and amphetamines. 
In recent population surveys again only a rather small group of the respondents has indica-
ted experience of opiate use. Opiates continue to be the most relevant substance with re-
gard to problem drug use. In most cases they are injected, and a local scene in Vienna is 
practicing chinesing. The decreasing relevance of opiates, and especially heroin, mentioned 
in last year’s report has been confirmed by evidence from Salzburg and Vorarlberg. Data 
provided by Upper Austria shows that, as already mentioned last year, addicts tending to 
poly-drug patterns of use increasingly often take morphine and other opiates instead of 
heroine. However, nation-wide data is scarce and sometimes contradictory so no clear state-
ments can be made with regard to assumptions concerning such a trend. Opiates continue to 
be involved in almost all cases of fatal intoxications. After declining for several years the 
number of reports to the police concerning opiates now have markedly risen. 
Recent surveys show that experience of cocaine use has remained in line with the long-term 
average of one or two percent of the population; only a study carried out in Graz, Styria gives 
higher figures. It has been confirmed by practical experience that cocaine, due to falling 
prices and easy availability, has become more relevant in the open drug scene in the last few 
years and is often injected in the context of poly-drug use. Crack still does not play a major 
role in Austria. Overdoses of cocaine alone are very rare causes of drug-related death, but 
cocaine has more often been found in the context of poly-drug intoxications including 
opiates. The number of reports to the police as well as seizures have markedly risen in the 
reporting period. 
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As in the past poly-drug use is the most common pattern of consumption among addicts in 
Austria. In the context of poly-drug use or multiple drug use many different substances (such 
as heroin, other opiates, benzodiazepines, alcohol, cocaine, amphetamines etc.) are taken 
simultaneously. Most substances are injected, and in some cases they are consumed in a 
combined form. This is also reflected in the corresponding health consequences: poly-drug 
intoxications continue to be the most frequent cause of drug-related deaths. However, these 
fatalities have considerably declined compared to the year before, so the overall number of 
drug-related deaths has also gone down. The group of poly-drug users also tend to have 
more serious social problems such as unemployment, homelessness and high debts (cf. 
chapter 16). Several provinces (e.g. Salzburg and the Tyrol) report rises in poly-drug use of 
illicit substances among young people (cf. also chapter 15.1). However, in most cases 
experimental or sparetime drug use seems to prevail so far. What gives reason for concern, 
however, is lack of risk awareness on the part of the young people. 
Regarding other substances the role of biogenic drugs and poppers has been investigated 
in the reporting period, although they do not belong to the group of illicit drugs. Both drugs 
are primarily taken by young people. In the survey conducted in Burgenland 20% of the 
young people interviewed said they had experience of poppers, and 8% had already experi-
mented with biogenic drugs. This picture is reversed, however, in the survey of Graz, where 
poppers account for 9% and natural drugs for 21%. This may be due to the fact that very 
young adolescents seem to prefer poppers while older youths rather take biogenic drugs. 
The ChEckiT! survey among ravers also reports use of mushrooms and natural drugs.  Lack 
of risk awareness of many young people gives cause for concern also with regard to these 
substances. 
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7 Discussion 
The available data on the epidemiological situation in Austria supports a few of the trends 
emerging last year. The consumption surveys carried out so far reveal high prevalence rates 
in particular among adolescents and young adults. This year data on the relevance biogenic 
drugs and poppers for young people has been confirmed for the first time. A number of 
provinces report increases in poly-drug use of various substances among young people, in 
particular in the context of sparetime and experimental drug use. Surveys concerning 
possible trends towards problem use of stimulating substances and consumption of stimu-
lants in the context of poly-drug use have yielded contradictory results, however. While in-
dividual sources and reports mention to have registered developments as described last 
year, others do not indicate relevant changes. 
Rising average ages of the established drug scene and also with regard to drug-related 
deaths are backed by reports from some provinces. The number of drug-related deaths have 
markedly declined again compared to the previous year and gone back to the level of 1999. 
So last year’s sharp rise seems to be an exception. Obviously reliable analyses and state-
ments regarding trends can only be made on the basis of a compilation of many different 
data and taking into account developments over several years. 
On the whole the drug situation has remained stable, especially with regard to problem drug 
use. The levelling-out process of regional differences does not seem to have been completed 
yet. So even if aggravations are registered in particular in rural areas this does not contradict 
the general trend confirming a stable drug situation. 
The drug policy responses to rising prevalence rates among young people include additional 
secondary prevention and outreach services (cf. chapters 8 and 9). Prevention activities will 
focus more specifically on biogenic drugs and poppers. Services tailored to meet the 
demands of older addicts, who may also need nursing care, are still lacking, but for instance 
such approaches form part of the new draft of Vorarlberg’s drug plan (cf. chapter 8), which 
also includes plans to establish inpatient cocaine treatment facilities, as a response to the 
trend towards stimulating substances (cf. chapter 8). 
As was explained last year already (cf. ÖBIG 2001a) certain inconsistencies in the available 
data are due to deficits of Austria’s monitoring system (cf. annex A). Data often refers to 
rather small, local samples or studies, which do provide valuable information and are 
essential for deeper analysis, but what is lacking in some fields is complementary data that is 
collected annually for clearly defined groups and thus permit reliable monitoring yielding con-
clusive results. A relevant point in this regard is the lack of data on drug-related treatment 
and care that is comparable at a nation-wide level.  
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8 Strategies in Demand Reduction at National Level 
8.1 Major strategies and activities  
Activities at the provincial level in the reporting period include a new addiction plan adopted 
in Burgenland, the draft of the drug and addiction plan for Upper Austria and the review of 
the drug plan of Carinthia, Lower Austria, Salzburg, Vienna and Vorarlberg were implemen-
ting their drug or addiction plans. In Salzburg the implementation of the framework plan on 
addiction prevention focuses on establishing regional networks and drawing up continuing, 
systematic further training programmes for multipliers and persons working with children and 
adolescents. In August 2002 Lower Austria presented its final report on the implementation 
of proposed interventions. Based on a graduated plan the corresponding addiction coun-
selling services will be expanded until 2010. Vienna’s drug policy is focusing on the imple-
mentation of labour market measures. The implementation of Carinthia’s drug plan is parti-
cularly aimed at expanding primary and secondary prevention services as well as estab-
lishing a drug outpatient clinic for central Carinthia. In the Tyrol restructuring measures have 
been implemented; by now drug and alcohol counselling centres have been created in all 
districts (cf. also map 10.2 on p. 49). 
The addiction plan of Burgenland as well as the drafts of Upper Austria’s and Vorarlberg’s 
drug plans endorse the principle of therapy instead of punishment for drug users, paralleled 
by consequent prosecution and punishment for drug dealers (cf. chapter 1.1). All plans state 
that a wide range of different, innovative treatment and care approaches are necessary to 
attend to individual problems. Addicted patients shall have access to medical, psychological 
and psychotherapeutical help as well as support by social workers. 
Upper Austria’s addiction plan also includes the goal to establish prevention and outpatient 
counselling centres all over the province. For other services such as low-threshold centres 
and inpatient clinics the relevant demand will be analysed at first. The addiction plan of 
Burgenland stresses the specific geographical situation of Burgenland at an EU border, 
which makes it highly important to cooperate with Eastern neighbours (in particular Hungary). 
The drug plan of Vorarlberg points to a trend towards stimulating substances and changes in 
patterns of use, and will respond to this by expanded secondary prevention activities. On the 
other hand the need to be able to provide adequate treatment options as soon as possible is 
stressed. The aim of Vorarlberg’s drug help centres is instant treatment, i.e. to provide 
therapy for each person willing to undergo treatment. To achieve this, in line with the psy-
chiatry plan of Vorarlberg, six beds at the Provincial Hospital at Rankweil have been re-
served for withdrawal patients. 
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8.2 Approaches and new developments 
The trends described in our reports of the last few years (ÖBIG 2000, ÖBIG 2001a) have 
continued as far as concrete demand reduction interventions are concerned. Due to the rise 
in prevalence rates among young people (cf. chapter 2.2) the expansion of secondary pre-
vention still plays an important role. Tertiary prevention sees trends towards flexible inpatient 
services not exclusively aimed at abstinence that may be adapted to the individual situation 
of the patients (cf. chapter 11). Young people in danger of addiction have become an in-
creasingly relevant target group of new treatment and care approaches (cf. chapters 9.2 and 
15.3). Here integrative aspects and accommodation (assisted housing, temporary sleeping 
facilities) are regarded as central necessities. In the Tyrol a group of experts has recommen-
ded to draw up a social sciences study assessing the demand for multi-faceted help services 
for adolescents and young adults and developing the corresponding strategies. 
The increasing number of older addicts and also in adolescent drug addicts with serious psy-
chological problems already mentioned in last year’s report has continued (cf. chapters 2.1 
and 15.2). Both groups need specific forms of assistance that have not yet been provided (cf. 
chapter 15.3). As a response to the rising number of drug addicts with multiple physical, psy-
chological and social problems and especially cocaine addicts, the drug plan of Vorarlberg 
includes plans to provide specific training schemes for the stuff of drug help services in 
addition to a specialisation in cocaine treatment and cocaine-related disorders of existing in-
patient programmes.  
Another aspect worth mentioning is that more and more young people have been placed 
under medical supervision due to violations of the Narcotic Substances Act, which has re-
sulted in capacity problems of the drug and addiction counselling centres (cf. chapter 1.3). As 
immigrants are underrepresented in the drug help centres Vienna established the networking 
initiative Migration, aimed at assessing the demand for assistance to drug-using immigrants 
and coordinating relevant activities (cf. also chapter 16). 
The trend towards intensified regional networking and professionalisation has continued (cf. 
chapter 1.1). For instance, Vienna organises regular networking meetings of all workers in 
the drug help centres of Vienna, and also networking meetings at the district level (e.g. re-
gional forums). Participation in EU programmes has also become increasingly important. A 
number of drug help organisations take part in the EU programme Equal (Vienna Social 
Fund), the DAPHNE project Addiction as a chance of survival for women with experience of 
violence (Dialog and Streetwork of the Vienna Social Fund) and the EU project AC Company 
(Streetwork of the Vienna Social Fund), just to mention a few examples. 
Chapters 9 to 13 give examples of various interventions in the field of demand reduction in 
Austria, which do not claim to be exhaustive. For more detailed presentations of individual 
projects and interventions please consult the reports of past years and the EDDRA database 
of the EMCDDA (cf. list of Austrian EDDRA projects in the Bibliography section). 
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9 Prevention 
Prevention is of central importance in Austria, and corresponding interventions are found 
regarding both primary and secondary prevention. The distinction between primary preven-
tion1 and secondary prevention2 is regarded as fundamental and is based on the principles of 
prevention policy established in Austria. Preventive measures are usually implemented at the 
local or regional levels. In this context the Addiction Prevention Units of the individual provin-
ces play a major role. For information on the legal framework and strategies please consult 
chapters 1 and 8 as well as the reports of the last few years (most recent: ÖBIG 2001a). De-
tails on expenditures with regard to prevention are given in chapter 14). 
9.1 School programmes 
 
The school sector continues to be an important setting of prevention measures. Preventing 
addiction has been defined as a general educational principle in the context of health promo-
tion at Austrian schools. The majority of the prevention projects in this field focus on pupils 
between 10 and 18 (cf. table A23 of annex B), although the number of prevention projects 
carried out in primary schools is also rising. The most relevant methods of primary prevention 
at schools include educational theatre play and peer group education. The youth and drug 
counselling centre Auftrieb at Wiener Neustadt, Lower Austria, has organised drama work-
shops for students of the Waldegg school of tourism, apart from information and consulting 
hours (since 2001). In the Tyrol the dance and theatre programme Klassenzimmerzauber 
(classroom magic) for primary schools was again put on the programme of the Tyrolean Cul-
tural Service, as it had met which much acceptance also in the past. Peer education projects 
are found for instance in the Tyrol, where the fun&friends project is being run in 19 lower 
secondary schools and three upper secondary schools, and in Upper Austria, where about 
60 schools are already participating (ISP 2000). 
The EU school programme Gläserne Schule, in which 40 classes from Innsbruck took part, 
has been evaluated in the meantime. Approximately two thirds of the students interviewed 
indicated that they had benefited from the prevention initiatives. 89% said they had taken 
considerably smaller quantities of drugs during the monitoring period. in motion, a project of 
Upper Austria, was also completed by the end of 2001 and was very favourably assessed by 
both pupils and teachers. 
 
 
 
1 The aim of primary prevention is to avoid the development of addiction among persons who do not belong to a specific at-risk 
group and who have not had addiction problems so far. The pertinent measures are often based on the concept of health 
promotion. Other relevant scientific approaches forming the basis of primary prevention include the concept of life skills and 
protective factors such as social learning. Primary prevention especially focuses on children and young people. 
2 Secondary prevention is oriented towards defined at-risk groups and persons who do have problems, which have not become 
manifest to their full extent, however. The priority target group of secondary prevention is young people. 
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Other developments worth mentioning are that the Working Group for Addiction Prevention 
of Burgenland is drawing up a comprehensive, networked model of prevention for schools in 
the province and that the Provincial Council of Education of Salzburg established KIS, a 
specific coordination centre for addiction prevention at schools. KIS understands itself as a 
place where pupils, parents and teachers may turn to find answers to their questions concer-
ning prevention and drug abuse among pupils. The activities of KIS focus on training of 
liaison teachers and drawing up detailed guidelines concerning legal questions related to Art. 
13 of the NSA. 
In addition many initiatives aim at providing information on addiction, addiction careers and 
causes of addiction on the one hand and guidance on how to act in situations of crisis on the 
other. For instance Upper Austria is preparing a manual for parents (ISP 2002), and in 
Vienna the booklet Schultüte for parents of primary school children was published in five 
languages. Teachers all over the country have access to specific teaching materials methodi-
cally and didactically adapted to the theme of joint learning and active addiction prevention at 
schools, and in addition the Tyrol provides its tools4schools materials. Apart from this further 
education courses and prevention programmes such as Becoming Independent (primary pre-
vention in primary schools) and Step by Step (secondary prevention) are organised; cf. 
chapter 15.3)  
9.2 Youth programmes outside school 
In Austria numerous primary prevention projects focusing on youth work outside schools are 
run (ÖBIG 1999, 2000, 2001a), e.g. the information flyer It’s up 2U, which now also includes 
the subjects of heroin, cocaine and amphetamines. In the Tyrol act it, an educational theatre 
play programme for youth centres, was started. As it was very successful it will now also be 
used in schools. Art based empowerment is a new prevention approach, combining art and 
prevention. Courses in this field are organised by associations such as Kinderfreunde for the 
target group of persons working with children and young people (VIVID e-mail information of 
4 February 2002). The prevention centre kontakt&co in the Tyrol has tried a new approach: 
in summer 2001 six young people, assisted by experts, studied the themes of addiction, pre-
vention and youth work in Zillertal valley in the context of holiday jobs (SommerFor-
schungsJob). This initiative will be repeated at a larger scale in summer 2002. The subjects 
dealt with are environments where young people feel comfortable, consumption, role models 
and concrete community projects. The results will eventually be presented to the public. 
As use of legal and illegal drugs is part of adolescence, i.e. many young people are experi-
menting with drugs (ÖBIG 2001c), to keep up the distinction between primary and secondary 
prevention for this target group does not always seem appropriate. What is needed most of 
all is integrative measures so as to prevent young people from stigmatisation and from 
stumbling into the drug scene. Most adolescents in danger of becoming addicted have 
numerous social problems and needs apart from problem drug use, which should be put at 
the centre of attention and tackled by a variety of programmes and methods (cf. also chap-
ters 15 and 16). 
Secondary prevention approaches have also been intensified, however (cf. also chapter 15). 
For instance in May 2002 a new centre of mobile youth work/streetwork was opened in 
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Mödling, Lower Austria. Lower Austria plans to expand its streetwork projects to a greater 
number of regions in the next few years: for 2003 mobile youth work activities will be intensi-
fied at Krems and in the Waldviertel region. Vorarlberg plans to run a special secondary pre-
vention project covering the whole province and closely cooperating with all relevant help or-
ganisations so that assistance may be provided to drug-using adolescents and young adults 
at the earliest possible stage. Apart from assistance and counselling with regard to project 
planning, in cases of crises joint actions may be taken. 
At present Auftrieb, a youth and addiction counselling centre at Wiener Neustadt, Lower 
Austria, which provides counselling and care as well as crisis intervention, is being evaluated 
(cf. EDDRA). Initial results show that Auftrieb’s services are accepted both by young people 
and parents (parents’ group) and that the sociopolitical climate of the town has been in-
fluenced favourably. Discussions of young people with experts and politicians were orga-
nised, and as a result problems relating to young people and drugs have ceased to be taboo 
subjects (Verein Jugend & Kultur 2002). 
9.3 Family and childhood 
Interventions aimed at children and families in particular focus on kindergartens (cf. table 
A24 of annex B). This includes specific primary prevention projects for kindergarten children, 
such as the therapeutical support kindergarten for children of addicted parents at the Parents 
and Children House of Grüner Kreis, or Waldkindergarten in Burgenland. Other approaches 
stress further training schemes for kindergarten teachers (cf. EDDRA) and parent activities. 
In Styria parent talks on prevention during childhood are organised under the heading of 
Strong Parents – Strong Children. In autumn 2001 Lower Austria saw the start of a parents’ 
group for relatives of young people in danger of becoming addicted, organised by the youth 
and addiction counselling centre Auftrieb. Since early 2002 the Addiction Prevention Institute 
in Vienna has taken part in the EU project Generation E – workshop for creative parent work 
(FSW 2002b). 
9.4 Other programmes 
The role of community projects is becoming more and more important, e.g. the model 
project Addiction Prevention at Trofaiach, Styria. The aim of the project was to start 
measures of addiction prevention that involve as many decision makers as possible and also 
the target group of young people, and to change approaches to legal and illegal drugs in the 
district of Trofaiach. An evaluation carried out in 2001 showed that the measures developed 
and adopted in this context met with acceptance and that the situation was eased (cf. 
EDDRA). The project Practical Prevention of Addiction in Communities, which was also 
evaluated in 2001 is aimed at training locals to become addiction prevention contacts in their 
communities in order to raise awareness of this issue among the inhabitants and to gather 
ideas for projects and implement them. However it showed that although a number of towns 
succeeded in training contacts they often did not have the necessary resources or support 
within their communities to carry out independent prevention projects (cf. EDDRA). 
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In Radenthein, Carinthia, further education courses and training schemes for multipliers in 
various occupational groups were organised in the context of a community project on preven-
tion. In addition prevention activities focusing on children and young people were started and 
many locals were encouraged to take part in these efforts (Koordinationsstelle für Suchtprä-
vention 2002). The Addiction Prevention Unit of Upper Austria organised community projects 
such as 1-2-free, taking place from September 2001 to March 2002 in the district of Wels-
Land. The aim of the project was information and awareness-raising of the population, in par-
ticular young people between 13 and 16, on the issues of addiction and prevention. In the 
context of this project a web site for young people was designed, and lectures, seminars and 
workshops were organised in communities, associations and youth centres, in addition to 
projects and action days taking place at all lower secondary schools (ISP 2002). 
By now most of the regional Addiction Prevention Units and also many other drug-help and 
counselling centres have their own web sites. The web site of It’s up 2U also has a 
discussion forum for young people. Regarding mass media campaigns, in summer 2002 
the Vienna Social Fund started a campaign to make drug help options known to users and to 
raise public awareness of this issue (Wiener Zeitung of 7 August 2002). In Lower Austria a 
touring exhibition about drugs will be presented over the next two years, and as of 2003 a 
telephone hotline will be operated. 
Persons performing military service have been defined as a specific target group for pre-
vention. In spring 2002 the Federal Ministry of Defence adopted a number of measures in 
this field, after a marked rise in the number of conscripts dismissed prematurely due to re-
peated drug incidents (cf. chapter 2.2). The relevant interventions include intensified informa-
tion on the consequences of repeated drug incidents and also training for officers acting as 
liaisons for conscripts. In addition the curricula of the college study programme Military 
Leadership and also at Theresianum Military Academy will include lessons on drug 
problems.  
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10 Reduction of Drug-Related Harm 
Harm reduction plays a very important role in Austria. Many provinces plan intensified activi-
ties in this field. Reducing drug-related harm comprises a wide range of interventions 
addressing drug users or drug addicts. Most of these measures are not primarily oriented 
towards drug-free ways of life, their aim is rather to provide low-threshold assistance for drug 
addicts in their actual life situation and to reduce the risks and problematic consequences of 
drug consumption as far as possible. Therefore the corresponding measures are often 
referred to as accepting drug assistance, survival assistance or harm reduction. For an over-
view of the relevant interventions and facilities in the individual provinces see maps 10.1 and 
10.2 (cf. pp. 48 and 49). 
10.1 Description of interventions 
Outreach work is an important service in this regard, provided primarily by streetworkers 
and mobile facilities. This type of intervention makes it possible to contact persons who 
would not turn to a counselling centre of their own accord but nevertheless need help or 
support (cf. table A25 of annex B). In the context of the project The Karlsplatz Issue run by 
Streetwork Vienna open information events are organised, where basic information is 
provided as a low-threshold service close to the drug scene. In 2001 ten events with the sub-
jects of first aid, hepatitis/HIV, safer sex for men, safer sex for women and safer use took 
place (VWS 2002b). 
Another outreach work service is the pill testing project organised by the ChEckiT! team at 
events in Vienna. In 2001, subsidised by the Federal Ministry for Social Security and Genera-
tions, pill tests were also carried out in Lower Austria, the Tyrol and Upper Austria. By coope-
rating with local counselling centres the testers could refer persons with addiction problems 
directly to the staff of these facilities. High access rates registered at online counselling ser-
vices in 2001 (VWS 2002e) show the important role these platforms play. In 2002 a special 
working group will prepare an online counselling guide. The secondary prevention aspect of 
ChEckiT! is also reflected in the rising number of counselling talks at raves in relation to the 
total number of contacts (5-minute talks). 
Low-threshold centres are essential for the provision of harm reduction services. Since 
August 2001, in addition to Ganslwirt outpatient clinic, which for a long time has been the 
only drug help facility in Vienna providing medical care during weekends and on holidays, at 
these days now other facilities may also be contacted: the drug outpatient department of Otto 
Wagner Hospital provides addiction-related medical care for patients with severe addiction 
problems and in situations of psychosocial crisis, the doctors participating in the medical off-
hours service may be consulted by patients undergoing substitution treatment, and 
Ganslwirt’s outpatient clinic provides care for patients outside substitution programmes who 
need medical treatment because of acute withdrawal symptoms. Although relevant functions 
have now been taken over by other service providers Ganslwirt still registers very high 
numbers of clients during weekends (VWS 2002a). 
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The demand for low-threshold accommodation for drug users continues to be high. In 2001 a 
daily average of 20.3 clients applied for one of the 14 beds available in Ganslwirt’s sleeping 
facility (VWS 2002a). Mentlvilla at Innsbruck, the Tyrol, accommodated rising numbers of 
addicted adolescents and young adults in 2001 (39% were between 18 and 22 years old), 
which required a change in their work routine. Compared to 2000 the demand has again 
sharply risen, and absolute emergency admissions have slightly risen (Caritas 2002). 
Preventing infectious diseases is another relevant aspect of harm reduction interventions 
(cf. also chapter 3.3). The most important activities in this field include information, syringe 
exchange, vaccination programmes and counselling with regard to safer use and safer sex. 
These services are usually provided by streetwork projects and low-threshold facilities. In 
many provinces the AIDS Assistance Service plays an active part here, for instance by 
running syringe vending machines. The number of syringes exchanged has again risen in the 
reporting period (cf. figure 10.1). In the Tyrol the Komfüdro and Mentlvilla drug help centres 
and the syringe vending machines of the AIDS Assistance Service distributed a total number 
of 88 339 syringes. 
Figure 10.1: Number of syringes sold or exchanged in the context of the syringe distribution 
programme in the open drug scene in Vienna from 1993 to 2001 
 
With regard to the prevention of drug-related deaths the CONTACT hospital connection 
service of Vienna is an important instrument. In 2001 a total number of 362 patients in 
hospital received help by CONTACT (FSW 2002d). This is a rise by 27.5% compared to the 
previous year. The number of first contacts rose to 442 (+22.1%), the number of contacts 
during hospital stays to 930 (+11.2%), and the number of contacts after hospital stays to 
1 496 (+25.4%). 
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10.2 Standards and evaluation 
For information on standards please consult the reports of the last few years and chapter 13 
of this report. In 2001 a team consisting of doctors of the Vienna Social Projects Association, 
the association Dialog, the University Hospital of Psychiatry (Vienna University) and Baum-
gartner Höhe Centre of Social Medicine (Otto Wagner Hospital) agreed on a consensus from 
the point of view of addiction medicine on the treatment of drug users in Austria suffering 
from chronic hepatitis C. This consensus is based on the 5-axes model, by which existing de-
ficits or imminent problems may be diagnosed before or during treatment and specifically 
tackled (Hasenöhrl und Haltmayr 2002). 
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Map 10.1: Specialised  for treatment, counselling of and assistance to drug patientsoffers
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2    Number of offers (at the right of the symbol) if more than one
      offer of the category in question is found in a place
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Prevention of infectious diseases - testing and vaccination
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Housing for drug addicts (temporary sleeping facilities, etc.)
Occupation projects for drug addicts (low threshold)
Occupation projects for former drug addicts (aftercare, reintegration, etc.)
Prevention of infectious diseases - syringe exchange, -distribution
Outpatient psycho-therapy for drug addicts
Note:
The map provides an overview of selected drug-related offers, broken down by district. The map does not specify quantitative and qualitative aspects (i.e. opening hours or number and qualification of personnel, respective-
ly). The map differentiates by offer and not by facility (cf. Map 10.2), therefore a single facility can appear in several categories.
Source: ÖBIG - based on information by the Drug Coordinators and Drug Representatives as of   August 2002
   








4


11
2



2

2

















3
3
2





 





















(Sopron/
Hungary)


3







5 5

























2






Karte 10.2: Specialised  for treatment, counselling of and assistance to drug patientsfacilities  
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2    Number of facilities (at the right of the sybol) if more then one 
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Note:
The map provides an overview of selected drug-related facilities, broken down by district. The map does not specify quantitative and qualitative aspects (i.e. opening hours or number of qualification of personnel, respective-
ly). However, a distinction was made in the field of counselling, which is frequently offered by general facilities covering a broader range of services (psycho-social counselling centres, addiction counselling centres, etc.) 
though limited to a few hours a week. Specialised drug counselling organisations with limited opening hours have been listed seperately (see legend).
Source: ÖBIG - based on information by the Drug Coordinators and Drug Representatives as of August 2002.
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11 Treatment 
By now Austria has reached almost full coverage regarding treatment, counselling and health 
care centres (cf. map 10.2 on p. 49), although there are pronounced differences as to size 
and specific focus of individual centres (cf. ÖBIG 2001a). The necessary services are pro-
vided both by specialised agencies and in the framework of general health care (e.g. by psy-
chiatric hospitals, psychosocial service centres etc.). 
Generally speaking Austria provides a wide range of diversified services in both outpatient 
and inpatient departments. The trend towards flexible services tailored to meet specific de-
mands has continued, so it is becoming easier to respond to individual needs of clients and 
take new trends into account. This tendency also shows in inpatient facilities, which by now 
offer a wide range of modular programmes so patients may choose the modules in which 
they want to take part (e.g. API, Grüner Kreis and Erlenhof - cf. ÖBIG 2001a and EDDRA). 
11.1 Drug-free treatment and health care at national level 
Many therapy centres provide different kinds of treatment, counselling and other forms of in-
tervention, and there is also a number of important facilities situated between the low-thres-
hold and treatment sectors. They provide counselling and act as links to treatment centres 
and also aftercare and reintegration facilities. 
The association Dialog in Vienna, which celebrated its 20th anniversary in September 2001, 
is a good example of an outpatient centre providing a variety of services. In the context of the 
expert meeting Wirkungskreise Dialog’s activities for the next few years were planned: con-
tinuation and diversification of substitution treatment (e.g. low-threshold substitution for 
young people), prevention and treatment of hepatitis, definition of gender-related drug work, 
more intensive cooperation with key actors of addiction prevention especially in the work-
place, interventions related to the labour market, cooperation with established physicians, 
ways of dealing with problematic clients and young people and development of adequate or-
ganisational structures. As work with young people played an increasingly important role for 
Dialog, in autumn 2001 specific further training courses were held. In addition in autumn 
2001 a one-year counselling group for partners of addicts was started (Dialog 2002). 
In Carinthia, apart from a drug department, complete facilities according to Art. 15 of the NSA 
will be established at Villach, Spittal and Wolfsberg, and also at Klagenfurt a drug outpatient 
department has been planned. Lower Austria will expand its treatment services by creating 
four competence centres for addiction therapy. Three of these centres will specialise in alco-
hol problems and one in illicit drugs. In addition to inpatient departments for withdrawal or de-
toxification they will also house an addiction outpatient department and possibly a day-care 
clinic as well. 
Creating forms of treatment oriented at individual needs also means that gender-related 
services should be provided. The essential role of such an approach is supported by the re-
sults of a diploma thesis on women undergoing treatment at the women’s house of Grüner 
Kreis (Gruber 2002). Although many of these women did not show interest in services
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specifically aimed at women before treatment started, afterwards they said that the gender 
aspect had been very important for therapy to be successful. 
11.2 Substitution and maintenance programmes 
In 2001 a feasibility study on opiate withdrawal inpatient treatment with morphine sulphate 
pentahydrate was carried out at the drug withdrawal department of the Hospital of Psychiatry 
at Hall, the Tyrol. The outcome of this study was that when patients were administered mor-
phine, abstinence syndromes could be effectively suppressed, their craving for drugs was 
reduced and they were highly satisfied with this kind of treatment. Consequently the number 
of patients abandoning therapy was markedly reduced. Another study has shown that it is of 
central importance for addicts to keep up inpatient withdrawal treatment, as about 40% of the 
patients dropping out of withdrawal treatment did so during the first 11 or 12 days, while 90% 
of the persons finishing therapy as planned underwent withdrawal treatment for more than 19 
days (Madlung-Kratzer und Altenstrasser 2001). 
The general conditions of substitution treatment (cf. chapter 3.1 and ÖBIG 1999) have not 
changed. The guidelines for opioid-supported substitution treatment have been laid down in 
a consensus paper of the Coordination Office for Addiction Prevention and Drug Help of 
Carinthia and the Centre for Mental Health at the Provincial Hospital at Klagenfurt, Carinthia. 
These guidelines correspond to the Substitution Decree of the FMSSG and provide the 
prerequisites and procedures for substitution treatment. In 2002 Salzburg will establish an 
extramural substitution centre and implement substitution monitoring at the regional level. 
Parallel to this a trend towards inpatient substitution treatment has been registered (e.g. 
therapeutic community Seniobio of Vorarlberg). 
The trend towards prescribing medicines other than methadone is continuing. In Vorarlberg 
roughly two thirds of all patients were already treated with other substitution substances in 
2001. The preparation primarily prescribed is Substitol (35%), followed by Subutex (15%), 
Compensan (9%), Mundidol and Vendal (1% each) and Kapanol. Upper Austria reports a 
similar distribution for 2001, but Compensan and Mundidol are not used there. In the Tyrol 
and Vienna about half of the substitution patients are treated with methadone. 
11.3 Aftercare and reintegration 
Interventions aimed at aftercare and (re)integration of (former) drug addicts address both 
clients having undergone drug-free treatment and persons with manifest addictions. General 
aftercare measures (e.g. psychotherapy or counselling by social workers) are provided by 
many drug help centres. In addition there are specific social (re)integration services in the 
fields of education, occupation and housing (see also ÖBIG 1998, ÖBIG 1999, ÖBIG 2000 
and 2001a). For more details on interventions in this field and their approaches see chapter 
16 of this report. 
Regarding education and training programmes it should be mentioned that in future 
Promente of Styria, which runs a number of job training centres preparing people with psy-
chosocial for job reintegration, will also employ drug users with acute addiction problems. 
Since November 2001 the Vienna Social Fund has taken part in the EU programme Equal, 
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with the project drug-addicts@work. The aim of this initiative is to improve the reintegration of 
jobless drug patients by means of a cooperation of all drug help organisations in Vienna, the 
Vienna Employment Promotion Fund and the Public Employment Service of Vienna (FSW 
2002b, API 2002).  
The socioeconomic project Fix und Fertig of the Vienna Social Projects Association provides 
employment on a per-day basis and transition jobs. As a result of a considerable expansion 
in the last few years, in 2001 organisational restructuring was necessary. However, demand 
for the 19 per-day jobs was so high that an average of 15 persons had to be turned down 
every day. A total number of 57 persons work in transitional jobs and also receive coun-
selling. 32% out of those 25 clients who completed the care programme in 2001 could be 
transferred to other jobs. Similar programmes are also run in the Tyrol: Abrakadabra, with 8 
per-day jobs in postal dispatch, and Jobshop, offering 7 integration jobs. 
Demand for assisted housing is also high. In Innsbruck the project 4 Walls as a Chance run 
by Caritas has helped to ease the situation in the temporary sleeping facility. The target 
group of this project is persons living in Mentlvilla, who will receive counselling by Mentlvilla 
staff also at 4 Walls. Housing for 12 clients is available. 
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12 Interventions in the Criminal Justice System 
12.1 Assistance to drug users in prisons 
The legal and organisational framework of drug-related interventions in prison was discussed 
in detail in chapter 13 of last year’s Report on the Drug Situation (ÖBIG 2001a). No relevant 
changes have taken place in this regard. 
Generally speaking there is a wide range of drug-related interventions taking place in the cri-
minal justice system, e. g. drug-free zones, substitution treatment, drug-free treatment and 
prevention of infectious diseases (cf. Bundesministerium für Justiz 2002). By now 6 prisons 
have drug-free zones and 8 prisons have treatment departments, while syringe exchange 
programmes are still not being run (cf. table A26 of annex B). 
The prisons and the drug help centres cooperate in many ways. The care services the 
Dialog drug counselling centre provides for were expanded in 2001. In 2002 a social work 
project for imprisoned addicts at the police prison of Vienna will be implemented so that not 
only medical but also many other needs of the prisoners may be met (Dialog 2002). 
In 2001 the Diagnoses Institute of the Vienna Social Fund and the Federal Ministry of Justice 
concluded an agreement on treatment and care for prisoners at the Münchendorf branch of 
the Prison of Vienna/Favoriten. As a result group psychotherapy sessions are scheduled 
twice a week and substitution treatment is provided. 
12.2 Alternatives to prison for drug-dependent offenders 
As has already been mentioned in chapter 8, the principle of therapy instead of punishment 
is a central aspect of all drug and addiction plans in Austria. Alternatives to punishment are 
provided by the general drug help system. As a rising number of drug users, in particular 
young people, are referred to drug help organisations for obligatory health-related measures 
imposed in the context of violations of the Narcotic Substances Act, this has put considerable 
strain on the capacities of the counselling centres (cf. chapters 1.3 and 4.2). To tackle this 
problem specific (further) education and training schemes will be organised for public health 
officers (cf. chapter 13), so that health-related measures according to Art. 11 of the NSA will 
be prescribed in a more carefully directed way in the future. 
12.3 Evaluation and training 
Based on the guidelines for addiction prevention events organised by police officers that 
were adopted in 2001, a separate addiction prevention office will be established in the 
Federal Criminal Agency (Department II/BK/12). This office organises one-week courses for 
police officers working in the field of addiction prevention. Other competences in particular in-
clude regional networking and coordination of activities with the Addiction Prevention Units. 
In Styria the expert conference Addiction Prevention, Counselling and the Police was orga-
nised in January 2002 in cooperation with VIVID, the provincial Addiction Prevention Unit. In 
the context of this conference regional cooperation models were drawn up and common 
addiction prevention aims were defined. Similar expert conferences will also take 
y 54 
place in Lower Austria (autumn 2002), Carinthia, Salzburg and the Tyrol  (Tauber W; perso-
nal information). In autumn 2001 a conference on the issue of addiction and drugs from the 
point of view of the police force was held in Upper Austria in the context of the model project 
PräGend (ISP 2002). 
In March 2002 the evaluation of the addiction prevention work of the Criminal Police Informa-
tion Service of Vienna focusing on problems with legal and illegal drugs at schools was con-
cluded. The evaluation covered activities at two schools in Vienna, consisting of one lecture 
for 9th-grade students in one school and a peer education project at the other school. The re-
sults will be presented in autumn 2002. 
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13 Quality assurance 
Quality assurance continues to play an increasingly important role in the field of drug-related 
demand reduction. The corresponding methods of quality assurance include guidelines for 
prevention work, evaluation of projects and activities as well as (further) education and 
training programmes. 
Regarding new guidelines, the consensus from the point of view of addiction medicine on 
the treatment of drug users in Austria suffering from chronic hepatitis C described in chapter 
10 deserves mention. In Styria quality guidelines for drug help centres are being drawn up, 
and Dialog of Vienna and the Vienna Social Projects Association take part in the EU project 
Addiction as a chance of survival for women with experience of violence started in December 
2001. The aim of the project is to define gender-sensitive criteria for and methods of 
addiction work for women, taking into account the aspect of violence in the experience of or-
ganisations for the protection of women on the one hand and traditional addiction help orga-
nisations on the other (Dialog web site, July 2002). 
Evaluation of projects and activities is becoming a standard instrument in the drug help 
sector and has already been included in many plans and programmes. However, funding for 
this purpose is still limited. The reporting period again saw the start or conclusion of several 
project evaluations, e. g. of Living Together (Institute of Drug Prevention, Vienna), Practical 
Prevention of Addiction in Communities (VIVID Addiction Prevention Unit), Children of Drug-
Addicted Mothers (Department of Child Neuropsychiatry at Rosenhügel Hospital of Neurolo-
gy, Vienna), Health Promotion and Addiction Prevention in the Workplace (SUPRO addiction 
prevention workshop) and the pilot project Addiction Prevention at Trofaiach (cf. also chapter 
9.4). 
Since October 2001 ChEckiT! has taken part in an EU project for evaluating the 
effectiveness of secondary prevention measures and in particular the effects pill-testing pro-
grammes have on consumption patterns and risk awareness among users of synthetic drugs 
(ecstasy). This project includes a comparison of drug screening programmes carried out in 
Vienna, Amsterdam and Hanover, which use different procedures. In addition ChEckiT! is 
conducting a survey of demographic variables and consumption patterns at various rave 
events, for which a standardised questionnaire was drawn up (cf. chapters 2.2 and 15.1). 
This survey will be continued in 2002 (VWS 2002e). 
Another measure taken in the field of quality assurance is the certification according to ISO 
9001:2000 of Dialog (Dialog 2002) that was achieved in 2001. 
Training for professional is also a part of quality assurance and plays an important role in all 
related fields. Regarding youth work demand for further education and training in dealing with 
addiction and young people in danger of becoming addicts has been registered. The training 
programme Riscflecting, which has again been scheduled for 2002/3, provides opportunities 
to study risk behaviour and how to deal with this problem. In the Tyrol the prevention centre 
kontakt&co cooperates with MDA basecamp to organise further training schemes for all staff 
of youth organisations (join2gether). The aim is to increase competences with regard to 
identifying and assessing problematic developments that their young clients might ex-
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perience in the context of drugs, and to draw up models for dealing with such situations 
(kontakt&co 2002). In Styria the Addiction Prevention Unit VIVID also organises training pro-
grammes for the staff of youth work centres outside schools. In 2002 the key subjects of 
these programmes are Searching for the Kick (introductory course), Merry Go Down (young 
people and drinking) and Rules for Rules (options for action) (VIVID web site, July 2002). 
As of autumn 2002 the study programme M.S. Social Therapy – Focus on Addiction will take 
place at Danube University Krems. It is a postgraduate course for experts in social work, 
aimed at providing assistance in work with addicted patients and their relatives. 
In October 2001 the Faculty of Medicine at Innsbruck University, again cooperating with the 
Province of Bolzano/South Tyrol, started the 3rd university study course on joint actions in 
the work with addicted patients. 21 persons take part in this course, which will be completed 
in March 2003. 
ÖBIG, on behalf of the Federal Ministry for Social Security and Generations, is drawing up a 
plan for drug-related further education and training for five occupational groups active in this 
field (social workers, clinical/health psychologists, psychotherapists, physicians and public 
health officers; cf. also chapter 12.2), which will be available by mid-2003. 
 
  
 
 
Part 4 
Key Issues 
 
  
 59
14 Demand Reduction Expenditures on Drugs3 
This key issues chapter deals with funds provided for drug-related demand reduction in 
Austria. Here only directly assignable expenditures are taken into account, while social costs 
incurred as an indirect consequence of drug use are not considered. As no relevant figures 
were available in Austria apart from an overview for the year 1997 of expenditures and ser-
vices of drug facilities (Bruckner und Zederbauer 2000), ÖBIG conducted a survey on drug 
expenditures when preparing this key issues chapter in spring/summer 2002. The institutions 
that were contacted included on the one hand the most important financing sources (relevant 
federal ministries and departments, the provinces, social insurance funds, the Public Employ-
ment Service, the Healthy Austria Fund and municipalities that are members of the Local 
Government Federation), and on the other, selected drug help organisations. For more de-
tails regarding samples and return rates see the presentation of the results (cf. chapters 14.3 
and 14.4). The survey covers the years 1999 and 2001. The figures for 1999 were needed 
for the EMCDDA and they are relevant with regard to evaluating the European Action Plan 
on Drugs for the period 2000–2004. In addition it was decided at the Austrian level also to in-
clude the year 2001 to obtain recent figures. In order to give a concise description both years 
are dealt with in this key issues chapter. 
14.1 Concepts and definitions 
The concept of drug-related demand reduction comprises a variety of interventions 
(prevention, harm reduction, counselling and care, treatment, reintegration etc.) aimed at 
preventing use or abuse of illicit drugs and/or reducing the corresponding health and social 
consequences, independent of the actors providing such services. This also includes treat-
ment programmes in prisons or prevention activities by the police force, among other 
measures. In addition to expenditures on the implementation of interventions (i.e. activities 
directly oriented at the target group in question), expenditures on planning and coordinating 
demand reduction and also measures of quality assurance (evaluation, training, relevant re-
search) have been taken into account. 
Regarding financial sources a distinction between internal staffing expenses and cost of 
materials on the one hand and financial support to third parties on the other had to be made. 
In order to calculate net expenditure, revenues were also taken into consideration (cf. chap-
ter 14.3). Expenditures of specialised organisations (prevention and drug work) have been 
broken down by staffing costs, costs of supervision/further training, operating expenditure, in-
vestments and other expenditures (cf. chapter 14.4). 
                                                
3  We wish to acknowledge the invaluable assistance of all persons and institutions who have contributed to this survey of 
demand reduction expenditures on drugs.  
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14.2 Financial mechanisms, responsibilities and 
 accountability 
Funding for treatment and care is mostly provided by the federal, provincial and local 
governments as well as the social insurance institutions. Due to the federalist structure of 
Austria’s health care and social systems the provinces play a central role in this regard. Out-
patient drug facilities are usually financed by way of annual subsidies. Provincial funding pro-
vided for treatment in inpatient drug departments however is often based on individual appro-
val and defined as a personal service for which daily costs are remunerated from resources 
of funds for handicapped persons, social or youth funds. The Health Department of the 
FMSSG grants annual subsidies for inpatient and outpatient departments according to Art. 
16 of the NSA, on the condition that other federal, regional or local authorities also grant 
subsidies at least to the same amount. Funding by the social insurance institutions is avail-
able for patients who have health insurance coverage and for whom a service defined in the 
statutes of the respective health insurance fund is provided by a doctor or institution under 
contract with this insurance fund. Such services provided by established doctors are not 
usually defined in terms of drug help. An exception is specific medical counselling for drug 
patients by established doctors under contract with the Vienna Health Insurance Fund mostly 
in the context of substitution treatment. Doctors are remunerated for this service if they take 
part in special further training programmes (cf. chapter 1.5). 
Treatment in hospital is funded by several different sources. In the context of an agreement 
between the federal and provincial governments dealing with restructuring the health care 
system and hospital financing for the period from 2001 to 2004, provincial funds responsible 
for financing all hospitals in the province that are entitled to subsidies were established. 
Unless exemption has been granted the patients have to contribute co-payment. 
An exceptional case in this field is taking over of costs in the case of alternatives to 
punishment if this is not covered by the social insurance funds. According to the NSA the 
federal government shall be liable subsidiarily for cost coverage (Art. 41(1) of the NSA) if cer-
tain prerequisites are met. But as some of the provincial welfare assistance laws also include 
subsidiary cost coverage provisions, a negative conflict of competences between the federal 
and provincial governments has existed for many years (cf. ÖBIG 2001a). In 2000 the 
Ministry of Justice, which assumes the corresponding costs at the federal level, issued a 
decree (703.015/58-II 2/2000) stipulating criteria for the assessment of subsidiary cost 
coverage obligation on the part of the Federal Government. Based on this decree individual 
agreements with six drug centres have been concluded so far but what is still lacking is ge-
neral coordination with the social welfare departments at the provincial level. 
Expenditures on the Addiction Prevention Units and regional prevention programmes are 
almost exclusively taken over by the provincial, and in some cases also local, governments. 
Nationwide prevention activities both of a general nature and activities in and outside schools 
are financed by the Federal Government from the budgets of the competent federal 
ministries or departments. Prevention activities may be financially supported by the Healthy 
Austria Fund (cf. ÖBIG 1998, 1999). Regarding occupational reintegration co-financing 
comes from the Public Employment Service. 
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Generally speaking, most projects and facilities in the drug help sector receive funding from 
public sources. A number of projects and non-profit associations, especially in the field of 
occupational reintegration, raise a small part of their resources themselves by selling pro-
ducts or providing services in the market (e. g. postal dispatch services, renovation work). 
Profit-oriented enterprises have not traditionally been active in this sector in Austria. As a rule 
public subsidies, also from the Federal Government, directly go to the respective organisa-
tions and projects. There is no nationwide financing programme for drug-related demand re-
duction, which has repeatedly given rise to conflicts between the Federal and Provincial 
Governments. 
14.3 Expenditures at national level 
To get an overview of national expenditures on drug-related demand reduction the most 
important financial sources, i.e. federal, provincial and local governments, social insurance 
institutions, the Public Employment Service and the Healthy Austria Fund, have been consi-
dered in our survey. Analysis of the data obtained and the return rate show that drug-related 
expenditures in specialised and clearly assignable areas (in particular addiction prevention 
and drug-help organisations) may be covered to a satisfactory extent in this way, whereas 
data with regard to the corresponding expenditures in the general health care and social 
systems (e.g. established doctors, hospitals) can be collected with restrictions only. There-
fore based on the data obtained, additional estimates and projections in particular for substi-
tution treatment and inpatient treatment in hospitals (see further below) have been made. In 
some fields it was also difficult to extract expenditures explicitly spent with regard to illegal 
substances. For instance, primary prevention in Austria pursues a comprehensive approach 
(cf. ÖBIG 1998) and is not oriented at specific substances. For this area all expenditures re-
ported were taken into account as all corresponding measures aim at preventing drug 
addiction, although this is not always their only goal. For other kinds of interventions how-
ever, where possible, expenditures specifically focusing on illicit drugs were considered. 
These introductory remarks should make it clear that the following results regarding expen-
ditures at various levels are rough estimates only. 
At the federal level five out of a total number of eight competent ministries or departments 
provided information on demand reduction expenditures (cf. table 14.1), including the Health 
Department of the FMSSG and the Federal Ministry of Justice as the two major financial 
sources. The Health Department sent a comprehensive description, while the Ministry of 
Justice was able only to make available expenditures related to subsidiary cost coverage 
according to Art. 41 of the NSA (therapy instead of punishment, see above) and expendi-
tures of the Prison of Vienna/Favoriten, which specialises in addiction treatment. So what is 
lacking is information on expenditures with regard to other drug-related interventions in the 
criminal justice system – prevention, substitution treatment, therapy departments, infection 
prophylaxis etc. (cf. table A26 of annex B) – and interventions in the field of probation 
assistance. The Youth Department of the FMSSG and the Education Department of the 
FMESC, which provide funding for primary prevention and related measures of quality 
assurance, were able to report only those expenditures that are explicitly used for drug or 
addiction purposes. 
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Three Ministries or Departments (Interior, Defence, Family Affairs) did not provide informa-
tion. Relevant expenditures in the Ministry of the Interior are spent for prevention work by 
police officers, treatment and counselling in police prisons (cf. chapter 12) and young men 
performing civilian service who work in drug help centres. The Ministry of Defence spends 
rather small sums in the context of prevention measures, and the Family Department 
subsidises family counselling centres, some of which also work in the field of drug help. 
Table 14.1: Federal demand reduction expenditures on drugs in 1999 and 2001 
Area 1999 (EUR 1 000) 2001 (EUR 1 000) Ministry/Department1 
Primary prevention 365.9 173.7 Health, Youth, Education 
Outreach work 207.0 198.9 Health 
Substitution treatment2  132.6 141.7 Health 
Outpatient departments 1 152.3 1 047.4 Health 
Inpatient departments 373.5 344.5 Health 
Therapy instead of punishment3 4 433.1 2 986.8 Justice 
Treatment in prison4 3 035.9 2 938.1 Justice 
Quality assurance 347.7 461.9 Health, Youth, Education 
Other expenditures5 319.5 335.4 Health 
Overall expenditures (EUR 1 000) 10 367.5 8 628.4  
1  Ministries and departments providing information on expenditures in this field. 
2  Expenditures on narcotic drug prescriptions in the context of substitution treatment. 
3  Expenditures in the context of subsidiary cost coverage according to Art. 41 of the NSA. 
4 Expenditures on the Prison of Vienna/Favoriten, which specialises in treatment of addicted prisoners. The estimate of 
expenditures on addicted clients is based on the overall expenditures for this prison, with a share of 25% legal and 75% 
illegal drug users. For this purpose overall expenditures and not only drug-related additional costs have been taken into 
account. Expenditures on prevention and treatment in other prisons have not been available (cf. table A26 of annex B). 
5 Other expenditures comprise a number of additional expenditures (staffing costs, travelling expenses, refunding of urinalysis 
costs according to Art. 12 of the NSA) in the Department of Health. 
Sample: ÖBIG sent the questionnaire to those eight Ministries or Departments (Health, Youth, Family, Education, Science, 
Justice, Interior and Defence) where expenditures related to demand reduction expenditures on drugs may incur. Five 
Departments or Ministries (Health, Youth, Education, Science and Justice) took part in the survey, and one of these 
Departments (Science) reported no expenditure on drug-related demand reduction. 
Source: survey by ÖBIG, spring/summer 2002 
An analysis of the data provided shows that a large part of federal demand reduction expen-
ditures on drugs are used for the treatment sector (cf. table 14.1). At the federal level no 
specific revenues in this field were indicated. As a few departments and ministries did not 
supply data, and some expenditures were not registered completely, the overall expenditures 
at the federal level are estimated to be considerably higher than the amounts of EUR 10.4 
million and EUR 8.6 million, respectively, that are given in our survey. The decline of federal 
funds explicitly used in the field of drugs from 1999 to 2001 may be explained by budgetary 
economies (cf. ÖBIG 2000), which also led to a reduction of drug-related funds. 
Due to the federalist structure of Austria’s health care and social system the provinces play a 
central role with regard to expenditures in the field of drugs (cf. chapter 14.2). All nine provin-
ces took part in the survey, but only four provinces (Lower Austria, Salzburg, Upper Austria 
and Vorarlberg) provided data on both 1999 and 2001. This data was used as a basis for 
estimates of the expenditures by the rest of the provinces or in the years for which no infor-
mation could be supplied (cf. table 14.2). The returned questionnaires show that expen-
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ditures in fields not explicitly related to drugs (e.g. emergencies, ambulance services 
needed) or hospital treatment (see below) often could not be specified for the purposes of 
our survey. 
Table 14.2: Demand reduction expenditures on drugs by the provinces in 1999 and 2001 
Area 1999 (EUR 1 000 )
survey 
1999 (EUR 1 000)
estimate1 
2001 (EUR 1 000) 
survey 
2001 (EUR 1 000 )
estimate1 
Primary prevention 1 383.0 1 627.9  3 161.3 3 273.3 
Outreach work and harm reduction2 1 112.8 2 875.0 5 236.7 5 273.4 
Outpatient departments 3 549.4 6 021.5 6 570.1 6 574.9 
Inpatient departments 4 208.1 5 817.0 11 709.4 11 857.1 
Reintegration 254.7 1 164.2 1 031.2 1 031.1 
Quality assurance 90.1 236.9 447.6 492.8 
Other expenditures3 137.3 155.0 151.8 155.1 
Overall expenditures (EUR 1 0004 ) 10 735.4 17 897.5 28 308.1 28 657.7 
1 Not all provinces supplied data for both years (see sample). Therefore based on the average increases (or decreases) in 
expenditures of those four provinces that communicated data both for 1999 and 2001, figures for all nine provinces in the 
individual areas were estimated.  
2 As it was not possible in a few provinces to distinguish between expenditures on outreach work and on harm reduction the 
figures for these two groups have been summed up in one area. 
3 Other expenditures give the sum of additional measures (e.g. drug and addiction coordination, secondary prevention, self-
help, competition, other expenses) that were indicated only sporadically.  
Sample: ÖBIG sent the questionnaire to all nine provinces. Five provinces (Burgenland, Lower Austria, Salzburg, Upper Austria 
and Vorarlberg) communicated data for 1999, seven provinces (Lower Austria, Salzburg, Styria, Upper Austria, the 
Tyrol, Vienna and Vorarlberg) provided data for 2001, and four provinces (Burgenland, Carinthia, Styria, Upper Austria) 
also supplied data for 2000. The latter was taken into account for data analysis regarding the years 1999 and 2001 in 
the case of those provinces that did not supply information on the respective years. However, in our projections these 
figures were corrected correspondingly. For the Tyrol and Vienna only data for 2001 was taken into account, and the 
projection gives correspondingly adjusted figures. 
Source: survey by ÖBIG, spring/summer 2002 
Also at the provincial level a considerable share of expenditures go to the treatment sector, 
however the differences between the individual fields of interventions are not as pronounced. 
The respondents indicated relevant revenues (mostly transfer payments) amounting to 
approximately EUR 133 900 (1999) and EUR 183 300 (2001), respectively. These receipts 
were subtracted from the expenditures. With the exception of Vienna, at the provincial level 
distinctions according to cost type were made in most cases. The focus of expenditures is 
clearly placed on financial support to third parties. Regarding the proportions of funds used to 
cover internal staffing costs and cost of materials on the one hand and financial support to 
third parties on the other (1999: 8%, 2% and 90%), the percentages used for financial 
support to third parties was further increased in 2001 (5%, 1% and 94%). The actual overall 
expenditures at the provincial level are likely to be higher than the sums indicated in the 
survey (roughly EUR 17.9 million and EUR 28.7 million, respectively). The rise from 1999 to 
2001 seems very high, which on the one hand could be due to the fact that resulting from the 
method used the expenditures of 1999 were underestimated (cf. also chapter 14.5), but on 
the other hand this rise obviously also reflects considerable actual increases in funding by 
the provinces (cf. chapter 1.5). 
Local governments (municipalities) also provide remarkably high funds for demand reduction. 
As Austria has as many as 2 359 municipalities, not all of them could be covered by our 
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survey. For our sample we selected those 189 municipalities that are members of the Local 
Governments Federation (cf. table 14.3), where due to larger populations significant expen-
ditures used on drug-related demand reduction are more likely. A total number of 50 muni-
cipalities took part in the survey, and 31 of them did not register drug-specific expenditures in 
the relevant two years. 
Table 14.3: Demand reduction expenditures on drugs by Austrian municipalities in 1999 and 2001 
Area 1999 (EUR 1 000) 2001 (EUR 1 000) Number of municipalities
1999             2001 
Primary prevention 257.0 385.3 8 7 
Outreach work 163.2 288.0 6 7 
Harm reduction  60.3 63.0 2 2 
Outpatient departments2 264.0 294.2 7 8 
Inpatient departments 18.2 86.1 1 2 
Reintegration 11.4 10.5 2 2 
Quality assurance 2.7 42.8 2 2 
Other expenditures3 327.1 12.6 5 3 
Overall expenditures (EUR 1 000) 1 103.9 1 182.5 17 17 
1 Number of municipalities indicating expenses in the individual areas . 
2  Expenditures on substitution treatment by a municipality are listed under outpatient departments.  
3  Overall expenditures also include (rather insignificant) expenditures for emergencies as well as expenditures that could not be 
assigned (a few municipalities did not distinguish between intervention areas but only provided data on overall expenditures). 
Sample: The Local Governments Federation sent the questionnaire to all 189 members, which include all towns of 10 000 
inhabitants or more and approximately 60% of the towns between 5 000 and 10 000 inhabitants. 50 municipalities took 
part in the survey, and 31 reported no demand reduction expenditures on drugs. 2 out of the remaining 19 
municipalities registered demand reduction expenditures in only one of the two years surveyed. Expenditures by the 
municipality (= province) of Vienna are listed under provincial expenditures.  
Source: survey by ÖBIG, spring/summer 2002 
A rather high number of municipalities reported expenditures on primary prevention, outreach 
work and outpatient facilities. These areas of activities also account for most of the funds. 
Revenues (primarily transfer payments) amounting to approx. EUR 320 600 (1999) and 
283 600 (2001), respectively, were indicated, which were subtracted from the expenditures. 
Compared to the provinces the apportionment of funds according to internal staffing ex-
penses and costs of materials on the one hand and financial support to third parties on the 
other (1999: 43%, 19% and 35%; 2001: 24%, 15% and 61%) is more evenly balanced in the 
municipalities, but here also the share of financial support had risen in 2001. As in the case 
of the provinces compared to previous years the municipalities have increased their demand 
reduction expenditures on drugs. The overall expenditures of all municipalities in Austria are 
likely to be noticeably higher than the sums reported by the 50 municipalities taking part in 
our survey (i.e. approx. EUR 1.1 million for 1999 and EUR 1.2 million for 2001). 
A relevant share of drug-related expenditures incurred in the context of the general health 
care system are covered by the social insurance funds. This in particular applies to substitu-
tion treatment (for more details see ÖBIG 1999) and inpatient treatment in hospitals (cf. 
chapter 14.2 and below). 21 out of a total number of 22 health insurance funds took part in 
the survey (cf. table 14.4). However, many health insurance funds could provide information 
only to a limited extent as drug-related data is not collected separately in most cases. For in-
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stance, only Vienna explicitly provides remuneration for the service of specific medical coun-
selling for drug patients by established doctors (cf. chapter 14.2), so the corresponding pay-
ments may be identified as drug expenditures. In addition substitution patients in Austria are 
often prescribed prolonged-action morphines, which also play an important role in the context 
of pain treatment and thus do not necessarily come under drug expenditures. Still, with re-
gard to substitution treatment sufficient data was available to permit at least a projection and 
thus a more exact estimate. 
Table 14.4: Demand reduction expenditures on drugs by the health insurance funds in 1999 and 2001 
Area 1999 (EUR 1 000 )
survey 
1999 (EUR 1 000)
estimate 
2001 (EUR 1 000) 
survey 
2001 (EUR 1 000 )
estimate 
Substitution substances1 1 392.7 1 669.1 3 539.7 4 349.3 
Substitution – other costs2 767.8 1 207.8 1 209.1 1 946.8 
Inpatient treatment in hospital3 1 357.7 6 646.2 1 179.8 7 401.6 
Other expenditures4 481.5 481.5 436.6 436.6 
Overall expenditures (EUR 1 000) 3 999.7 10 004.6 6 365.2 14 134.3 
1 The figures given refer to those substances that may be assigned to substitution treatment as explicitly as possible 
(methadone, Subutex, Substitol). As a few provinces could not extract their corresponding expenditures, projections based on 
the available data and the number of substitution clients were made. 
2 These figures primarily relate to expenditures on counselling services for substitution patients provided by established 
doctors. These expenditures could be specifically identified and thus extracted only for Vienna (remuneration of specific 
medical counselling for drug patients by established doctors). Based on the expenditures and patients registered in Vienna 
and the number of substitution patients in the individual provinces, the expenditures of the other provinces were estimated. 
3 In the estimate regarding expenditures for inpatient treatment in hospitals 40% of the calculated costs of inpatient drug-
related treatments in hospitals were taken into account. 
4 This group summarises a number of expenditures (psychotherapy, outpatient treatment in hospitals, outpatient treatment in 
drug facilities, other expenditures with regard to established doctors etc.) as each of these cost types was indicated by only 
one health insurance fund. No comparison figures were available in this field so no projection was made. 
Sample:  The Main Association of Austrian Social Insurance Institutions sent the questionnaire to all 22 health insurance funds. 
21 of them took part in the survey, 7 of which reported no expenditures on drug-related demand reduction, while two 
other replied that drug-related expenditures could not be identified.  
Source: survey by ÖBIG, spring/summer 2002 
In addition to the survey drug-related expenditures on inpatient treatment in hospitals were 
also calculated, as the financial sources taken into account could not provide these data to a 
sufficient extent. The calculation of the corresponding expenditures is based on hospital days 
of patients with drug-related main diagnoses in 1999 and the average expenses of those 
hospital departments where drug patients are most frequently treated. The data for 2001 was 
projected taking into account increases from 1999 to 2000. In 1999 a total of 76 148 hospital 
days could be assigned to drug-related main diagnoses, which corresponds to an estimated 
expenditure of approximately EUR 16.6 million. Estimates for 2001 are roughly 80 000 
hospital days and expenditures of about EUR 18.5 million. Approximately 40% of the costs 
are taken over by the social insurance funds, however, a more detailed breakdown by other 
financial sources is not possible (cf. chapter 14.2). 
Problems with data assignment not only concern expenditures but also revenues. A number 
of health insurance funds reported receipts, mostly in the form of prescription fees, but the 
respective amounts, i.e. approximately EUR 6 900 (1999) and EUR 15 000 (2001), obviously 
are too low to be realistic. The estimated overall expenditures of health insurance funds 
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markedly rose from roughly EUR 10 million in 1999 to approximately EUR 14.1 million in 
2001. Apart from inpatient treatment in hospitals, substitution treatment also accounts for an 
important share in expenditures. 
Regarding occupational reintegration of drug users and addicts the Public Employment 
Service (AMS) is a significant provider of funding. The federal office of AMS sent the 
questionnaires to the nine provincial offices, six of which (Burgenland, Lower Austria, Styria, 
Upper Austria, Vienna and Vorarlberg) took part in the survey. It has already been mentioned 
that the expenditures indicated (with the exception of Vorarlberg) only refer to financial 
support to drug-related projects, as regarding financial support to persons (i.e. personal fun-
ding provided either to enterprises or the person in question) and subsidies for labour costs 
one cannot usually specify which share is used for drug-related work. Calculated on this 
basis the drug-related expenditures of the Public Employment Service amounted to EUR 3.1 
million in 1999 and EUR 3.6 million in 2001. 
The Healthy Austria Fund subsidises health promotion measures, which also include 
addiction-preventing interventions and quality assurance measures in this field. In 1999 the 
Fund spent approximately EUR 0.3 million on drug-related demand reduction, and in 2001, 
about EUR 0.2 million. 
14.4 Expenditures of specialised drug centres 
The expenditures of specialised drug centres have been estimated on the basis of a sample. 
The FMSSG sent the questionnaire to those centres that receive subsidies according to Art. 
16 of the NSA (cf. table 14.5). For our analysis data on roughly 45 centres4 was available, 
which covers a cross-section of the different kinds of services provided (prevention of 
addiction, outreach services, harm reduction, inpatient and outpatient treatment, counselling, 
reintegration). However, the results obtained do not give a complete picture regarding 
expenditures but still provide an overview of the structure of expenditures and the different fi-
nancial sources of these centres. In order to avoid double counts the expenditures of specia-
lised centres were not taken into account when the overall expenditures on drug-related de-
mand reduction were calculated (cf. chapter 14.5). 
10% of the calculated overall expenditures of approximately EUR 18.0 million and 20.7 
million respectively (cf. table 14.5) go to the Addiction Prevention Units, 25% to outpatient 
centres for counselling, care and treatment, 45% to inpatient departments, and the remaining 
20% to organisations focusing on outreach work, low-threshold intervention and 
reintegration. 
The major part of the expenditures of specialised centres is used for staffing costs and 
especially staff directly working with the target group (clients; cf. Table 14.5). This structure 
of expenditures has not significantly changed over the years investigated in our survey. 
                                                
4 According to a survey by ÖBIG (cf. ÖBIG 2001b), in 2000 Austria had approximately 160 drug help centres (in addition to the 
eight Accition Prevention Units). Our sample includes many, though by far not all, important service providers in this field. 
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Table 14.5: Expenditures of drug-help centres by cost type in 1999 and 2001 
Cost type Expenditures in 
1999 
(EUR 1 000) 
Expenditures in 
1999 (%) 
Expenditures in 
2001 
(EUR 1 000) 
Expenditures in 
2001 (%) 
Staffing costs – total1 12 357.4 68.7 14 121.3 68.2 
  of these:  for work with clients 9 867.3 54.8 11 293.5 54.5 
    of these: other fields (administration etc.) 1 202.1 6.7 1 358.8 6.6 
Supervision/further training 147.5 0.8 173.7 0.8 
Building expenses and related running cost 922.5 5.1 1 039.5 5.0 
Operating expenses2 1 851.7 10.3 2 065.6 10.0 
Investments 590.8 3.3 576.8 2.8 
Other costs2 2 120.0 11.8 2 745.7 13.2 
Overall expenditures (EUR 1 000) 17 989.9 100.0 20 722.6 100.0 
1 Total staffing costs are higher than the sum of staffing costs directly related to client work plus other staffing costs (e.g. for 
administrative staff), as a number of facilities could only provide information on overall staffing costs.  
2 In a number of facilities operating expenses or other expenditures include all costs apart from staffing costs. So the relevant 
figures given here are somewhat higher than in reality. 
Sample: The FMSSG sent the questionnaire to all prevention centres and drug help facilities that receive annual subsidies by 
the FMSSG according to Art. 16 of the NSA (cf. chapter 14.2). 30 out of a total number of 39 centres took part in the 
survey. As a number of them also provided data on facilities not subsidised by the FMSSG or on the overall 
expenditures of various centres, information on approximately 45 drug help centres was available. Two centres only 
communicated data on the year 2001, and the figures for 1999 were calculated on the basis of the average data of the 
other centres, taking cost types into account. 
Source: survey by ÖBIG, spring/summer 2002 
The analysis of revenues (cf. table A27 of annex B) shows that the drug help centres receive 
funds from a large number of different sources and authorities. In this context the provinces 
play the most important role, accounting for approximately 46% of the receipts of the centres, 
however also the provincial hospital financing funds (Hospital Funds), the social insurance in-
stItutions and a number of federal ministries (especially the Ministry of Justice, due to 
subsidiary cost coverage according to Art. 41 of the NSA) provide relevant contributions in 
particular with regard to inpatient treatment. Comparison of the two years of reference shows 
a decline in federal funding (cf. also chapter 14.3), while receipts coming from other financial 
sources have risen. 
14.5 Conclusions 
As this was the first survey of public expenditures on drug-related demand reduction carried 
out for Austria a number of problems arose (cf. chapters 14.3 and 14.6). In order neverthe-
less to give a rough estimate of total expenditures it was necessary to estimate expenses in 
some fields. Calculations on this basis show overall expenditures on drug-related demand re-
duction amounting to at least EUR 52.3 million in 1999 and at least EUR 66.8 million in 2001 
(cf. table 14.6). By far the largest share is accounted for by counselling, care and treatment. 
This is primarily due to high costs of inpatient treatment. The largest share of expenditures 
are financed by the provinces (cf. table A28 of annex B). 
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Table 14.6: Overall demand reduction expenditures on drugs in Austria by area in 1999 and 2001 
Area 1999 (EUR 1 000) Percent 2001 (EUR 1 000) Percent 
Primary prevention 2 477.1 4.7 4 009.3 6.0 
Outreach work and harm reduction1 3 305.7 6.3 5 825.0 8.7 
Counselling, care and treatment2  40 770.4 78.1 50 736.8 76.0 
Reintegration 4 296.6 8.2 4 667.2 7.0 
Quality assurance 662.1 1.2 1 016.3 1.5 
Other expenditures/not assignable3 801.4 1.5 501.4 0.8 
Overall expenditures (EUR 1 000) 52 313.3 100 66 756.0 100 
1 This group includes expenditures for outreach work, harm reduction, low-threshold centres, temporary sleeping facilities etc. 
and emergencies. 
2 This group includes expenditures for inpatient and outpatient departments, substitution treatment, interventions with regard to 
therapy instead of punishment, treatment in prisons, inpatient treatment in hospitals and other expenditures by health 
insurance funds. Double counts have been excluded here. 
3 Other expenditures also include expenditures by some local authorities that could not be specifically assigned as no 
distinction between areas of intervention was made but only figures on overall expenditures were provided. 
Note: For calculating overall expenditures the results of the projection and not the data collected were used. For further details 
regarding sample, rate of return and projection see chapter 14.3. Expenditures by drug-help centres (cf. chapter 14.4) 
were not taken into account when calculating overall expenditures in order to avoid double counts. 
Source: survey by ÖBIG, spring/summer 2002 
The study by Bruckner and Zederbauer (2000) gives estimates of expenditures on prevention 
and drug help in 1997 amounting to EUR 53.1 million. This roughly confirms our estimates 
but also indicates that the expenditures for 1999 are likely to be higher, as provincial expen-
ditures in this year were rather underestimated (cf. chapter 14.3). So a corrected estimate 
taking this factor into account indicates demand reduction expenditures on drugs of approxi-
mately EUR 60 million in 1999 and EUR 67 million in 2001. 
In order to illustrate the actual significance of these figures the calculated overall 
expenditures will also be related to other expenditures. According to the study by Bruckner 
and Zederbauer (2000) expenditures for criminal prosecution with regard to drugs (police and 
judicial authorities) amounted to approximately EUR 96.7 million in 1997. As reports to the 
police and also convictions have risen (cf. chapter 4.2) by now expenditures in this field 
seem to have gone up considerably, so one may assume that compared to demand reduc-
tion, expenditures on repressive interventions tend to be about twice as high. The proportio-
nalities may also be shown by comparison to social expenditures according to ESSPROS, 
which includes health and social expenditures. In Austria approximately EUR 54.7 million 
were spent in this field in 1999 (Statistik Österreich 2002). This means that expenditures on 
drug-related demand reduction account for only 0.1% of overall social expenditures. 
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14.6 Methodological information 
Data with regard to demand reduction expenditures on drugs are not traditionally collected in 
Austria, so routine data has not been available so far. Only a few years ago, the first and only 
study on this subject was drawn up, providing figures on expenditures in 1997 (Bruckner und 
Zederbauer 2000). Although not all areas are covered this study is a good basis for further 
investigations. 
As no data for the years 1999 and 2001 was available ÖBIG conducted a survey especially 
for this key issues chapter. What was encouraging was the readiness to take part of the or-
ganisations and authorities contacted, so in spite of methodological problems and restrictions 
it has been possible to provide a rough estimate of the total expenditures. Generally 
speaking the procedure of data gathering has proved its worth. A more exact analysis would 
have taken considerably more time and exceeded the resources available for drawing up this 
key issues chapter. 
In order to gather experience for future work in this field, the questionnaires included a page 
for comments, which some of the respondents used for replies. The main aspects pointed 
out were problems of distinguishing between expenditures for legal and illegal substances, 
so often shares of the respective drug clients in the total number of patients were used as a 
guideline for cost assignment. Another problem is that it is often very difficult, and sometimes 
impossible, to identify drug expenditures in fields that do not exclusively focus on illicit drugs 
where expenses are not usually broken down in this way. Regarding substitution treatment 
and inpatient treatment in hospitals, however, reliable results may be obtained on the basis 
of cost estimates. 
In the context of this survey the wish was expressed to develop standards for future routine 
data collection, as major problems generally arise when subsequent surveys have to be con-
ducted. In the next few months this will be organised in cooperation with national partners, on 
the basis of the experience made in the context of this year’s survey and analysis. What 
would also be interesting is a discussion of standards in the European Union so as to im-
prove comparability of data at the European level. 
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15 Drug and Alcohol Use Among Young People 
This key issues chapter focuses on the trends of drug use among young people. In accor-
dance with the guidelines of the EMCDDA it was attempted to limit the age group to 12 to18 
year olds (cf. table A29 of annex B) and to further distinguish between young people of 12 to 
14 and 15 to17 years of age. However, this was only possible for part of the available data. 
Therefore studies and data not exactly limited to the above mentioned age group, which 
nevertheless provide interesting insights as to drug trends among young people, are also in-
cluded. The survey concentrates on illegal substances. In order to render a more compre-
hensive view of the consumption of addictive substances among young people, reference is 
also made to the use of legal drugs, especially alcohol.  
15.1 Prevalence, trends and patterns of use 
In Austria there are three relevant groups of young drug users: 
• The first groups is young people who have tried – mostly single/individual – substances 
at one time or other, without repeating this experience. 
• The second group is young drug users experimenting intensively with various substances 
over a prolonged period of time. In most cases the consumption of drugs is limited to this 
specific period in their lives without leading to problem use or addictive behaviour.  
• The third (and smallest) group shows massive drug abuse patterns already at an early 
age, in most cases linked to substantial social and psychological problems. 
Data on the first group of young experimental drug users is available from a number of 
surveys (cf. table A1 of Annex B). The most recent information comes from a survey of 
schools in the province of Burgenland, a study on young people in the city of Graz, Styria, 
and data on cannabis use included in the HBSC survey (cf. also chapter 2.2).  
In spring 2001 a survey regarding legal and illegal drug use among a total of 1 078 respon-
dents aged between 12 and 19 was carried out at 22 schools in Burgenland (Schönfeldinger 
2002). Apart from alcohol (97%) and nicotine (47%) the respondents primarily indicated to 
have tried cannabis and poppers (20% respectively) at one time. High prevalence rates were 
found for the experience of biogenic drugs, followed by ecstasy (4%), speed and hallucino-
gens (3%), cocaine (2%) and heroin (1%). The survey reveals marked age and gender 
differences. 11% of the responding 12 to 14 year-olds indicate experience of at least one 
illegal substance, the corresponding value for the group aged 15 to 19 is 29%. Experience of 
poppers and biogenic drugs, however, is indicated somewhat more frequently among the 
younger age group (25%) compared to the older one (22%). Reports of regular alcohol and 
nicotine use are more frequent among older adolescents. Approximately half of the younger 
and 85% of the older age group responded to have been drunk at least once. In both age 
groups experience of illegal substances and the incidence of regular alcohol use is higher 
among the young men compared to the young women. The respondents indicated that they 
used drugs primarily in the company of close friends, and solitary use was rarely practised. In 
the course of the Austrian survey within the framework of the international WHO project.
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entitled Health Behaviour in School-aged Children (HBSC) dealing with the state of health 
and health behaviour/management among the target group, in 2001 data on cannabis con-
sumption was collected for the first time (cf. Dür und Mravlag 2002). Out of the total number 
of respondents aged 15 (1 292), 8% indicated to have used cannabis once or twice, another 
6% at least three times. Intoxication caused by alcohol was reported by 11.2% of the 13 
year-olds and 17.2% of the 15 year-olds.  
A study carried out in Graz, Styria in spring 2002 (cf. chapter 2.2), in the course of which 515 
adolescents and young adults aged 12 to 25 were surveyed (X-Sample 2002), generally 
showed a higher prevalence of illicit drugs. However, the difference becomes somewhat less 
marked when narrowing down the age groups. Illegal drug use is insignificant among the 12 
to 13 year-olds, and experience of drugs is limited to cannabis on a small scale (3.4 %). For 
all substances there is a substantial increase of indicated drug use with age, the most rele-
vant substances being cannabis (40% among the respondents aged 14 to 15), natural drugs 
(19%), party drugs and poppers (9% each). Regarding multiple drug use alcohol and 
cannabis is named as the most frequently used mixture.  
The representative surveys organised by the Institute for Social and Health Psychology in 
Carinthia, Lower Austria and Vienna among a total number of  4 668 respondents aged be-
tween 13 and 18 years in the period from 1996 to 1998 (Bohrn und Bittner 2000) also 
demonstrated a clear correlation between the use of legal and that of illegal drugs. To give 
an example, 34.6% of the respondents reporting to drink alcohol several times a week also 
indicate experience of cannabis. Similarly, there is an increased readiness/propensity/inclina-
tion towards trying ecstasy among users of other legal or illegal substances. 
Data for the second group of young people is available from several studies focusing on spe-
cific youth cultures, which do not claim to be representative. A study on the significance and 
use of psychoactive substances among young people in Austria (Springer et al. 1999) 
surveyed 200 respondents between 14 and 23 years of age from four different backgrounds: 
ravers, fun sports, youth associations and a control group. According to the indications by the 
respondents, the raver group had the strongest tendency to experiment with legal and illegal 
drugs (e.g. alcohol 94%, cannabis 82%, ecstasy 64%, stimulants 54%, cocaine 42%, LSD 
40%, sedatives 20%). The fun sports group ranks second (alcohol 100%, cannabis 76%, 
ecstasy: 10%, stimulants 20%, cocaine 22%, LSD 24%, sedatives 26%), while the other two 
groups tend less towards illicit drug use. Concerning the use of alcohol, however, they are at 
the same level as the ravers and fun sports groups. 96% of the youth association group and 
94% of the control group indicated to consume alcohol. The value for all illegal substances 
decreased markedly in all groups when they were asked to indicate consumption within the 
preceding three months. While for cannabis, occasional solitary use at home was indicated, 
ecstasy, stimulants, cocaine, LSD and other drugs were consumed among friends, particu-
larly at rave parties, and stimulants were used specifically to fight/prevent exhaustion.  
Data on the experience of use and behaviour of rave attenders was also collected in the 
context of the pilot project ChEckiT! in Vienna (cf. chapters 2.2 and 15.3) and the EU project 
Drug affinity of young persons in the techno party scenes of European cities. The 346 
respondents surveyed in the ChEckiT! study reported experience of a variety of legal and 
illegal drugs (alcohol 98%, nicotine 94%, cannabis 73%, speed 56%, ecstasy 53%, LSD and 
poppers 40%, cocaine and smart drugs 30%). Regarding consumption patterns it turned out 
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that speed, ecstasy, LSD, cocaine and smart drugs were used preferably among friends at 
rave events and in clubs. One remarkable finding was that in comparison to representative 
studies, consumers of synthetic drugs used more nicotine and cannabis than average, but 
only half the amount of alcohol compared to their peers. Among the responding ravers mul-
tiple drug use is very common, but there is a certain amount of caution regarding the simul-
taneous use of several substances (Kriener et al. 1999).  
In the course of the EU study (Tossmann et al. 1999) techno events were investigated both 
in Vienna and in the province of Vorarlberg, in order to obtain complementing data for more 
rural areas. The results for Vienna are similar to and comparable with those of ChEckiT! in 
many respects. The consumption experience for individual substances is also approximately 
at the same level, with the exception of ecstasy and speed, for which experience is reported 
by markedly fewer respondents (below 40%). This is hardly surprising, considering that the 
ChEckiT! questionnaires were filled in by persons interested in the project (and particularly in 
having the quality of their pills tested). In Vorarlberg the figures for experience of illegal drugs 
were generally much lower (cannabis 59%, ecstasy 32%, speed 26%, hallucinogens 23%, 
cocaine 16%). It was also shown that users in Vorarlberg have less affinity towards poly-drug 
use and are more cautious regarding simultaneous use of various substances.  
However, it should be pointed out once more that these surveys result from investigations of 
specific youth cultures and do not claim to be representative. Moreover, not only adolescents 
but also young adults were included. Still, their findings have yielded remarkable insights into 
the consumption patterns of young people, so they were included in the absence of more 
specific data.  
Data concerning the third group, problematic drug users or drug addicts, is even more 
scarce. According to a prevalence estimate carried out for 1995, the number of problem 
opiate users was 4 000 in the age group between 15 and 24, with a presumable majority in 
the older age group (cf. Uhl und Seidler 2000). On the whole a stable situation is reported for 
the number of young problem drug users in Austria, with regional variations however. The 
trend towards abuse of stimulating substances in the context of poly-drug use registered in 
last year’s report appears to apply especially to young people. At the therapy community 
Grüner Kreis (Muhr 2002), use of ecstasy has been found among young clients (50.4%) prior 
to therapy to a significantly higher degree than among adults (23.8%). This third group of 
young drug users is also the only one where intravenous consumption patterns can be 
expected to be of any relevance.   
According to a survey conducted in the Tyrol (Schüßler et al. 2000) the high-risk group of 
young people who massively abuse drugs for the greatest part does not consist of pupils. In 
the course of an ÖBIG study on young people in danger of becoming addicted that was 
based on the analysis of relevant literature and expert interviews (ÖBIG 2001c), the common 
denominator for the various psychological and social risk factors turned out to be lack of 
care, structure, orientation and positive relationships as well as perspectives for the young 
people in question. What was found to lead to addiction in this context was an accumulation 
of problem situations in connection with lacking resources (protective factors) rather than 
individual risk factors (cf. also chapter 16.1).  
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Some of the surveys that have been mentioned include motives for use, attitudes towards 
drugs and risk assessment indicated by young people. According to the survey of schools in 
Burgenland (Schönfeldinger 2002) young people say they take drugs because “you’ve got to 
try everything” (30%) and because they want to enhance a positive mood (17%). In the 
comparative study of various youth cultures (Springer et al. 1999) the young people reported 
that drugs would get them in a good mood (cannabis, ecstasy), would make them happy 
(ecstasy, LSD, cocaine, stimulants), enhance their performance (stimulants, cocaine) and 
expand their minds (LSD, ecstasy). According to the survey conducted in Innsbruck, the 
Tyrol in spring 1999 among 493 adolescents aged between 14 and 19 (Schüßler et al. 2000), 
“fun” was indicated as the most important motive for drug consumption (40%) followed by “it 
tastes good” and “drugs are common among my friends“.  
The study carried out in Graz (X-Sample 2002) demonstrates that the attitudes of the 
respondents to illegal drugs in general (soft and hard drugs) become more liberal with age, 
but cannot be termed extraordinarily liberal in any of the age groups. The social pressure 
exerted by groups of drug users also goes down with age. Remarkably, younger respondents 
tend to be convinced that they won’t become addicted to drugs to a larger extent than young 
adults aged 20 years and over. On average, cannabis is classified as by far the least harmful 
drug (an assessment which reaches its peak in the age group of the 16 to 17 year-olds), 
while alcohol and tobacco are considered to be rather harmful. As to gender-specific 
differences, compared to the assessments by young women, young men classify cannabis 
products, speed and hallucinogens as significantly less harmful. 
An overview of the findings concerning the use  of illegal drugs by young people shows that 
the prevalence of drug experience has risen over the past decade. From the mid-90s on par-
ticularly ecstasy, and consequently stimulants in general, became established as youth drugs 
beside cannabis, the latter still being of much greater significance, however. Hardly any com-
parable data is available on biogenic drugs and poppers, for which high prevalence rates are 
currently found. In recent years the simultaneous use of various substances in combination – 
especially, but not only, in the rave scene – has been a topic of discussion. The number of 
problem drug users or drug addicts among young people in Austria is considered to be 
stable. 
 
15.2 Health and social consequences 
Negative health and social consequences of drug consumption are found particularly in the 
third group of young drug users indicated above, i. e. problem drug users or addicts. 
The number and share of young people among drug victims has varied strongly over the last 
decade. The number of deaths directly related to drug use ranged from seven (or 6.0% in 
1998) to 31 (or 19.7% in 1993) among young people under 19 years of age (cf. table A5 in 
annex B). The corresponding figure for 2001 is 21 (15.1%), in six cases death was caused by 
a mixture of opiates and psychoactive medicines and in seven cases, by a mixture of 
opiates, other addictive substances and psychoactive medicines (cf. table A7 in annex B). 
With regard to overdoses and emergencies connected to drug use, there is hardly any youth-
specific data available. In Vienna the ambulance services were called because of drug-re-
lated emergencies concerning persons aged between 11 and 20 in 19% of all cases in the 
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year 2000 (FSW 2001). The hospital connection service CONTACT of Vienna (cf. EDDRA) 
has registered a stable number of first contacts with young people over the past years, 
approximately 20% out of the total number of first contacts. A survey carried out in 1998/99 
among clients with overdoses included 27 adolescents. Different from the situation of the 
adults, their problems were related to family and partnerships rather than to addiction 
(Seidler 2000). Statistics in the field of road accidents do not permit any conclusions to be 
drawn as to risks connected to drug use among young people.  
Data on the demand for treatment among young people is available from the statistics of 
substitution treatment services and information from the drug help organisations. In the last 
decade a total of 340 persons aged between 15 and 17 were undergoing substitution treat-
ment in Austria; the number of young people among them rose from 11 in 1992 to 93 in 
2001, representing a share of 1.7% of all clients undergoing substitution treatment in 2001. 
cf. also chapter 3.1).  
In spring 2002 the subject of children and adolescents was on the agenda of the Vienna 
Drug Advisory Board, and in this context various data and experience from the drug-related 
services were presented. In a survey of the attendance of clients under 19 years of age at 
drug help services in Vienna in 2001 (FSW 2002c) a total of 798 adolescents were registered 
in outpatient and 208 in inpatient services, multiple counts not excluded. The therapy 
community Grüner Kreis, which offers special housing to young people (cf. chapter 15.3 and 
EDDRA), registered a high share of 18% of young people (under 18) among its clients in 
long-term inpatient therapy (Muhr 2002). At the long-term therapy drug department of Otto 
Wagner Hospital the share of clients under 20 years is 10%. The withdrawal and short-term 
therapy department at Anton Proksch Institute (API 2002) registered a share of clients under 
19 between 4.5% (1998) and 7.9% (1999) for the past few years, the most recent figure for 
2001 was 7.2%. In the field of low-threshold services, approximately 6% of all contacts in 
2000 referred to young people (FSW 2001).  
It is remarkable that the gender distribution is balanced in the various fields of drug-related 
work with young clients, or there are even more young women than men involved, while 
among adult clients men have a clear majority. 
The experts of the Vienna Drug Advisory Board unanimously stated that there has been no 
rise in numbers of problem drug users among young people. However, there are some re-
ports regarding qualitative deterioration of the psychological and social situation of the young 
people concerned. To give an example, the drug department of the Anton Proksch Institute 
has registered an increase of young patients with severe personality disorders and anti-so-
cial behaviour in addition to drug problems (API 2002). Also in the Tyrol, the issue of young 
people in a situation where a number of other severe problems and worries come on top of 
massive poly-drug use has become a topic of discussion (Oberarzbacher 2002). Even young 
problem drug users and addicts have grave social problems, e.g. homelessness, arising not 
so much as a consequence of drug use (cf. chapter 16.3) but rather in the context of a so-
cially problematic situation that has existed before.  
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15.3 Demand and harm reduction responses 
Measures relating specifically to young people exist at all levels of demand reduction. There-
fore only some selected examples of projects and programmes can be discussed here.  
In Austria young people have traditionally been an important target group of primary preven-
tion measures (cf. chapter 9 and EDDRA). Corresponding interventions concentrate on 
schools and youth work outside schools, but over the last few years young people have also 
increasingly often been reached via addiction prevention programmes in communities and 
enterprises. In addition to adolescents themselves multipliers are a relevant target group of 
the corresponding measures. One example is the Knowledge Exchange for supportive youth 
work in the field of prevention, which offers further education to a variety of actors working 
with young people full time or as volunteers. The education and information package Step by 
Step (cf. EDDRA) has been designed for teachers and is aimed at improving competences in 
tackling the issue of drugs in class. Following a test stage this programme with a focus on 
secondary prevention has been expanded on a nationwide basis. 
In the past few years secondary prevention measures have clearly gained in importance and 
are expanded in many provinces (e.g. Lower Austria, Carinthia, Vorarlberg; cf. also chapter 
8.1). On the one hand this is a response to rising prevalence rates among young people (cf. 
chapters 2.2 and 15.1), and on the other the aim is to prevent problem drug use and 
addiction among young people who already take drugs. In the mid-90s the focus was placed 
on synthetic drugs. Projects in line with this approach continue to play an important role. The 
Vienna-based project ChEckiT! (cf. EDDRA) combines secondary prevention activities with 
pill-testing services on the spot for attenders of rave events, thus reaching a group of young 
people who despite regularly taking drugs often do not see themselves as drug users and 
would not access the established drug help services. In 2001 ChEckiT! for the first time be-
came active in other provinces (Lower Austria, Upper Austria, the Tyrol) and uses new infor-
mation technologies by providing a web site and an online counselling service (cf. chapter 
10). The project MDA basecamp run in the Tyrol has also carried out secondary prevention 
activities in the party scene for some years. In the last few years the general trend in secon-
dary prevention has been to establish outreach facilities and mobile services. In several 
districts of Lower Austria for instance mobile youth work projects were created and their 
expansion has been planned (cf. chapter 9).  
In the approach towards young people in danger of becoming addicted, the main concern is 
integration. In the ÖBIG study cited above (2001c) it was recommended to counteract the 
existing deficiencies with regard to counselling young people at risk of becoming addicted by 
providing integrative measures in the field of youth work (outside schools). Some provinces 
have already implemented this approach. In Vienna a competence centre was created at the 
Youth and Family Office for the purpose of improving the youth welfare counselling services 
(particularly assisted housing) for young people at risk of becoming addicted, through 
interface management, transfer of competence and knowledge as well as counselling and 
further education in the field of drugs. With excellent assistance by the drug help organisa-
tions it was possible to reduce fears connected to the issue of drugs and solve many 
problems without external help, so that the mobile task force intended to back up the 
counselling staff in crises and emergencies has not had to become active so far (Bäcker 
2002). 
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Also in the field of treatment there are services especially designed for young people. In this 
context it is interesting to view the experience made at the association Grüner Kreis (cf. 
EDDRA) providing long-term inpatient therapy in a special house for young people, among 
other measures. While the rate of adolescents abandoning therapy used to be approximately 
90% some years back, they have gone down to the current rate of between 60% and 70%. 
At the young people’s house Frankenau the rate was even lowered from 80% to 40%. 
Apparently this favourable development has been caused by a change in the therapy pro-
gramme. Following the trend of the time, in the beginning work with young people was 
strongly oriented towards adventure programmes, which however soon lost their appeal to 
the young patients. The revised programme focuses on (continuing) education and personal 
freedom. The aim is to give young people the opportunity to develop responsibility for their 
own lives and a perspective for the future. The core elements of the programme now relate 
to structure, freedom and perspective, which has proved more successful by far. Moreover 
the age range of the clients of the house for young people, which used to be 15 to 22 years, 
could be lowered to a current maximum of 19 years (Muhr 2002). 
The low-threshold services are contacted by young clients as well. Out of 18 089 contacts re-
gistered at the Ganslwirt day care facility, 4% refer to persons under 19 years of age. For the 
sleeping facility the corresponding figure is 7%. In the syringe exchange programme at 
Ganslwirt the share of young people is 4% (FSW 2001). However, experts do not consider 
low-threshold services mainly frequented by adults to be an ideal setting for young people, 
as there is danger of intensified contacts with the drug scene. Thus a certain – however 
small – group of young people with massive drug problems would benefit from adequate low-
threshold facilities especially aimed at adolescents.  
The existing social problems are addressed particularly in the field of housing, with in-
creasing importance attributed to integrative facilities (cf. also above). Both Chill out in Inns-
bruck (the Tyrol) and Airbag in St. Pölten (Lower Austria) provide assisted housing, which is 
open to young drug consumers and adolescents in danger of becoming addicted. However, 
they are not the only target group, the main focus is social problems and homelessness 
among the young people. In Graz the emergency sleeping facility Schlupfhaus is at the 
service of young people. Furthermore, many counselling and treatment services for young 
people stress (continuing) education and the development of a job perspective (see above) 
especially for adolescents who have not completed school. 
15.4 Methodological information 
In Austria a number of consumption surveys have been carried out, mostly at the regional 
level and especially in schools. Although it was not always possible to limit the data to the 
desired age groups, the surveys are of great value for the analysis of changing consumption 
patterns. For the future it would be desirable to adapt the methodology to core matters in 
order to improve the comparability of results. In surveys conducted outside schools the pre-
valence rates tend to be higher, which may be due on the one hand  to greater trust of the 
respondents and on the other to better access to young people with problems. Surveys of 
specific youth cultures and sub-groups are a valuable complement to the representative 
surveys, as they yield insights into the consumption patterns that are common among young 
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people with greater drug experience, who are hard to reach in the context of representative 
surveys.  
Routine data and the annual reports of drug help facilities contribute to the analysis of the 
health and social consequences for young people using drugs. However, the data is compar-
able over several years only to some extent and lacking as to specific aspects (e.g. emer-
gencies, infectious diseases). Better insights could be gained by giving more attention to 
young people and differentiating data collection accordingly. The experience and assess-
ments of experts working with young drug users and addicts are a valuable basis for informa-
tion, as they facilitate an in-depth view of the drug issue. 
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16 Social Exclusion and Reintegration 
Social exclusion can become apparent in homelessness, unemployment or delinquency, but 
also in difficult access to health care and social benefits. Common factors to all forms of so-
cial exclusion are lack of social acceptance, limited opportunities, bleak future perspectives, 
and the experience of a generally negative social image. Especially in the field of illegal 
drugs this image has massive effects and far-reaching consequences for the people con-
cerned. Eisenbach-Stangl (2001a) also underlines the difference in social and societal 
effects depending on whether consumers of illegal drugs are perceived and treated as 
suffering from an illness or as criminals, as  drop-outs or as fashionable and trendy.  
16.1 Definitions and concepts 
When discussing the causes of problem drug use, social exclusion is frequently named as 
one factor among many others. However, social exclusion should not be regarded just by 
itself, as it is the accumulation of problem situations and the interdependence of individual 
hardships and resources which is of relevance for arising drug problems and addiction in the 
sense of risk and protection factors. In particular it would be wrong to infer that certain 
groups as such, for instance unemployed, homeless or delinquent people of any age, should 
be classified as in danger of becoming addicted (ÖBIG 2001c). For this reason no par-
ticularly vulnerable groups are defined regarding drug use in Austria. 
Social exclusion as a consequence of problem drug use has been observed and confirmed 
by numerous experts in Austria. However, the deterioration of living conditions which is often 
linked to drug addiction by far does not apply to all drug consumers. In this sense social ex-
clusion is less related  to drug taking than to ensuing problems such as poor health, unem-
ployment or homelessness, unstable relationships and material want. Also the issue of social 
exclusion or integration should be regarded from the point of view of those concerned. In 
many cases, drug addicts are socially integrated, namely into their subgroups. Should they 
decide to leave the drug scene, they have to give up their subgroup and try to integrate into 
another social group instead (Tomas 2001). 
Because of the close relation of problem drug use to the various forms of social exclusion, 
social (re)integration measures have been attributed great importance in Austria. This 
becomes manifest in the principle of integrative drug policy (cf. chapter 8) with the aim of in-
tegrating marginalised groups and especially drug users in order to prevent their exclusion 
(cf. e.g. Drogenkoordination der Stadt Wien 1999). In a broader sense a variety of drug-rela-
ted demand reduction measures could be regarded under the aspect of social integration.  
One example is the principle that social and health policy measures for people suffering from 
addiction should be given priority over punishment (cf. chapter 8). 
In a stricter sense, however, social (re)integration measures are defined as programmes and 
activities directed at the specific social problem areas of drug users and addicts, especially 
housing, work and education/training. This definition is the basis of the following presen-
tation.  
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In Austria social (re)integration measures are increasingly intended to provide support for 
people who are currently addicted rather than only as a follow-up to drug-free treatment (cf. 
chapter 11 and 16.4). Counselling in this case does not focus primarily on drug use but 
rather on specific problem areas such as work, housing, social networks and relationships, in 
order to achieve stability and (re)integration. In the course of tackling the whole range of 
problems drugs can be treated with as one issue among many. At the same time efforts are 
directed at reducing stigmatisation and its negative consequences  (Schinnerl 2001). 
16.2 Drug use patterns and consequences observed 
among socially excluded population groups 
In Austria there are hardly any surveys or data available on the theme of consumption 
patterns and consequences among socially excluded groups. On the basis of a few findings 
and observations by experts some information can be given on the drug use patterns in 
prisons, among immigrants and male sex workers. 
Regarding drug use in prisons the results of a representative inquiry in six Austrian prisons 
in 1999 is available (Spirig 2001), apart from assessments by experts. The share of prison in-
mates injecting drugs is assumed to be 20%. Taking into account occasional drug use during 
imprisonment, a share of 50% of the inmates would be realistic. This high figure is partly ex-
plained by the fact that many criminal offences are connected to addiction. A detailed 
description of this group is included in the corresponding key issues chapter in last year’s re-
port (Drug users in prison, ÖBIG 2001a). 
Another population group frequently confronted with social exclusion and social stigmatisa-
tion is immigrants. Their situation is often characterised by an accumulation of problems as 
described above (cf. chapter 16.1) such as a difficult position in the job market, material 
want, limited access to education and training, etc. Moreover, immigrants who do not hold 
the Austrian citizenship often have an insecure status of residence and encounter barriers in 
the job market and regarding social benefits. However, there are no precise figures on drug 
use among immigrants, as this group is hardly reached via drug help services. Still, some in-
teresting data was collected in the course of a survey of a specific group of socially dis-
advantaged adolescents (AG SCHOP 1999). While drugs such as cannabis, heroin and 
cocaine played a great role in the surveyed group, intravenous use was rarely encountered. 
All the young people came from immigrant families and lived in an extremely precarious so-
cial situation. More than half of the 40 respondents said that they were unemployed or would 
hold a temporary job every now and then. Moreover some of the young people interviewed 
had an insecure status of residence, which severely limited their access to the job market. 
Thus the social problems of the respondents were of much greater relevance than the fact 
that they used drugs. This finding has been confirmed by several experts, who have pointed 
out that immigrants and asylum seekers in Austria show no elevated prevalence of drug use, 
however (networking initiative Migration – personal information, Halbartschlager 2001). 
Especially for second-generation adolescents no marked differences of consumption 
patterns compared to other Austrian adolescents is found (ÖBIG 2001c).  
According to experts, another group frequently consuming legal and illegal substances in 
relevant amounts is sex workers. Detailed information is only available for male sex workers 
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in Vienna, as this subject was discussed by the Vienna Social Projects Association in the 
course of preparing a social work plan for male sex workers (VWS 1997). It has become 
apparent that especially among young male streetwalkers their occupation is connected to 
addictive behaviour in various forms. Addiction may be the motive for prostitution (prostitution 
for the purpose of drug acquisition), but may also be a concomitant factor. Sex workers en-
gaging in prostitution for the purpose of drug acquisition are under enormous pressure to 
procure drugs, which is their main motive for prostitution. The problems encountered in this 
group are frequent intoxications and health deterioration, a wide range of criminal offences, 
difficulties when trying to integrate in drug help institutions (because they are discriminated 
against on grounds of being sex workers) and acute homelessness. Drug use has the pur-
pose of temporarily alleviating the hardships that are currently experienced, but also 
aggravates the problem situation (VWS 1997). 
16.3 Relationship between social exclusion and drug use 
Based on the existence of a large proportion of drug addicts who in spite of problem drug use 
remain inconspicuous for a long period of time and are fully integrated in their social settings, 
it may be assumed that drug use alone does not automatically lead to social exclusion (Uhl 
und Springer 1997). Nevertheless a number of investigations and surveys have shown that 
problem drug use in the sense of prolonged addiction may lead to social exclusion. The 
following data mainly applies to the situation at the core of the drug scene and the problems 
encountered by the clients of low-threshold services, henceforth referred to as drug addicts. 
As to the financial situation of drug addicts, unemployment benefits and social welfare 
assistance form an essential part of their income (Uhl und Springer 1997, Seidler 1997, 
Dialog/Die Fähre 1998). Most drug addicts have several sources of income. Approximately 
one third have a regular job or count on financial support by relatives. Making debts, and fi-
nancial support by partners, are also found among the ways of making a living. Other 
sources of income are making connections to drug dealers, drug dealing, prostitution and 
other criminal offences. 
Another relevant problem is long-term unemployment, concerning a share between 50% 
and 90% of the clients, depending on the data source and institution. In contrast, according 
to Eurostat the unemployment quota for Austria in June 2002, calculated in line with the 
criteria of the International Labour Organisation (ILO), was 4.1% (http://europa.eu.int). For 
those concerned unemployment has a number of negative effects: lack of income, no time 
schedule to structure the day and deficiencies with regard to social contacts and experience 
of success connected to work. Often the clients have a low level of endurance, so they have 
a hard time sticking to a set schedule of working hours and meeting the demands of their 
employers (Dialog/Die Fähre 1998). Therefore many drug addicts would probably fail on the 
primary or secondary labour markets, but they could do well in a job on an hourly basis 
(Caritas 2002). 
As to education and training the data indicates that the majority of clients of counselling 
centres only completed compulsory school and had no further education or training. This 
absence of qualification also has a negative effect on the employability of drug addicts. 
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Homelessness is another factor that affects many drug addicts. For example, when 
investigating the demand situation for a health-care room in the low-threshold service 
Komfüdro in Innsbruck (Zurhold et al. 2001), it turned out that 21% of the clients lived in an 
unstable housing situation. This includes temporary housing with friends or acquaintances 
(8%), in sleeping facilities/hostels (8 %), and sleeping in the streets (5%). Even among those 
respondents who did have a more or less stable housing situation, only few lived in an apart-
ment of their own. One reason is that because of their drug use, their outward appearance 
and their obviously poor health they have little opportunities to find apartments offered in the 
free market (Caritas 2002). The problem of homelessness also becomes apparent in the 
excessive demand for places in the sleeping facility of Ganslwirt in Vienna, concerning above 
all beds for men. As was shown on evaluation, this situation is largely due to long-term 
homeless clients (VWS 2002a und EDDRA).  
Drug addicts often have a very poor state of health, infectious diseases (especially hepa-
titis) being widespread among them (cf. chapters 3.3 and 3.4); compared to the average 
population their mortality rate is up to 20 times higher (cf. chapter 3.2, Caritas 1999). More-
over, they often do not accept, or are not entitled to, medical care, because of bad ex-
perience with medical services in the past on the one hand and lacking insurance or social 
welfare cost coverage for the treatment of diseases on the other (Caritas 1999, Dialog 2000). 
Also, it repeatedly happened that they were denied vital services or benefits that they were 
legally entitled to (e.g. medical aid, social welfare payments according to a fixed rate; Caritas 
1999). These problems in the field of social and health stability are aggravated in the case of 
people who are not Austrian citizens, as they are not entitled to receive social welfare pay-
ments or health insurance, which means they have neither the right even to receive minimal 
health care nor the possibility to enter a withdrawal programme (networking initiative Migra-
tion, personal information). 
Drug addicts are confronted with social exclusion in a variety of forms. Apart from having to 
face a situation characterised by limited or lacking opportunities and perspectives, they are 
met with rejection or even hostility by the general public and by authorities. For example, 
there is hardly a public spot where they can meet without being expelled, which is especially 
problematic for them as the drug scene often is the only social environment where they can 
exchange experience with others who are in the same situation. Ousted from public space, 
they are deprived of their last social relationships. The creation of new drug help facilities has 
also repeatedly met with massive resistance from the general population. Moreover, the 
respondents of a study carried out in the Prison of Vienna/Favoriten (Waidner 1999) reported 
that they had experienced prejudice-laden and violent treatment by police abusing their 
power, as well as being blamed and treated without the appropriate care. 
Investigations have also shown a greater tendency towards criminal offences among drug 
addicts. For example in 2001 a share of 57% of each of the persons in outpatient and in-
patient treatment at the respective drug therapy departments of Otto Wagner Hospital had a 
previous conviction (Otto-Wagner-Spital 2002). However, in many cases the criminal acts 
were mainly of a self-endangering nature and directly related to the acquisition of their daily 
doses of drugs. Schinnerl (2001) points out that imprisonment promotes the integration into a 
criminal setting. This type of criminalisation increases social exclusion and severely limits the 
opportunities and perspectives of the persons concerned. 
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16.4 Political issues and reintegration programmes 
In Austria social (re)integration measures are part of a diversified, multiprofessional drug 
help network covering many different interventions such as primary and secondary pre-
vention measures, accepting assistance, harm reduction and substitution measures as well 
as drug-free treatment and rehabilitation (ÖBIG 2000).  
In addition to social work, therapy and medical care many inpatient facilities (e.g. Grüner 
Kreis, Stiftung Maria Ebene, Anton Proksch Institute (API), Erlenhof) focus on social (re)inte-
gration measures. They mainly concentrate on the areas of education and training, work and 
housing and in most cases are an essential component of after-care for (former) drug 
addicts. 
It has been mentioned above (cf. chapters 16.1 and 11) that different from many other 
countries, in Austria social integration measures not only follow abstinence-oriented treat-
ment, but are also increasingly directed at people who are currently dependent on drugs. Ex-
perience has shown that social integration and life perspectives enhance the motivation of 
drug addicts to become abstinent (e.g. occupational project WALD, Fix und Fertig, Betreutes 
Wohnen, cf. EDDRA). 
Measures promoting (re)integration in the job market for drug addicts play an essential 
role and follow a three-stage model. The first stage includes job orientation measures, 
training and qualification, which is provided in Austria in the form of special programmes (e.g. 
Needles or Pins, Vienna Job Exchange, Promente Styria association) as well as in the 
course of inpatient therapy (see above). 
At the second stage, clients take part in a social and economic occupational project of the 
secondary labour market. The aim of the projects (e.g. Needles or Pins, Fix und Fertig, Shop 
23, WALD) is the gradual (re)integration of people with a drug career of several years into 
the training and job market. In the protected setting of the occupational project WALD (cf. 
EDDRA), clients get to know their own resources and capabilities and experiment with action 
strategies and everyday coping. ABRA KADABRA in the Tyrol as well as Fix und Fertig in 
Vienna give drug users the opportunity to work on an hourly or per-day basis and free 
themselves of the pressure that rules the drug scene. The demand for per-day jobs by far 
exceeds the existing supply (VWS 2002c, cf. EDDRA). 
At the third stage, support is provided for reintegration into the primary labour market. In this 
context the Public Employment Service (AMS) has promoted the Vienna Job Exchange, a 
job market policy counselling service functioning as a link between the drug help facilities 
and the AMS services (ÖBIG 2000, Wiener Berufsbörse 2002). The Vienna Job Exchange 
has commissioned a study on the subject of job integration of persons affected by addiction, 
the results of which are expected to be available by the end of 2002. 
The various services of the therapeutic community Grüner Kreis provide job oriented groups 
as a part of therapy relating to the subject of work. These groups also follow a stage-by-
stage system, starting with job orientation and guiding patients through application training, 
job reality and job planning to job search (web site of Grüner Kreis). 
Furthermore, in the context of job (re)integration of drug addicts, the need for creating a 
network of drug help services and work-specific institutions has been stressed. It was 
g 83
demanded that a coordinating body for the field of work and drugs should be established, 
with the tasks of drawing up a plan in various steps in order to coordinate counselling of the 
target group, negotiating with funding institutions, servicing other providers in the field of drug 
help, coordinating regional services, etc. (Bacher 2001). A similar cooperative approach is 
now followed by drug.addicts@work (cf. chapter 11). 
Beside work, housing is another central component of (re-)integration plans. In addition to 
temporary sleeping facilities in case of emergency and crises (e.g. Ganslwirt/Vienna, 
Mentlvilla/the Tyrol, DOWAS/Vorarlberg) there are also longer-term housing places, in gene-
ral with mobile assistance, in the form of housing communities and projects. Here the idea is 
to provide long-term accommodation characterised by safety and continuity, which 
constitutes a stabilising factor in the (re)integration process. The aim is to provide a definite 
place to live. 
For clients who are already settled in their flats there is the possibility of comprehensive 
after-care provided by various counselling centres and services and by assisted housing faci-
lities. The short-term therapy service Haus am Seespitz at Maurach, the Tyrol has run an 
open after-care group meeting every week since 2000 (Oberarzbacher 2002). 
The outcome evaluation of the occupational project WALD, the social and economic project 
Fix und Fertig and the drug therapy service SENOBIO (Vorarlberg) has revealed that 
approximately one fourth of the clients who have completed counselling find jobs in the regu-
lar labour market. Fix und Fertig reports that clients who worked in a social and economic 
project in the long run have by 20% longer periods of employment compared to clients who 
only participated in a training course (cf. EDDRA). 
The evaluation of the long-term inpatient treatment at the drug therapy facility SENOBIO has 
shown that social integration has been successful. Out of a total of 30 surveyed clients, 18 
(60%) completed treatment as planned, while 12 abandoned therapy prematurely. Of the 18 
clients with full treatment, 15 had a stable housing and working situation, while three clients 
had a stable housing situation, but had not (yet) succeeded in re-entering the job market. In 
comparison, three of the clients who had abandoned treatment prematurely had a stable 
accommodation and employment situation, and for three others the housing situation was 
stable, but they did not have a job (Mika 2000; cf. EDDRA). 
In the period from 1996 to 2000 the assisted housing service Betreutes Wohnen (Vienna) 
had completed counselling for 39 clients, for half of them with a positive outcome, and 
another 13% had left counselling prematurely with a positive prognosis. This means that 62% 
of the counselling relationships took a positive development. The changes regarding the drug 
situation are also remarkable: after counselling, out of 19 client using drugs 37% were absti-
nent and 58% used substitution substances. This clearly indicates that stabilising social fac-
tors pave the way to drug abstinence (VWS 2001 and EDDRA). 
16.5 Methodological information 
In general it can be stated that few routine data and data comparable at a nationwide level 
are available in Austria. Therefore a lot of basic information and statements contained in the 
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annual reports of the various drug help organisations, the reports of the Provincial Drug Co-
ordinators and the Reports on the Drug Situation in Austria of previous years were collected. 
Evidently, there is a lack of data on social exclusion as a cause of drug problems and on 
drug use by socially marginalised individuals. A lot of information was obtained in communi-
cating with experts, who in turn also complained of lacking data material. Important informa-
tion was provided by the networking initiative Migration, which was founded in 2000 and 
consists of representatives of various organisations active in drug help, youth and immigra-
tion work who meet every three months in order to exchange experience related to the 
themes of drug use and immigration. 
Comparatively more data is available on social exclusion as a consequence of problem drug 
use. However, in many cases the surveys and data refer to members of the open drug scene 
or to clients of low-threshold facilities. Here it should be taken into account that among the 
clients of low-threshold services there is a disproportionately large share of people who are 
out of a job, homeless, who have insufficient financial means, who suffer from (sometimes 
life-threatening) diseases and are socially excluded (Caritas 1999). There are no surveys or 
data available on the living conditions of socially integrated drug abusers. 
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DATABASE 
 
EDDRA = Exchange on Drug Demand Reduction Action 
Internet-Database of the EBDD: http://www.reitox.emcdda.org:8008/eddra/ 
Austrian Projects in the EDDRA-Database: 
Addiction Prevention in the village. Sub-programme of the Pilotproject “Local capital for 
social purposes“ of the GD V of the EU, Programme “Social innovative 2000" (EU-Regional-
management Oststeiermark)* 
(Volkshilfe Steiermark, VIVID Fachstelle für Suchtprävention, Regionalbüro Oststeiermark) 
After care of children of drug abusing mothers. Viennese Pilot Project "Pregnancy and 
Addiction" - Comprehensive care project for substance abusing mothers and their children  
(Department of Child and Adolescent Neuropsychiatry, Hospital Rosenhügel, Vienna) 
API Mödling – Inpatient long-term therapy for drug addicts*  
(Anton Proksch Institut, Lower Austria) 
Assisted Housing 
(Vienna Social Projects Association, Vienna) 
Auftrieb - Youth- and Addiction-Counselling-Centre 
Association Youth and Culture Wiener Neustadt,  Lower Austria)  
CARINA – Long term therapy facility 
(Foundation Maria Ebene, Vorarlberg) 
ChEck iT! Scientific Pilot Project Check iT! 
(Vienna Social Projects Association, Vienna) 
CONTACT – Liaison service for hospitals 
(Vienna Social Fund) 
Drug-free zone at the prison of Hirtenberg 
(prison of Hirtenberg, Lower Austria) 
Drug-free zone at the prison of Innsbruck 
(prison of Innsbruck, the Tyrol) 
Drug Out – therapy unit at the prison of Innsbruck 
(prison of Innsbruck, the Tyrol) 
Employment programme WALD 
(H.I.O.B. – Contacting and counselling centre for drug addicts, Vorarlberg) 
“Empower our children“ - Campaign 
(SUPRO – Addiction Prevention Unit of Vorarlberg, Vorarlberg) 
Empower our Children through sports* 
(SUPRO - Addiction Prevention Unit of Vorarlberg, Vorarlberg) 
Erlenhof – Inpatient treatment centre for addicts 
(Pro mente, Upper Austria) 
 
* will be available by the beginning of the year 2003  
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European Networking in addiction prevention 
(Institute for Addiction Prevention, Upper Austria) 
Fantasy instead of Ecstasy – addiction prevention through peergroup education in a 
vocational high school at Neumarkt, Salzburg 
(AKZENTE Salzburg – Addiction Prevention Unit, Salzburg) 
FITCARD – Health Promotion with apprentices. Sub-Programme of the programme 
“Health Promotion and Addiction Prevention at Workplace" * 
(SUPRO - Addiction Prevention Unit Vorarlberg) 
Fix und Fertig – socio-economical company  
(Vienna Social Projects Association, Vienna) 
H.I.O.B. Help – Information – Orientation – Counselling for Drug Addicts 
(H.I.O.B. – contacting and counselling centre for drug addicts, Vorarlberg) 
In motion – a multiplier-project for addiction prevention in schools* 
(Institute for Addiction Prevention, Upper Austria) 
Youth counselling service WAGGON  
(TENDER – Association for youth work, Lower Austria) 
Youth-house – Therapy for adolescents at the therapeutic community Grüner Kreis* 
(Association Grüner Kreis) 
Lukasfeld – short-term therapy department for persons addicted to illegal drugs 
(Stiftung Maria Ebene, Vorarlberg) 
Needles or Pins – European project to develop innovative projects for social and labour 
integration of people with drug related problems – Viennese sub-project 
(Support and counselling centre for drug addicts and their relatives – Dialog, Vienna) 
Needles or Pins – European project to develop innovative projects for the social and pro-
fessional rehabilition of people with drug problems – sub-project of Vorarlberg 
(Die Fähre, Vorarlberg) 
Parents-Child-House - Therapy for Parents and Children at the therapeutic community 
Grüner Kreis 
(Association Grüner Kreis) 
Pilotproject – Addiction Prevention in Trofaiach, Styria 
(b.a.s. - concerns alcohol and addiction - steirischer Verein für Suchtkrankenhilfe) 
Probation assistance for inmates at the prison  of Favoriten, Vienna, provided by voluntary 
staff 
(Vienna Association of Probation Assistance and Social Help) 
Promote health – prevent addiction – Action programme of the Federal Ministry of Education 
and Cultural Affairs 
SAS – Pupils Searching for Alternative Solutions. A pupil-multiplier-project of primary 
addiction prevention based on the concept of peer-group education  
(VIVID – Addiction Prevention Centre, Styria) 
 
 
* will be available by the beginning of the year 2003  
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Senobio – Inpatient drug therapy* 
(Drug therapy service Senobio, Vorarlberg) 
Socialmedical drug counselling centre Ganslwirt - Sleeping facility for crises* 
(Vienna Social Projects Association, Vienna) 
Step by Step - Early detection and intervention with regard to problematic drug use 
and addiction  
(kontakt&co – Addiction Prevention Unit, the Tyrol) 
Schweizer Haus Hadersdorf – Medical and psychosocial sanatorium   
(Evangelisches Haus Hadersdorf – WOBES: Medizinische, Psychologische und 
Psychotherapeutische Gesundheits- und Heilstätte “Schweizer Haus Hadersdorf“ (SHH) 
Ges.m.b.H., Vienna) 
Toyfree kindergarten. Addiction prevention by promoting life skills 
(ISP – Information Centre for Addiction Prevention of the City of Vienna, Vienna) 
Training course on addiction prevention in the kindergarten, for kindergarten teachers 
(VIVID – Addiction Prevention Unit, Styria) 
Umbrella–Network–Projekt Austria – Switzerland: Analysis of problems with HIV, 
AIDS and STDs in European border regions as well as development of co-operative, 
border-crossing prevention methods  
(Institut für Sozialdienste, Vorarlberg) 
URBAN - Wien Gürtel Plus. Secondary addiction prevention for youths in urban 
areas 
(Drug advisory centre Change, Vienna) 
Wiener Berufsbörse – Vienna Job Exchange Association for the vocational 
integration of persons who are addicted to (pharmaceutical) drugs and/or alcohol 
(Vienna Job Exchange, Vienna) 
Wien-Favoriten – Treatment and care of addicted offenders in Vienna Favoriten Prison 
(Vienna Favoriten Prison, Vienna) 
 
 
 
 
 
 
 
 
 
 
 
* will be available by the beginning of the year 2003  
 95
WEBSITES  
The following pages provide WebSites of facilities working in the addiction and drug field, 
mentioned in the report.  
A detailed list of relevant Internet-addresses concerning addiction and drugs can also be 
found via http://www.oebig. at (activity Drugs / Links). 
AIDS-Hilfe (AIDS Assistance Service) 
http://www.aidshilfe.at 
AKZENTE Salzburg, Suchtpräventionsstelle (Addiction Prevention Unit Salzburg) 
http://www.akzente.net 
Arbeitsmarktservice Oberösterreich (Public Employment Service, Upper Austria) 
http://www.ams.or.at/ooe 
ARGE Suchtvorbeugung (Working Group Addiction Prevention) 
http://www.praevention.at/projekte/arge.html 
Anton Proksch-Institut (treatment facility) 
http://www.api.or.at 
Bundesministerium für Bildung, Wissenschaft und Kultur (Federal Ministry of Education, 
Science and Culture) 
http://www.bmbwk.gv.at 
Bundesministerium für Inneres (Federal Ministry of the Interior) 
http://www.bmi.gv.at 
Bundesministerium für Justiz (Federal Ministry of Justice) 
http://www.bmj.gv.at 
Bundesministerium für soziale Sicherheit und Generationen (Federal Ministry for Social 
Security and Generations) 
http://www.bmsg.gv.at 
Carina – Therapiestation (therapy facility) 
http://www.mariaebene.at/carina/welcome.htm 
Caritas - Diözese Innsbruck  
http://www.caritas-innsbruck.at 
CheckiT! - Verein Wiener Sozialprojekte (pill testing project) 
http://checkyourdrugs.com   
CONTACT – Spitalsverbindungsdienst (Hospital Connection Service) 
http://www.drogenhilfe.at/rathilfe/skh/r-s-contact.htm 
Cybertown - Internetforum für Prävention (Internetforum for Prevention) 
http://www.cybertown.at 
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dialog - Beratungs- und Betreuungszentrum (Counselling and Support Centre for Drug 
Addicts and their Relatives) 
http://www.dialog-on.at  
Drogenambulanz - AKH Wien (Outpatient Drug Clinic of the General Hospital Vienna) 
http://www.akh-wien.ac.at/drogenambulanz  
EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) 
http://www.emcdda.org 
European Network on HIV/AIDS and Hepatitis Prevention in Prisons 
http://members.aol.com/orspaca/gbp1.htm  
Fachstelle für Suchtvorbeugung NÖ - Gesundheitsforum NÖ (Addiction Prevention Unit, 
Lower Austria) 
http://www.fachstelle.at  
Fonds “Gesundes Österreich“ (Healthy Austria Fund) 
http://www.fgoe.org 
Fonds Soziales Wien (Vienna Social Fund) 
http://www.drogenhilfe.at 
Ganslwirt - Verein Wiener Sozialprojekte (low threshold service) 
http://www.vws.or.at/ganslwirt/index.html 
GIVE - Servicestelle für Gesundheitsbildung im Österreichischen Jugendrotkreuz (Service 
unit for Health Promotion at the Austrian Red Cross) 
http://www.give.or.at 
Grüner Kreis (therapeutic community) 
http://www.gruenerkreis.at 
Haus am Seespitz - Kurzzeittherapie für Drogenabhängige (short term therapy facility) 
http://www.jugendweb.at/drogenhandbuch/einrichtung/seespitz.htm 
Institut für Medizinische und Chemische Labordiagnostik der Universität Wien (Institute for 
Medical and Chemical Diagnostics at the Vienna University) 
http://www.univie.ac.at/med-online/A5273/index.html 
Institut für Suchtforschung der Universität Innsbruck mit Sitz am Krankenhaus Maria Ebene 
(Institute for Addiction Research at the University of Innsbruck, the Tyrol) 
http://www.suchtforschung.at 
Institut für Suchtprävention OÖ (Institute for Addiction Prevention, Upper Austria) 
http://www.praevention.at      
IZS - Interdisziplinäres Zentrum Suchtforschung, Universität Wien (Interdisciplinary Addiction 
Research Unit at the Vienna University) 
http://www.univie.ac.at/sucht/ 
Komfüdro - Kommunikationszentrum für DrogenkonsumentInnen (low threshold service) 
http://www.caritas-innsbruck.at/komfuedro.htm 
kontakt&co - Suchtpräventionsstelle Tirol (Addiction Prevention Unit, the Tyrol) 
http://www.kontaktco.at 
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Krankenhaus Rosenhügel (Hospital Rosenhügel, Vienna) 
http://www.health.magwien.gv.at/welt/kavw/nkr/ 
Kriminalpolizeilicher Beratungsdienst Wien (Counselling Centre of the Viennese Police) 
http://www.polizei.gv.at/wien/fixlokal/kriminalpolizeilicher_beratungsd.htm 
Landes-Nervenklinik Wagner Jauregg (Neurological Hospital Wagner Jauregg, Upper 
Austria) 
http://www.wagner-jauregg.at 
Ludwig Boltzmann-Institut für Suchtforschung (Ludwig Boltzmann-Institute for Addiction 
Research) 
http://www.api.or.at/lbi/index.htm 
Lukasfeld – Therapiestation (therapy facility, Vorarlberg) 
http://www.mariaebene.at/Lukasfeld/welcome.htm 
Needles or Pins – dialog (programme for labour integration) 
http://www.dialog-on.at/dialog/channels/standorte/base2_html 
Otto Wagner-Spital – Drogeninstitut (Drug Treatment Centre as the Otto Wagner-Hospital, 
Vienna) 
http://www.drogenhilfe.at/rathilfe/skh/r-s-ows.htm 
Pädagogische Akademie des Bundes in Oberösterreich (Federal Paedagogical Academy, 
Upper Austria) 
http://www.pa-linz.ac.at/ 
pro mente Oberösterreich (central organisation of various drug centres) 
http://www.promenteooe.at/ 
risiko - Institut für Sozial- und Gesundheitspsychologie (Institute for Social- and Health 
Psychology) 
http://www.members.aon.at/isg 
Stiftung Maria Ebene (central organisation of various drug centres) 
http://www.mariaebene.at 
Substanz - Verein für suchtbegleitende Hilfe (low threshold service) 
http://www.substanz.at  
SUPRO - Werkstatt für Suchtprophylaxe (Addiction Prevention Unit, Vorarlberg) 
http://www.supro.at 
Verein für Bewährungshilfe und Soziale Arbeit (Association for Probation Assistance and 
Social Help) 
http://www.vbsa.at/ 
VIVID - Fachstelle für Suchtprävention, Steiermark (Addiction Prevention Unit, Styria) 
http://www.vivid.at 
VWS - Verein Wiener Sozialprojekte (Vienna Social Projects Association) 
http://www.vws.or.at 
Wiener Berufsbörse (Vienna Job Exchange Association) 
http://www.bhakwien13.at/Beruffoerd/default.htm 
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Data source 
 
Responsible institution 
Type of data New developments and activities 
Relevant monitoring and information systems at the federal level 
Drug-related deaths -  
special register 
Federal Ministry for 
Social Security and 
Generations 
(FMSSG) 
Fatalities related to drugs 
directly (overdoses) or indi-
rectly (suicide, AIDS, 
accidents, premature natural 
death, etc.) 
When the annual statistics of 2000 was drawn up the issue of how 
to count drug-related deaths was extensively discussed. Based on 
the EMCDDA's requirements for special registers it was decided 
that future statistics should distinguish between more groups of 
deaths, giving separate figures also for poly-drug use including alco-
hol. What is still under discussion is the question whether to take 
into account intoxications with psychoactive medicines. For the time 
being cases for which only psychopharmaceuticals are found in toxi-
cological investigation will not be included in the statistics. The 
groups defined for the statistics of 2000 (cf. ÖBIG 2001) were also 
used for the year 2001. 
In the reporting period the Austrian working group on the epidemiol-
ogical key indicator of drug-related deaths prepared a form to be 
used by forensic institutes for registering drug-related deaths and 
discussed this form with the institutes concerned. Plans for future 
data collection include the creation of an online database for forensic 
institutes to enter drug-related deaths. This would assure data qual-
ity at the national level and also make current information available 
within short time. 
Drug-related deaths – 
general mortality 
register 
Statistics Austria 
Deaths with drug-related 
ICD codes for cause of death 
As of 2002 deaths have been classified in the general mortality reg-
istry according to ICD 10 instead of ICD 9. It is now being checked 
to which extent this change influences the collection of data on drug-
related deaths and if a comparison of new data and data of former 
years is possible. Parallel to this recommendations for future routine 
data interpretation based on ICD 10 will be drawn up. 
Substitution treatment 
FMSSG 
Reports on the beginning and 
end of substitution treatment 
by physicians in charge of 
treatment 
In order to improve the situation regarding completeness and quality 
of data it has been considered to involve the provinces more inten-
sively in data collection and routine comparisons of data available at 
federal and provincial levels. This has not been implemented until 
now. 
Drug-specific treatment 
and care  
FMSSG 
Aggregate statistics on 
clients of drug centres an-
nounced according to Art. 15 
of the Narcotic Substances 
Act (NSA) 
At present the relevant organisations receiving financial support pro-
vide annual client statistics communicated to the FMSSG in the form 
of aggregate data, which permit epidemiological analyses to a very 
limited extent only. In the context of the working group convoked by 
the FMSSG concerned with the establishment of a uniform nation-
wide treatment reporting system in line with European requirements, 
in spring/summer 2001 a client questionnaire was drafted and tested 
in practice. This test run had positive results, and the protocol that 
had been drawn up was assessed as suitable for routine use, with 
only a few necessary amendments. However, before implementing 
this system all partners involved have to agree on the corresponding 
organisational, financial and legal framework. These discussions 
have not yet been completed. 
Register of drug 
offences according to 
Art. 24 of the Narcotic 
Substances Act (NSA)  
FMSSG 
Personal and episode-specific 
data of all persons reported to 
the FMSSG according to Art. 
24 of the NSA (especially with 
regard to reports to the police, 
court proceedings or alterna-
tives to prosecution) 
The Focal Point, acting on behalf of the FMSSG, is analysing the 
epidemiological conclusiveness of the data. This analysis will be 
completed in autumn 2002. Then recommendations for quality im-
provements, easier collection and more intensive use of data in the 
context of epidemiological monitoring will be drawn up. Based on the 
data available in the register and data on substitution treatments and 
drug-related deaths collected by the FMSSG (see above) a meth-
odological pilot study on estimates of the prevalence of problem opi-
ate use will be carried out for the period from 1998 to 2000. In future 
this will form the basis for regular updates of prevalence estimates 
carried out by the Focal Point. 
In the FMSSG activities concerning the technological redesign of the 
data base have been continued, so as a result all data will be avail-
able on one single platform. 
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Data source 
Responsible institution 
Type of data New developments and activities 
Hospital discharge 
diagnoses  
FMSSG, ÖBIG 
Number of drug-related hospi-
tal discharge diagnoses ac-
cording to ICD 9 
In the context of a project to further develop drug-related monitoring, 
which the Focal Point is carrying out on behalf of the FMSSG, the 
hospital discharge codes are analysed with regard to their epidemi-
ological relevance and recommendations for future routine 
interpretations are drawn up. 
Reports to the police for 
violation of the NSA  
Federal Ministry of the 
Interior (FMI) 
Episode-related data on all re-
ports for violations of the NSA 
registered by federal and pro-
vincial police or customs au-
thorities (double counting can-
not be excluded) 
No relevant changes. The online network of all the units involved - 
installed in the beginning of 2000 - seems to work very well. Data 
can now be made available earlier than in the past. 
Seizures of narcotic 
drugs 
FMI 
Number and quantity of sei-
zures registered by federal and 
provincial police or customs 
authorities 
No relevant changes. The online network of all the units involved – 
installed in the beginning of 2000 – seems to work very well. Data 
can now be made available earlier than in the past. 
Convictions under the 
NSA 
Statistics Austria 
Number of convictions under 
the NSA and type of punish-
ment  
Due to lack of resources, at the moment only data referring to 
leading offences is available.  
Relevant monitoring and information systems at the provincial level 
Vienna 
Drug Coordination Office 
of the City of Vienna 
Data on the number of clients 
and services provided by drug 
help centres; drug-related 
deaths; substitution treatment; 
overdoses; ambulance ser-
vices required; population sur-
veys 
Vienna’s monitoring system includes many different kinds of infor-
mation (see type of data) and is being developed further: the basic 
documentation has now been implemented at the offices of the drug 
help network of Vienna and the preparation of a performance docu-
mentation has been continued. In addition current results of the 
population survey from autumn 2001,on prevalence of drug use, as-
sessment of the drugs situation and drug-policy attitudes, have been 
made available (comparable surveys have been carried out every two 
years since 1995). 
Other provinces 
Drug/Addiction 
Co-ordinators 
Data on the number of clients 
and services provides by the 
drug help centres; drug-related 
deaths; substitution treatment; 
examinations 
according to the NSA; in part: 
population surveys 
In the other provinces the scope of the monitoring and information 
systems vary. Almost all of them collect data from the regional drug 
help centres as well as data on substitution treatment and drug-
related deaths. In many provinces the monitoring systems are in the 
process of being expanded. All provinces participate in a working 
group convoked by the FMSSG to discuss the establishment of a 
nation-wide uniform treatment reporting system that will meet EU 
requirements. In four provinces (Burgenland, Lower Austria, the Ty-
rol and Vorarlberg) the client protocols were tested during a pilot 
stage in spring and summer 2001. 
In Burgenland the results of the school survey carried out in spring 
2001 have been presented, so for the first time province-related 
prevalence data is available. 
Upper Austria carried out the pilot project Rapid Situation Assess-
ment in 2000/1, which will form the basis for investigations of the 
drug situation in the province that will be carried out at regular inter-
vals. 
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Table A1: Overview of selected studies on drug experience among the Austrian population, 
published between 1996 and 2002 
Study 
(year of publication) 
Area covered, 
year of data 
collection 
(period covered) 
Target group 
(sample) 
Drug types surveyed Percentage of 
respondents with 
drug experience 
Age group         % 
Schulstudie Kärnten / 
school survey, Carinthia 
(Bohrn/Bohrn 1996) 
Carinthia 
1996 
(lifetime) 
Students in their 7th to 
12th/13th school years
(n = 1 234) 
Hashish 
Ecstasy 
LSD 
Cocaine 
Heroin 
13–19 
13–19 
13–19 
13–19 
13–19 
7.7
3.2
1.0
0.3
0.3 
NÖ Jugendstudie / youth sur-
vey, Lower Austria 
(Brunmayr 1997) 
Lower Austria 
1996/97 
(lifetime) 
Students in their 9th to 
12th/13th school years
(n = 1 300) 
Hashish 
Ecstasy 
Hallucinogens 
Cocaine 
Heroin 
15–19 
15–19 
15–19 
15–19 
15–19 
20 
4 
> 1 
> 1 
>1 
Schulstudie NÖ / 
school survey, Lower Austria 
(Institut für Sozial- und 
Gesundheitspsychologie 
1999) 
Lower Austria 
1997 
(lifetime) 
Students in their 7th to 
12th school years 
(n = 1 899) 
Cannabis 
Ecstasy 
LSD 
Cocaine 
Heroin 
13–18 
13–18 
13–18 
13–18 
13–18 
13.6
3.8
1.7
1.3
0.6 
Linzer Suchmittelstudie / 
drug survey, Linz 
(Institut für Soziologie der  
Universität Linz o. J.) 
Linz 
1998 
(lifetime) 
General population 
aged 15 and older 
(n = 394) 
Cannabis 
Cannabis 
Cannabis 
Cannabis 
Cannabis 
15–19 
20–29 
30–39 
40–49 
50 + 
28 
37 
19 
7 
5 
Jugendstudie Tirol 
youth survey, the Tyrol 
(Schüßler et al. 2000) 
Innsbruck 
1999 
(lifetime) 
Young people aged 
14 to 19  
(n = 493) 
Hashish 
Other illegal drugs 
14–19 
14–19 
22 
3 
Wiener Suchtmittelstudie / 
general population drug sur-
vey, Vienna 
(Wiener Drogenkoordinati-
on/IFES 2000) 
Vienna 
1999 
(lifetime) 
General population 
aged 15 and older 
(n = 623) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Other illegal drugs (e.g. LSD) 
16+ 
16+ 
16+ 
16+ 
16+ 
16+ 
11 
1 
1 
1–2 
1 
1–2 
Bevölkerungsbefragung OÖ / 
general population survey, 
Upper Austria 
(market 2000) 
Upper Austria 
2000 
(lifetime) 
General population 
aged 15 and older 
(n = 1 011) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Morphine 
LSD 
Smart drugs 
15+ 
15+ 
15+ 
15+ 
15+ 
15+ 
15+ 
21 
4 
1 
4 
1 
3 
1 
Schulstudie Burgenland / 
school survey, Burgenland 
(Schönfeldinger 2002) 
Burgenland 
2001 
(lifetime) 
Students in their 7th to 
13th school years  
(n = 1 899) 
Cannabis 
Ecstasy 
Cocaine 
Heroin 
Speed 
Hallucinogens 
Solvents 
Biogenic drugs 
12–19 
12–19 
12–19 
12–19 
12–19 
12–19 
12–19 
12–19 
20 
  4 
  2 
   1 
  3 
  3  
20 
  8  
HBSC-Studie / HBSC study 
(Dür und Mravlag 2002) 
Austria 
2001 
(lifetime) 
Students aged 15  
(n = 1 292) 
Cannabis 15 14 
Wiener Suchtmittelstudie / 
general population drug sur-
vey, Vienna 
(FSW/IFES 2002) 
Vienna 
2001 
(lifetime) 
General population 
aged 15 and older 
(n = 650) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Other illegal drugs (e.g. LSD) 
15+ 
15+ 
15+ 
15+ 
15+ 
15+ 
14 
1 
1 
1  
1 
2 
Grazer Jugendstudie / 
Youth survey Graz 
(X-Sample 2002) 
Graz  
2002 
(lifetime) 
Adolescents and 
young 
adults aged 
12 to 25 
(n = 515) 
Cannabis 
Party drugs 
Cocaine 
Heroin 
Speed 
Hallucinogens 
Solvents 
Biogenic drugs 
12–25 
12–25 
12–25 
12–25 
12–25 
12–25 
12–25 
12–255 
 58.2 
 15.4 
  7.3 
  4.9 
  6.0 
  7.2  
  9.2 
 21.1  
Summarised by ÖBIG 
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Table A2: Number of drug-related deaths in Austria by cause of death from 1992 to 2001 
Cause of death 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Intoxication by opiate(s) 48 37 63 49 69 39 27 25 18 17 
Poly-drug intoxication including opiate(s) 69 109 105 115 115 92 81 101 147 119 
(Poly-drug) intoxication by narcotic drug(s) excl. 
opiates 
9 5 4 4 6 5 1 2 2 3 
Psychoactive medicines 2 6 4 8 4 5 8 8 * * 
Intoxication of unknown type 3 5 1 2 1 0 0 0 0 0 
Total/direct drug-related deaths 131 162 177 178 195 141 117 136 167 139 
AIDS 39 47 41 28 23 9 20 11 13 12 
Other diseases 9 12 13 21 5 5 11 9 22 17 
Suicide (no intoxication) 7 4 13 9 2 8 8 12 16 9 
Accidents, homicides 1 1 6 5 5 9 4 3 8 6 
Unknown cause of death  0 0  0 0 0 0 2 3 1 1 
Total/indirect drug-related deaths 56 64 73 63 35 31 45 38 60 45 
* = as of 2000 no longer taken into account (cf. Annex A) 
Source: FMSSG (BMSG, Abt. VI/B/11) 
Table A3: Number of direct drug-related deaths in Austria by province from 1992 to 2001 
Province 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 1992–2001 
Burgenland 1 1 0 3 2 2 2 0 0 0 11 
Carinthia 2 1 3 1 3 3 3 7 2 5 30 
Lower Austria 5 9 7 9 18 12 9 8 11 14 102 
Upper Austria 4 4 9 9 6 6 6 2 11 8 65 
Salzburg 2 3 4 6 6 11 11 7 6 7 63 
Styria 5 4 4 6 9 13 5 6 11 9 72 
the Tyrol 8 21 18 12 12 8 12 14 11 16 132 
Vorarlberg 14 13 6 11 14 5 6 5 5 11 90 
Vienna 90 106 126 121 125 81 63 87 110 69 978 
Total 131 162 177 178 195 141 117 136 167 139 1 543 
Source: FMSSG (BMSG, Abt. VI/B/11) 
Table A4: Number of indirect drug-related deaths in Austria by province from 1992 to 2001 
Province 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 1992–2001 
Burgenland 0 0 4 0 0 1 0 0 0 0 5 
Carinthia 2 2 3 3 0 5 2 0 1 3 21 
Lower Austria 1 1 3 2 0 1 2 4 4 6 24 
Upper Austria 16 11 18 15 11 4 8 3 7 12 105 
Salzburg 1 0 1 1 0 1 2 2 1 0 9 
Styria 2 1 1 2 1 0 1 0 1 2 11 
the Tyrol 4 7 8 11 6 7 6 7 7 0 63 
Vorarlberg 5 5 14 13 6 2 7 5 5 6 68 
Vienna 25 37 21 16 11 10 17 17 34 16 204 
Total 56 64 73 63 35 31 45 38 60 45 510 
Source: FMSSG (BMSG, Abt. VI/B/11) 
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Table A5: Number of direct drug-related deaths in Austria by age group and total by gender 
from 1992 to 2001 
Age group 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
 abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % 
19 and younger 20 15.3 30 18.7 27 15.3 31 17.4 24 12.3 18 12.8 7 6.0 16 11.8 19 11.4 21 15.1 
20–24 36 27.5 56 34.6 48 27.1 35 19.7 45 23.1 32 22.7 35 29.9 23 16.9 33 19.8 20 14.4 
25–29 30 22.9 30 18.5 36 20.3 37 20.8 34 17.4 25 17.7 20 17.1 23 16.9 31 18.6 19 13.7 
30–34 26 19.8 33 20.4 34 19.2 42 23.6 47 24.1 30 21.3 20 17.1 27 19.9 27 16.2 27 19.4 
35–39 17 13.0 13 8.0 24 13.6 20 11.2 31 15.9 23 16.3 16 13.7 28 20.6 28 16.8 25 18.0 
40 and older 2 1.5 0 0.0 8 4.5 13 7.3 14 7.2 13 9.2 19 16.2 19 14.0 29 17.4 27 19.4 
Total 131 100 162 100 177 100 178 100 195 100 141 100 117 100 136 100 167 100 139 100 
Women 22 16.8 25 15.4 25 14.1 30 16.9 27 13.8 23 16.3 16 13.7 38 27.9 35 21.0 22 15.8 
Men 109 83.2 137 84.6 152 85.9 148 83.1 168 86.2 118 83.7 101 86.3 98 72.1 132 79.0 117 84.2 
abs. = absolute figures 
Source: FMSSG (BMSG, Abt. VI/B/11) 
Table A6: Number of indirect drug-related deaths in Austria by age group and total by gender 
from 1992 to 2001 
Age group 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
 abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % 
19 and younger 2 3.6 1 1.6 7 9.6 2 3.2 0 0.0 2 6.5 1 2.2 3 7.9 6 10.0 1 2.2
20–24 4 7.1 7 10.9 7 9.6 5 7.9 2 5.7 6 19.4 6 13.3 4 10.5 7 11.7 6 13.3
25–29 12 21.4 9 14.1 6 8.2 9 14.3 2 5.7 1 3.2 6 13.3 4 10.5 10 16.7 4 8.9
30–34 21 37.5 23 35.9 31 42.5 20 31.7 7 20.0 3 9.7 6 13.3 12 31.6 8 13.3 11 24.4
35–39 8 14.3 19 29.7 18 24.7 21 33.3 14 40.0 7 22.6 11 24.4 10 26.3 12 20.0 9 20.0
40 and older 9 16.1 5 7.8 4 5.5 6 9.5 10 28.6 12 38.7 15 33.3 5 13.2 17 28.3 14 31.1
Total 56 100 64 100 73 100 63 100 35 100 31 100 45 100 38 100 60 100 45 100
Women 11 19.6 15 23.4 15 20.5 15 23.8 9 25.7 6 19.4 8 17.8 10 26.3 25 41.7 15 33.3
Men 45 80.4 49 76.6 58 79.5 48 76.2 26 74.3 25 80.6 37 82.2 28 73.7 35 58.3 30 66.7
abs. = absolute figures 
Source: FMSSG (BMSG, Abt. VI/B/11) 
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Table A7: Distribution of drug-related deaths in Austria by cause of death and age in 2001 
Age group 
Cause of death 
< 15 15–19 20–24 25–29 30–34 35–39 40–44 45–49 > 49 Total 
One opiate 0 1 2 0 1 2 2 1 2 11 
Several opiates 0 2 0 1 1 1 1 0 0 6 
+ alcohol 0 1 4 0 5 5 1 0 1 17 
+ psychoactive 
medicines 0 6 2 4 6 3 4 1 2 28 
Opiates 
+ alcohol & psychoactive 
medicines 0 1 2 5 7 3 2 0 1 21 
Narcotic drug(s) only 0 3 2 3 0 3 2 1 0 14 
ND + alcohol 0 0 3 1 1 3 0 0 0 8 
ND + psychoactive 
medicines 0 7 2 3 4 1 1 1 0 19 
Opiates 
and 
other 
narcotic 
drugs ND + alcohol & psy-
choactive medicines  0 0 2 1 2 3 1 1 2 12 
Narcotic drug(s) only 0 0 1 0 0 0 0 0 0 1 
ND + alcohol 0 0 0 1 0 0 0 0 0 1 
ND + psychoactive 
medicines 0 0 0 0 0 0 0 0 0 0 
Narcotic 
drugs excl. 
opiates 
ND + alcohol & psy-
choactive medicines 0 0 0 0 0 1 0 0 0 1 
In
to
xi
ca
tio
ns
 
Total/direct drug-related deaths 0 21 20 19 27 25 14 5 8 139 
    of these: men 0 15 16 18 22 22 13 5 6 117 
AIDS 0 0 0 1 1 2 2 4 2 12 
Other diseases 0 0 2 0 5 5 1 4 0 17 
Suicides (no intoxication) 0 1 2 1 4 0 0 0 1 9 
Accidents, homicides  0 0 1 2 1 2 0 0 0 6 
Unknown cause of death 0 0 1 0 0 0 0 0 0 1 
In
di
re
ct
 d
ru
g-
re
la
te
d 
de
at
hs
 
Total/ indirect drug-related deaths 0 1 6 4 11 9 3 8 3 45 
    of these: men 0 1 4 2 7 7 3 5 1 30 
ND = narcotic drug(s) 
Source: FMSSG (BMSG, Abt. VI/B/11) 
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Table A8: Distribution of drug-related deaths in Austria by cause of death and province in 2001 
Province 
Cause of death 
B C LA UP S St T VB V A 
One opiate 0 0 1 0 0 0 1 0 9 11 
Several opiates 0 0 1 0 0 3 0 0 2 5 
+ alcohol 0 1 2 0 1 2 0 0 11 17 
+ psychoactive medi-
cines 0 0 7 2 2 0 5 3 9 28 
Opiates 
+ alcohol psychoactive 
medicines 0 0 0 2 3 3 1 2 11 22 
Narcotic drug(s) only 0 1 3 0 0 0 0 1 9 14 
ND + alcohol 0 0 0 0 0 0 1 1 6 8 
ND + psychoactive 
medicines 0 2 0 2 0 0 7 2 6 19 
Opiates and 
other nar-
cotic drugs 
ND + alcohol & psy-
choactive medicines 0 0 0 2 1 1 1 2 4 11 
Narcotic drug(s) only 0 0 0 0 0 0 0 0 1 1 
ND + alcohol 0 0 0 0 0 0 0 0 1 1 
ND + psychoactive 
medicines 0 0 0 0 0 0 0 0 0 0 
Narcotic 
drugs excl. 
opiates 
ND + alcohol & psy-
choactive medicines  0 1 0 0 0 0 0 0 0 1 
In
to
xi
ca
tio
ns
 
Total/direct drug-related deaths 0 5 14 8 7 9 16 11 69 139 
AIDS 0 2 0 6 0 0 0 1 3 12 
Other diseases 0 0 4 3 0 1 0 1 8 17 
Suicides (no intoxication) 0 1 1 0 0 1 0 3 3 9 
Accidents, homicides  0 0 1 3 0 0 0 1 1 6 
Unknown cause of death 0 0 0 0 0 0 0 0 1 1 In
di
re
ct
 d
ru
g-
re
la
te
d 
de
at
hs
 
 
Total/ indirect drug-related deaths 0 3 6 12 0 2 0 6 16 45 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, St = Styria, T = the Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
Source: FMSSG (BMSG, Abt. VI/B/11) 
Table A9: Development of AIDS cases in Austria by risk situation from 1992 to 2001 
Risk situation 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Homo-bisexual contact 78 91 71 71 59 25 28 26 12 11 
Intravenous drug use 56 60 42 39 25 22 25 27 19 14 
Heterosexual contact 30 31 27 34 21 16 24 31 28 12 
Other cause / unknown 28 54 27 62 34 35 21 16 23 10 
Total 192 236 167 206 139 98 98 100 82 47 
Source: FMSSG (BMSG, Abt. VI/D/2) 
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Table A10: Distribution of reports to the police for violations of the Narcotic Drugs Act/ 
Narcotic Substances Act in Austria by first offenders and repeat offenders and 
development from 1992 to 2001 
Reports 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Total number of reports 7 805 10 915 12 623 13 093 16 196 17 868 17 141 17 597 18 125 21 862 
First offenders 3 616 4 788 5 281 5 521 8 322 9 278 8 672 9 868 9 343 11 033 
Repeat offenders 3 893 5 882 7 117 7 313 7 511 8 325 8 228 7 463 8 296 10 052 
Difference between sum of individual province figures and total figure = unknown offenders 
Since 1998: all reports, not only narcotic drugs but also psychotropic substances 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Source: FMI/Central Office for Combating Drug Crime (BMI - Zentralstelle für die Bekämpfung der Suchtgiftkri-
minalität) 
Table A11: Distribution of reports to the police for violations of the Narcotic Drugs Act/ 
Narcotic Substances Act in Austria by province from 1992 to 2001 
Province 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Burgenland 368 332 343 669 694 759 707 603 843 712 
Carinthia 355 334 524 534 1 280 961 1 076 1 208 1 088 1 758 
Lower Austria 1 055 1 216 1 772 1 655 1 550 2 686 2 519 2 389 2 624 2 975 
Upper Austria 936 992 1 133 1 405 1 941 2 256 2 334 1 946 1 887 2 677 
Salzburg 268 504 436 355 962 855 1 053 840 718 1 471 
Styria 340 458 739 851 1 093 1 125 973 1 367 1 305 1 601 
the Tyrol 842 1 483 1 798 1 382 2 268 2 204 2 212 2 152 2 687 2 449 
Vorarlberg 748 973 888 1 082 1 040 933 1 144 1 848 1 183 1 447 
Vienna 2 893 4 623 4 990 5 160 5 368 6 089 4 606 4 858 5 233 6 212 
Total 7 805 10 915 12 623 13 093 16 196 17 868 16 624 17 211 17 568 21 302 
Difference between sum of individual province figures and total figure = reports not attributable to province 
1998/1999/2000: for the purpose of comparison only reports related to drugs have been considered. 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Source: FMI/Central Office for Combating Drug Crime (BMI - Zentralstelle für die Bekämpfung der Suchtgiftkri-
minalität) 
Table A12: Distribution of reports to the police for violations of the Narcotic Drugs Act/ 
Narcotic Substances Act in Austria by drug type from 1992 to 2001 
Drug type 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Cannabis 5 889 7 913 9 552 9 845 14 456 16 124 16 376 17 236 17 001 19 760
Heroin and opiates 2 803 4 340 4 394 4 386 3 727 3 434 2 850 2 524 2 413 3 802
Cocaine 819 1 267 1 404 1 603 1 912 2 764 2 103 2 608 2 494 3 416
LSD 200 296 234 315 640 893 736 532 477 506
Ecstasy - - 116 496 1 375 1 942 1 411 1 517 2 337 2 940
Amphetamines - - 103 81 342 1 068 - - 1 041 1 215
Psychotropic substances - - - - - - 802 750 780 822
Other drugs 222 226 306 302 430 850 - - - 1 288
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Because of data broken down by type of drug one report to the police may have been listed under several headings, therefore 
the figures differ from the total number of reports. 
Source: FMI/Central Office for Combating Drug Crime (BMI -Zentralstelle für die Bekämpfung der Suchtgiftkri-
minalität) 
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Table A13: Distribution of reports to the police for violations of the Narcotic Substances Act in Austria 
by drug type and province in 2001 
Drug type B C LA UA S ST T VB V Total 
Cannabis 954 2 222 3 003 2 927 1 399 1 979 2 709 1 495 3 072 19 760 
Heroin and opiates 21 34 486 138 310 298 154 149 2 212 3 802 
Cocaine 25 98 378 275 189 198 221 220 1 812 3 416 
LSD 34 26 136 158 20 54 21 46 11 506 
Ecstasy 72 384 521 648 245 335 293 226 216 2 940 
Amphetamines 49 43 335 319 88 199 13 56 113 1 215 
Psychotropic substances 2 28 51 25 20 17 65 11 603 822 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, ST = Styria, T = the Tyrol, VB = Vorarlberg, 
V = Vienna 
Note: Because of data broken down by type of drug one report to the police may have been listed under several headings, therefore 
the figures differ from the total number of reports. 
Source: FMI/Central Office for Combating Drug Crime (BMI – Zentralstelle für die Bekämpfung der Suchtgiftkri-
minalität) 
Table A14: Convictions under the Narcotic Drugs Act/Narcotic Substances Act and total number of 
convictions in Austria from 1992 to 2001 
Year Total number of convictions Convictions under Convictions under Convictions in Austria 
 under the NDA/NSA Art. 12 NDA/ 
Art. 28 NSA 
Art. 16 NDA/ 
Art. 27 NSA 
Total number Under the NDA/NSA
(percentages) 
1992 1 720 617 1 074 74 419 2.3 
1993 2 683 952 1 700 74 937 3.6 
1994 3 275 1 230 2 010 69 458 4.7 
1995 3 261 1 124 2 102 69 779 4.7 
1996 3 454 1 027 2 382 66 980 5.2 
1997 3 797 1 036 2 717 65 040 5.8 
1998 3 327 1 041 2 207 63 864 5.2 
1999 3 359 1 022 2 230 61 954 5.4 
2000 3 240 933 2 245 41 624 7.8 
2001 3 862 1 141 2 671 38 763 10.0 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
Note: These figures only refer to the leading offence, i.e. the offence with the highest range of punishment, so not all convictions un-
der the NDA, or the NSA, respectively, are covered.  
Source: Statistics Austria (Criminal Court Statistics) 
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Table A15: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act in Austria by age, 
gender and reason for conviction in 2001  
Reason for conviction  14–19 years 20–24 years 25–29 years 30–34 years > 35 years Total 
NDA/NSA total men 798 1 118 569 361 531 3 377 
 women 117 159 85 42 82 485 
Art. 12 NDA / Art. 28 NSA men 165 284 206 126 220 1.001 
 women 18 43 31 15 33 140 
Art. 16 NDA / Art. 27 NSA men 633 831 359 230 285 2 338 
 women 98 114 53 26 42 333 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
Note: These figures only refer to the leading offence, i.e. the offence with the highest range of punishment, so not all convictions un-
der the NDA, or the NSA, respectively, are covered.  
Source: Statistics Austria (Criminal Court Statistics) 
Table A16: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act, according to 
youths and adults, reason for conviction and form of punishment in 2001  
Reason for conviction  Fine Prison sentence 
 
Other 
punishment1 
Total 
   Probation No probation Partial probation   
NDA/NSA total young people 181 196 52 82 177 688 
 adults 1 091 864 829 358 32 3 174 
Art. 12 NDA / Art. 28 NSA  young people 5 39 34 46 0 124 
(felonies) adults 20 199 565 230 3 1 017 
Art. 16 NDA / Art. 27 NSA  young people 176 157 18 36 176 563 
(misdemeanours) adults 1 062 644 252 122 28 2 108 
Young people = persons younger than 19 at the time of the offence 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
1 Other punishment: partial probation (Art. 43 A (2) CC), referrals to institutions (Arts. 21 (1), 21 (2), 22 and 23 CC), no additional 
punishment (Art. 40 CC) and, though only in the case of young people, conviction with punishment reserved 
(Art. 13 JCA) and conviction without punishment (Art. 12 JCA) 
Note: These figures only refer to the leading offence, i.e. the offence with the highest range of punishment, so not all convictions 
under the NDA, or the NSA, respectively, are covered. 
Source: Statistics Austria (Criminal Court Statistics) 
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Table A17: Development of application of alternatives to punishment in Austria from 1994 to 2001 
Withdrawal of report/  
dismissal of proceedings 
1994 1995 1996 1997 1998 1999 2000 2001 
Total 3 446 4 395 5 248 5 817 7 468 7 030 8 098 12 088 
Art. 35 NSA (withdrawal of report) - - - - 6 699 6 360 7 088 11 190 
of these: Art. 35 (4) NSA (cannabis) - - - - 1 432 1 355 1 411 2 248 
Art. 37 NSA (dismissal of proceedings) - - - - 769 670 1 010 898 
Art. 35 NSA = temporary withdrawal of the report to the police by the public prosecutor 
Art. 35 (4) NSA = temporary withdrawal of the report to the police in the case of small quantities of cannabis for personal use 
Art. 37 NSA = temporary dismissal of proceedings by the court 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. A specification of the kind of 
alternative to punishment can be given for the period since 1998 only. Data on Art. 39 of the NSA (suspension of prison 
sentence – therapy instead of punishment) is not available at present. 
Source: FMSSG (BMSG, Abt. VI/B/11) 
Table A18: Number of seizures of narcotic drugs/substances in Austria from 1992 to 2001 
Narcotic drugs/substances 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Cannabis 2 334 2 953 3 510 3 757 4 838 4 957 4 683 5 079 4 833 5 249 
Heroin 859 1 289 1 225 1 298 1 110 861 654 452 478 895 
Cocaine 235 332 376 421 525 651 531 519 554 768 
Amphetamines 14 26 103 43 136 221 - - 141 161 
LSD 51 58 50 80 102 113 61 56 42 32 
Ecstasy - - 51 153 254 253 135 215 330 352 
Psychotropic substances - - - - - - 14 74 65 1 
Psychotropic medicines - - - - - - 521 517 501 566 
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, including since then also psychotro-
pic substances.  
Source: FMI/Central Office for Combating Drug Crime (BMI -Zentralstelle für die Bekämpfung der Suchtgiftkri-
minalität) 
Table A19: Seizures of narcotic drugs/substances in Austria by quantity from 1992 to 2001 
Narcotic drugs/substances 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Cannabis (kg) 248 546 394 697 517 912 1 336 451 1 806 456
Heroin (kg) 78.2 104.8 80.2 47.0 81.3 102 118 78 230 288
Cocaine (kg) 58.1 83.9 52.6 55.3 72.7 87 99 63 20 108
Amphetamines (kg) 0.4 0.3 0.7 1.6 3.7 7.9 - - 1 3
LSD (trips) 3 847 28 201 1 543 2 602 4 166 5 243 2 494 2 811 865 572
Ecstasy (doses) - - 3 003 31 338 25 118 23 522 114 677 31 129 162 093 256 299
Psychotropic substances (kg) - - - - - - 0.128 4.004 1.294 0.002
Psychotropic medicines (units) - - - - - - 82 018 36 437 38 507 31 377
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, including since then also psychotro-
pic substances. 
Source: FMI/Central Office for Combating Drug Crime (BMI - Zentralstelle für die Bekämpfung der Suchtgiftkri-
minalität) 
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Table A20: Ingredients of samples bought as ecstasy and analysed by the ChEck iT! project at rave 
parties, from 1997 to 2001  
Samples bought as ecstasy 
(percentages) Ingredients 
1997 
(n = 104) 
1998 
(n = 209) 
1999 
(n = 155) 
2000 
(n = 329) 
2001 
(n = 281) 
MDMA 33.65 32.54 84.52 82.37 75.80 
MDMA + MDE 2.88 0.00 0.00 3.04 2.14 
MDMA + MDA 0.96 0.96 0.00 0.91 1.42 
MDE and/or MDA 4.81 4.31 0.65 2.13 9.96 
MDMA + caffeine 0.00 0.96 1.29 1.22 0.00 
MDMA + amphetamines 0.96 0.96 0.65 0.61 0.36 
MDMA + various combinations* 25.96 2.87 4.52 2.13 0.36 
PMA/PMMA 0.00 0.00 0.00 1.52 0.36 
Amphetamines 1.92 9.09 4.52 1.52 0.36 
Metamphetamine 1.92 0.96 0.00 0.61 3.20 
Caffeine 0.96 3.35 0.00 0.91 0.00 
Quinine/quinidine 3.85 5.74 0.00 0.91 1.07 
Various combinations* 22.12 38.28 3.87 2.13 4.98 
* Various combinations: Combinations of more than two amphetamine derivatives and/or other substances and/or unknown sub-
stances  
Source: CheckiT! 2002e, calculations by ÖBIG  
Table A21: Ingredients of samples bought as speed and analysed by the ChEck iT! project at rave 
parties, from 1997 to 2001  
Samples bought as speed 
(percentages) Ingredients 
1997 
(n = 24) 
1998 
(n = 56) 
1999 
(n = 68) 
2000 
(n = 92) 
2001 
(n = 52) 
Amphetamines 4.17 84.21 55.88 58.70 57.69 
Amphetamines + caffeine 0.00 3.57 5.88 6.52 9.62 
Amphetamines + metamphetamine 0.00 0.00 1.47 0.00 0.00 
Amphetamines + various combinations* 33.33 8.93 10.29 8.70 5.77 
Metamphetamine 0.00 0.00 7.35 3.26 3.85 
Caffeine 0.00 5.36 0.00 3.26 7.69 
MDMA 0.00 1.79 4.41 3.26 0.00 
Ephedrine total 37.50 3.57 7.35 0.00 1.92 
Various combinations* 25.00 28.57 7.35 16.30 13.46 
* Various combinations: Combinations of more than two amphetamine derivatives and/or other substances and/or unknown sub-
stances  
Source: CheckiT! 2002e, calculations by ÖBIG  
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Table A22: Number of persons currently registered for substitution treatment in Austria by first 
treatment/continued treatment and province in 2001 
Treatment B C LA UA S St T VB V A* 
Continued treatments 23 80 375 311 278 182 207 370 2 810 4 650 
First treatments 3 19 129 40 37 75 6 53 351 714 
Total 26 99 504 351 315 257 213 423 3 161 5 364 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, ST = Styria, T = the Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
Note: Continued treatments are treatments started before the respective year or repeated treatments of persons having undergone 
substitution treatment before. First treatments are treatments of persons who have never been undergoing substitution treat-
ment before.  
* The total number of substitution treatments in Austria is higher than the sum of the substitution treatments by province since re-
cords of the provinces are incomplete in some cases.  
Source: FMSSG (BMSG/Abt. VI/B/11, calculations by ÖBIG) 
 
 
Table A23: Prevention programmes in schools 
Name Target groups Implementa-
tion by  
Number of 
teachers 
involved 
Related to 
family inter-
vention  
Related to 
school 
policy 
Regions covered Number of 
schools 
involved 
Number of 
students 
reached 
Number of 
teachers 
involved 
Number of 
families in-
volved 
Evaluation 
Students (13-21 years) Experts 30 No No 9 regions in Styria and the city of Graz 42 1 317 104 -  
Outcome incl. 
control Step by Step 
crisis intervention 
Teachers Experts 150 Yes Yes Lower Austria 90   150 -  Outcome incl. control 
Addiction prevention 
workshops in schools 
Students (10-18 years), 
teachers, parents  Experts 53 Yes Yes Lower Austria 18 1 250 53 360 
Outcome 
without control 
It’s Victoria’s Birthday Students (6-10 years),teachers, parents Experts 400 Yes No Lower Austria 70 6 100 400 220 
Evaluated pre-
viously 
Sankt Pölten project Students (10-14 years), teachers, parents Experts 40 Yes Yes 
District of St. Pölten
(Lower Austria) 15 600 40 200 
Evaluated pre-
viously 
Station model Students (10-18 years),teachers, parents Experts 350 Yes Yes Lower Austria 70 1 750 70 800 Other type 
Addiction prevention - 
further training for  
teachers 
Teachers Experts, educators 240 No Yes Lower Austria 110   240 -  Other type 
Becoming Independent Students (6-10 years) Teachers, educators 1 Yes Yes Vienna 23 700+ 50 0 
Outcome 
without control 
Living Together Students (10-19 years) Teachers, educators 2 Yes Yes Vienna 13 1 500 80 0 Other type 
- = not available 
Note: The survey of school programmes has been carried out for the first time. The projects presented here reflect the return rate and do not give a complete picture of prevention programmes at schools 
in Austria. 
Source: summarised by ÖBIG, spring/summer 2002 
 
 
Table A24: Prevention programmes in early childhood, 2001 
Name Target groups Related to family 
intervention 
Regions covered Number of kinder-
gartens involved 
Number of chil-
dren reached 
Number of teachers 
involved 
Number of ac-
tively partici-
pating family 
members  
Evaluation 
Weeping, raging, laugh-
ing 
Kindergarten teach-
ers No Lower Austria 42 840 42 - 
Outcome evaluation 
incl. control 
Drug prevention at pre-
school age 
Children (up to 6 
years), teachers, 
parents 
Yes City of Graz, district capitals in Styria - - - - 
Outcome evaluation 
incl. control 
Toy-Free Kindergarten Children (4-6 years),teachers, parents Yes 
Weidling 
(Lower Austria) 1 74 5 65 Other type 
- = not available 
Note: The survey of prevention projects in early childhood has been carried out for the first time. The projects presented here reflect the return rate and do not give a complete picture of interventions re-
lated to early childhood prevention projects in Austria. 
Source: summarised by ÖBIG, spring/summer 2002 
Table A25: Outreach work, 2001 
Name Target groups Staff Number of 
trained 
streetworkers 
Total num-
ber of staff
Total number of
contacts/year 
Number of 
clients 
reached 
Number of 
condoms dis-
tributed 
Evaluation 
Streetwork Graz Potential drug users Social workers 4 4 5 500 250 approx. 1 500 Monitoring and documentation 
Streetwork Vienna Problem drug users, young people at risk - 13 15 70 000 - - 
Monitoring and 
documentation 
H.I.O.B. (low-threshold counsel-
ling facility for drug addicts), 
Vorarlberg 
Others Social workers, legal expert 5 6 
approx. 100 
regular clients,
approx. 250 one-
time contacts
approx. 350 approx.  8 900 Monitoring and documentation 
MOJA (mobile youth work in the 
district of Mödling, Lower Aus-
tria) 
Young people at risk Social workers, psychologist, education expert 5 5 887 80 approx.  200 No evaluation 
ChEckiT! (Vienna) Sparetime drug users (esp. the techno scene) 
Social workers, psycholo-
gists, chemistry expert 10 20 756 approx. 1 800 approx.  6 000 
Monitoring and 
documentation 
- = not available 
Note: The survey of outreach programmes has been carried out for the first time. The projects presented here reflect the return rate and do not give a complete picture of outreach programmes in 
Austria.  
Source: summarised by ÖBIG, spring/summer 2002 
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Table A26: Assistance to drug users in prison in 2001 
Intervention Activities Number of prisons  
participating 
Notes 
Detoxification/withdrawal 29 In all prisons, carried out by doc-
tors 
Drug-free zones 6  
Abstinence-oriented treat-
ment 
Therapy departments in the prison 8  
Substitution treatment 
 
 Must be provided in all 
prisons; specific forms in 4 
prisons 
Only methadone so far; recently 
a pilot project with other sub-
stances has started 
Blood testing 29 Wherever needed 
Vaccination programmes 29 Wherever needed 
Supply of disinfectants 29 Wherever needed 
Syringe exchange 0  
Prevention 
Supply of condoms 29 Obligatory at admission exami-
nation  
Preparation for release 29  
Counselling for relatives 29  
Continuing counselling 6–10  
Therapy communities outside prison 15  
Cooperative relationships 
Cooperation with public health-care 
system 
In some prisons As a rule a task of the prison 
doctors 
1 Total number of prisons in Austria: 29 
Source: FMJ (BMJ) 2002 
Table A27: Revenues of facilities by financial source, 1999 and 2001 
Financed by Revenues 
1999 (EUR) 
Revenues 
1999 (%) 
Revenues 
2001 (EUR) 
Revenues 
2001 (%) 
FMSSG 1 302.7 7.9 1 226.8 6.4 
Other ministries 1 801.7 11.0 1 699.9 8.8 
Provincial governments 7 643.7 46.6 8 833.4 45.8 
Local governments 198.0 1.2 563.2 2.9 
Social insurance funds 2 060.7 12.6 2 273.3 11.8 
Hospital Fund 2 365.5 14.4 2 441.9 12.7 
Public Employment Service 385.6 2.3 550.8 2.8 
Other sources 652.1 4.0 1 701.5 8.8 
Total (EUR 1 000 ) 16 409.9 100.0 19 291.2 100.0 
 
1  The Hospital Fund comprises the individual Provincial Hospital Financing Funds 
Sample: The FMSSG sent the questionnaire to all prevention centres and drug help facilities that obtain annual funding by the 
FMSSG according to Art. 16 of the NSA (cf. Chapter 14.2). 30 out of a total number of 39 organisations took part in the sur-
vey. As a few facilities also communicated data from drug-help centres not funded by the FMSSG, information from a total 
number of 33 drug-help facilities have been available. Two facilities only communicated data for 2001, so the figures for 
1999 were calculated on the basis of the average figures of the other facilities, taking into account their specific areas of ac-
tivity and financing source. 
Source: calculations by ÖBIG, spring/summer 2002 
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Table A28: Total expenditures for drug-related demand reduction in Austria by financial source in 1999 
and 2001 
Area 1999 (EUR) Percentage 2001 (EUR) Percentage 
Federal government 10 367.5 19.8 8 628.4 12.9 
Provincial governments 17 897.5 34.2 28 657.7 42.9 
Local governments1 1 103.9 2.1 1 182.5 1.8 
Health insurance funds 10 004.6 19.1 14 134.3 21.2 
Public Employment Service 3 121.0 6.0 3 625.6 5.4 
Healthy Austria Fund 301.1 0.6 196.9 0.3 
Expenditures not attributable 9 517.7 18.2 10 330.6 15.5 
Total expenditures (EUR) 52 313.3 100 66 756.0 100 
1 Expenditures by the City of Vienna (= both a provincial and a local government) have been accounted for under provincial expendi-
tures only.  
2 Expenditures for inpatient treatments in hospitals that could not be attributed to a certain area. 
Note: For calculating total expenditures the results of extrapolations and not the data collected were used. For details concerning 
sample, return rate and extrapolation see Chapter 14.3. 
Source: calculations by ÖBIG, spring/summer 2002 
Table A29: Austrian population aged 12 to under 18 years by age and gender, in 2002 
Age (completed years) Male Female Total 
12 years 48 093 45 508 93 601 
13 years 47 928 45 644 93 572 
14 years 48 181 45 895 94 076 
15 years 48 337 46 141 94 478 
16 years 48 552 46 439 94 991 
17 years 49 561 47 534 97 095 
Total 290 652 277 161 567 813 
 
Source: Statistics Austria (Statistik Österreich), calculations by ÖBIG 
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Table A30: Austrian population statistics by age group and gender in 2001 
Age group Men Women Total 
  0 to less than 5 years 210 622 200 461 411 083 
  5 to less than 10 years 241 140 229 626 470 766 
10 to less than 15 years 243 590 231 698 475 288 
15 to less than 20 years 248 449 237 621 486 070 
20 to less than 25 years 241 724 234 141 475 865 
25 to less than 30 years 270 043 272 488 542 531 
30 to less than 35 years 339 365 332 601 671 966 
35 to less than 40 years 360 865 347 308 708 173 
40 to less than 45 years 317 958 310 514 628 472 
45 to less than 50 years 263 243 264 180 527 423 
50 to less than 55 years 257 214 259 476 516 690 
55 to less than 60 years 221 873 232 185 454 058 
60 to less than 65 years 217 938 234 424 452 362 
65 to less than 70 years 153 282 180 056 333 338 
70 to less than 75 years 140 486 187 492 327 978 
75 to less than 80 years 98 167 192 639 290 806 
80 to less than 85 years 45 918 105 717 151 635 
85 and older 35 367 105 594 140 961 
Total 3 907 244 4 158 221 8 065 465 
  0 to less than 15 years 695 352 661 785 1 357 137 
15 to less than 30 years 760 216 744 250 1 504 466 
30 to less than 45 years 1 018 188 990 423 2 008 611 
45 to less than 60 years 742 330 755 841 1 498 171 
60 to less than 75 years 511 706 601 972 1 113 678 
75 and older 179 452 403 950 583 402 
Total 3 907 244 4 158 221 8 065 465 
 
Source: Statistics Austria (Statistik Österreich), calculations by ÖBIG
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2-CB 4-bromo-2,5-dimethoxyphenethylamine 
AMS Public Employment Service 
API Anton Proksch Institute 
ATS Austrian schillings 
EDDRA Exchange on Drug Demand Reduction Action 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
ESSPROS European System of Integrated Social Protection Statistics 
EU European Union 
FMAFEW Federal Ministry of Agriculture, Forestry, Environment and Water Management 
(BMLFUW) 
FMD Federal Ministry of Defence (BMLV) 
FMESC Federal Ministry of Education, Science and Culture (BMBWK) 
FMF Federal Ministry of Finance (BMF) 
FMFA Federal Ministry for Foreign Affairs (BMA) 
FMI Federal Ministry of the Interior (BMI) 
FMJ Federal Ministry of Justice (BMJ) 
FMSSG Federal Ministry for Social Security and Generations (BMSG) 
FMTIT Federal Ministry for Transport, Innovation and Technology (BMVIT) 
FPÖ Austrian Freedom Party 
GHB gamma-hydroxydbutyric acid 
HAF Healthy Austria Fund (FGÖ) 
HBSC Health Behaviour in School-Aged Children 
IFES Institute for Empirical Research 
ILO International Labour Organisation 
INCB International Narcotics Control Board 
ISP Addiction Prevention Institute 
MDA 3,4-methylenedioxyamphetamine 
MDE 3,4-methylenedioxy-N-ethylamphetamine 
MDMA methylen-dioxy-methyl-amphetamine 
NDA Narcotic Drugs Act 
NFP National Focal Point 
NSA Narcotic Substances Act 
ÖBIG Austrian Health Institute 
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PMA paramethoxyamphetamine 
PMMA paramethoxymethylamphetamine 
REITOX European Information Network on Drugs and Drug Addiction 
(Réseau Européen d’Information sur les Drogues et les Toxicomanies) 
VSF Vienna Social Fund (FSW) 
VWS Vienna Social Projects Association 
 
